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ABSTRACT 
 
 
Relative Toxicity of Select Dehydropyrrolizidine Alkaloids and Evaluation of a 
Heterozygous P53 Knockout Mouse Model for Dehydropyrrolizidine Alkaloid Induced 
Carcinogenesis 
 
by 
 
 
Ammon W. Brown, Doctor of Philosophy 
 
Utah State University, 2015 
 
 
Major Professor:  Jeffery O. Hall 
Program:  Toxicology 
 
Dehydropyrrolizidine alkaloids (DHPAs) are a large group of globally important 
plant-derived pro-toxins that can contaminate or are naturally present in animal feed and 
the human food supply as well as herbal supplements.  Their bioactive metabolites are 
potentially hepatotoxic, pneumotoxic, genotoxic and carcinogenic.  Due to the difficulty 
in obtaining sufficient quantities of purified DHPAs, toxicity studies have largely relied 
on single intraperitoneal injections in rodent models, and carcinogenicity studies have 
been limited to a small handful of the hundreds of isolated DHPAs.  To assess the relative 
toxicity of structurally diverse DHPAs in a more biologically relevant manner, male 
California White chicks were dosed orally with 0.01, 0.04, 0.13, or 0.26 mmol of seven 
different DHPAs and three DHPA N-oxides kg
-1
 bodyweight for 7 days.  DHPAs were 
grouped in relation to their toxicity based on clinical, serum biochemical, and 
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histopathological evaluations as well as tissue adduct accumulation rates.  Using the same 
model, a reduced extract from comfrey, a commonly used DHPA containing herb, was 
compared to its two major constituent DHPAs, intermedine and lycopsamine.  Based on 
the same parameters, the comfrey extract was more toxic than pure lycopsamine or 
intermedine.  Addressing the need for a more sensitive carcinogenicity model, male 
heterozygous p53 knockout mice were treated with riddelliine 5, 15 or 45 mg kg
–1
 
bodyweight day
–1
 by oral gavage for 14 days, or given a long-term treatment of 
riddelliine 1 mg kg
–1
 bodyweight day
–1
 in pelleted feed for 12 months. Exposure to 
riddelliine increased the odds of tumor development in a dose-responsive manner (odds 
ratio 2.05 and Wald 95% confidence limits between 1.2 and 3.4). The most common 
neoplasm was hepatic hemangiosarcoma, which is consistent with previously published 
lifetime rodent studies.  
 The results of this research demonstrate that the California White chick model is 
sensitive for comparison of DHPA toxicity, and data obtained from this research can be 
used to validate previous DHPA toxicity research.  It also demonstrates that comfrey 
toxicity may have been previously underestimated. The heterozygous p53 knockout 
mouse model is beneficial for further investigation of comparative carcinogenesis of 
structurally and toxicologically different DHPAs and their N-oxides.   
(220 pages)  
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PUBLIC ABSTRACT 
 
 
Relative Toxicity of Select Dehydropyrrolizidine Alkaloids and Evaluation of a 
Heterozygous P53 Knockout Mouse Model for Dehydropyrrolizidine Alkaloid Induced 
Carcinogenesis 
 
Ammon W. Brown 
 
 
Dehydropyrrolizidine alkaloids (DHPAs) are toxins produced by approximately 3% 
of the world’s flowering plants that can be present naturally or as contaminants in animal 
feed and the human food supply.  Many of these compounds have been determined to 
cause cancer in animals and probably also cause cancer in humans.  Due to the difficulty 
in obtaining sufficient amounts of pure DHPAs most toxicity research has been done via 
injection of a small amount into the abdomen of a rodent, although natural exposure is 
exclusively oral. For the same reason, cancer research is limited to a handful of the 
hundreds of known DHPAs.  The present study evaluated more sensitive animal models 
for both toxicity and cancer research.  Toxicity of 10 different DHPA compounds was 
tested using male, California White chicks.  Through the evaluation of blood tests, tissue 
tests, and microscopic analysis of organs, the selected DHPAs were grouped according to 
toxicity.  In this model, some compounds such as heliotrine were found to be more toxic 
than expected based on previous research.  Using this same chick model, an extract from 
comfrey, a commonly used herb, was found to be more toxic than either of the two major 
DHPAs that it contains.  Because plants often contain multiple DHPAs, this suggests that 
the toxicity of plants, such as comfrey, may be higher than previously estimated.  A 
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mouse strain that is genetically susceptible to cancer (heterozygous p53 knockout) was 
tested and compared to previous studies using the same carcinogenic DHPA (riddelliine).  
The most common type of cancer was hemangiosarcoma (cancer of blood vessels) of the 
liver.  These results were similar to previous studies using substantially less pure DHPA, 
indicating the benefit of this model to test the cancer causing potential of other DHPAs.  
Additionally, it was also determined that exposure to DHPAs for only two weeks 
(compared to years) also increased the odds of developing cancer. 
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CHAPTER I 
 
 
Introduction 
 
 
Pyrrolizidine alkaloids are a group of chemical compounds composed of two five- 
membered rings, which share a nitrogen at the four position.  They are produced by a 
wide variety of plants and have presumably evolved to protect the plants from herbivory.  
It has been estimated that pyrrolizidine alkaloid containing plant species make up 
approximately 3% of the world’s flowering plants (Smith and Culvenor 1981).  A subset 
of pyrrolizidine alkaloids that contain a critical double bond between C1 and C2 are 
potentially toxic.  This group of potentially toxic dehydropyrrolizidine alkaloids 
(DHPAs) consists of approximately 500 structural variants of the monoesters, open chain 
diesters or macrocyclic diesters of the necine bases retronecine, heliotridine and 
otonecine (Wiedenfeld, et al. 2008). The DHPAs and their co-occurring (usually the 
major components) N-oxides are pro-toxins requiring activation in vivo by the 
cytochrome P450 monooxygenases that results in hepatotoxicity (Campbell 1956, Gilruth 
1904, Johnson, et al. 1985, Vardiman 1952), pneumotoxicity (Stalker and Hayes 2007) 
genotoxicity (Mei, et al. 2004, Mei, et al. 2005, Mei and Chen 2007), and carcinogenicity 
(Allen, et al. 1975, Schoental 1975, Schoental and Cavanagh 1972, Schoental, et al. 
1970, Shumaker, et al. 1976, Yuzo, et al. 1977).   
DHPAs are likely the most common poisonous plant problem worldwide 
(Stegelmeier, et al. 1999).  Animal exposure to DHPAs results in direct loss to cattle, 
swine, horse and poultry producers in the form of animal deaths and reduced 
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productivity.  Outbreaks in Africa and Middle Eastern countries have resulted in 
thousands of human deaths (Chauvin, et al. 1994; Mayer and Lüthy 1993; Mohabbat, et 
al. 1976; Tandon, et al. 1976; Tandon, et al. 1978) not to mention non-lethal effects.   
As a result of the health hazards posed by DHPAs, health organizations and food 
and drug safety agencies in several countries have developed regulations and 
recommendations regarding the sale and use of DHPAs.  The US Food and Drug 
Administration sent an advisory letter in 2001 to manufacturers of dietary supplements 
requesting that they remove all comfrey products intended for consumption from the 
market (FDA 2001).  In 2008, the UK Committee on Toxicity of Chemicals in Food, 
Consumer Products and the Environment released a statement on DHPAs in food, 
limiting daily oral exposures to less than 0.007 μg DHPAs kg-1 bodyweight BW 
(Committee on Toxicity of Chemicals in Food 2008).  In Germany, the Federal Institute 
for Risk Assessment (BfR) conducted a risk assessment for DHPAs and concluded that 
exposure should be kept as low as possible while also limiting tolerable daily intake to 
0.007 μg of unsaturated pyrrolizidine alkaloids kg-1 (BW) (BfR 2011).  The European 
Food Safety Authority, World Health Organization, and Dutch National Institute for 
Public Health and the Environment have all conducted similar reviews with similar 
concerns and recommendations (EFSA 2011; RIVM 2005; WHO 2011).  The Food 
Standards Australia New Zealand authority, basing their recommendation solely on 
hepatotoxicity as opposed to potential carcinogenicity, recommends a somewhat higher 
tolerable exposure of 1 μg DHPAs kg-1 BW per day (FSANZ 2001). 
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A potential relationship to common chronic human diseases has been postulated 
(Edgar, et al. 2014; Gyorik and Stricker 2009), which if substantiated would undoubtedly 
lead to further regulatory constraints and requirements for testing a wide variety of 
products.  Indirect human exposure from sources such as meat, milk, honey and pollen 
(BfR 2011; Committee on Toxicity of Chemicals in Food 2008; FSANZ 2001; WHO 
2011) are likely and the ability of the associated industries to control this exposure is 
limited. 
Not only are DHPAs toxic, they have also been found to be carcinogenic in multiple 
animal species.  One DHPA, riddelliine, has been listed as reasonably anticipated to be a 
human carcinogen by the National Toxicology Program (NTP 2011), and two DHPAs 
(riddelliine and lasiocarpine) have been listed by the International Agency for Research 
on Cancer (IARC) as class 2b carcinogens (IARC 1987; 2002).  More research is needed 
to determine if these two are human carcinogens as well as the relative potential for 
carcinogenicity of other DHPAs. 
The mechanisms for toxicity and carcinogenicity of DHPAs are thought to be the 
same.  DHPAs are bioactivated by cytochrome P450 enzymes primarily in the liver to 
reactive intermediates.  These reactive metabolites have the ability to bind with protein 
and DNA, and form cross-links (Coulombe, et al. 1999; Hincks, et al. 1991; Kim, et al. 
1995; Petry, et al. 1984).  Because of the common mechanism, The Committee on 
Toxicity of Chemicals in Food, Consumer Products and the Environment (COT) 
recommends using LD50 riddelliine equivalents to extrapolate carcinogenicity risks  
(Committee on Toxicity of Chemicals in Food 2008). 
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Plants containing DHPAs although common (to the extent that in some cases they 
invade pastures, fields, and ranges becoming the dominant species), do not tend to grow 
in large monocultures that allow for mechanical harvesting, rather they tend to be 
scattered among other plants.  The highest concentration of DHPA is often found in the 
roots of the plants making it labor intensive to harvest large quantities.  Furthermore, 
most DHPA containing plants have a number of different DHPAs along with their N-
oxides and other derivatives, thus making it necessary to separate very similar 
compounds in order to determine the impact of individual DHPAs. 
As a result of the cost in time, resources and money to obtain sufficiently large 
quantities of DHPA to perform studies, the vast majority of toxicity studies have been 
done using intraperitoneal (IP) injections rather than oral exposure.  Such studies avoid 
loss of valuable DHPA due to incomplete absorption.  Natural exposure however, is 
almost exclusively oral. Because of the inherent differences that result from route of 
exposure, it is necessary to compare the large bank of information derived via IP 
exposure in a more biologically relevant model.   
Where oral exposure studies do exist, they are usually done with plants rather than a 
single DHPA, and therefore contain a mixture of DHPAs.  The results of these studies 
often do not correlate well with the IP exposure studies.  For example, based on IP 
exposure studies, the anticipated toxicity of Senecio douglasii var. longilobus would be 
substantially higher than that of Cynoglossum officinale because the Senecio species 
contain primarily macrocyclic diesters and Cynoglossum officinale contains a mixture of 
monoesters and open chain diesters.  If comparisons are made using oral exposure studies 
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however, the two plants are very similar in toxicity (Stegelmeier, et al. 1996, Baker, et al. 
1989, Johnson and Molyneux 1984). 
A model must meet a number of minimum requirements to be biologically relevant.  
First, it must be able to be repeatedly exposed orally, and with minimal risk to the 
animals as well as researchers.  It must be a sensitive species that requires the least 
amount of purified alkaloid possible to detect a toxic effect.  Ideally a good model is also 
small enough that it does not require large amounts of laboratory space and specialized 
facilities. 
A number of studies have compared the relative susceptibilities of various species 
to DHPAs (Bull, et al. 1968, Cheeke 1998, Culvenor, et al. 1976, Mattocks 1972).  The 
most sensitive domestic species appears to be swine (Hooper 1978) followed by 
chickens.  Young animals have been found to be more sensitive than adults, and in many 
species males have been shown to be more sensitive than females (Mattocks 1986).  Due 
to the large size difference between poultry and swine, the total amount of DHPA 
required to produce a toxic effect in chickens is far less than that required for swine.  
Furthermore, due to ease of restraint and differences in behavior, oral dosing of chicks is 
much easier and less traumatic than oral dosing of piglets. 
In order to compare results of previous studies to this more biologically relevant 
model, it is necessary to compare the toxicity of multiple different chemical structures of 
DHPAs, preferably different bases as well as different R group structures. 
Carcinogenicity studies require chronic exposure, and consequently larger 
quantities of DHPA.  In order to study the relative carcinogenicity of DHPAs a more 
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sensitive model requiring less purified alkaloid is necessary.  The last phase of this 
research will therefore focus on development of a small animal model that will require 
less of the pure alkaloid, less time, and hence less funding to test the carcinogenic 
potential of DHPAs in a manner relevant to natural exposure in both humans and 
animals.   
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CHAPTER II 
 
PYRROLIZIDINE ALKALOID LITERATURE REVIEW  
 
 
Introduction 
 
 
Pyrrolizidine alkaloids are a large group of plant-derived pro-toxins.  To date, more 
than 500 pyrrolizidine alkaloids have been structurally identified. Combined with their N-
oxides, there are more than 950 different compounds (Wiedenfeld, Roeder et al. 2008).  
Plant sources of these pro-toxins can be found around the globe.  Pyrrolizidine alkaloid-
containing plant species make up an estimated 3% of the world’s flowering plants (Smith 
and Culvenor 1981).  Not all pyrrolizidine alkaloids are potentially toxic.  Pyrrolizidine 
alkaloids which consist of a saturated ring structure lack the necessary double bond that is 
required for them to exert their toxic effects.  In this review, only the 
dehydropyrrolizidine alkaloids (DHPAs) that contain the double bond that allows them to 
be bioactivated will be discussed.  This review will focus on sources, chemistry, 
toxicology, factors influencing toxicology, as well as human exposure and disease.   
 
Sources 
 
 
The original sources of all DHPAs are plants, and as a result this section will focus 
primarily on those plants known to produce hepatotoxic DHPAs.  There are however, 
secondary sources of exposure to DHPAs such as honey, pollen, and milk that will be 
discussed more thoroughly later.   
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Plants containing DHPAs are primarily from three plant families (Compositae, 
Leguminosae, and Boragnaceae) (Smith and Culvenor 1981, Stegelmeier, Edgar et al. 
1999).  The most common plant genera involved in domestic animal poisonings include:  
Amsinkia, Crotalaria, Cynoglossum, Heliotropium, Senecio, and Trichodesma (Stalker 
and Hayes 2007).  DHPA containing plants typically have a mixture of different DHPAs, 
and concentrations of individual DHPAs between plants can vary significantly 
(Stegelmeier, Edgar et al. 1999). 
 
Pyrrolizidine Alkaloid Containing Plants 
 
Senecio spp.   
 
Of the more than 3000 species of Senecio located throughout the world many 
contain toxic DHPAs (Stegelmeier, et al. 1999).  More than 30 of these have been linked 
to livestock and human poisonings (Johnson, et al. 1989; Mattocks 1986; Stegelmeier, et 
al. 1999).  In the western United States, three species of Senecio are responsible for the 
majority of DHPA associated cattle losses: Tansy ragwort (Senecio jacobea ), threadleaf 
or woolly groundsel (Senecio douglasii var. longilobus), and Riddell’s groundsel 
(Senecio riddellii) (Johnson, et al. 1989). 
Senecio jacobea or Tansy ragwort is an invasive weed originating in Western 
Europe (Johnson, et al. 1989; Stegelmeier 2011) that has invaded Eastern Europe, North 
America, Australia, New Zealand, and South Africa (Stegelmeier 2011).  In the United 
States, it has invaded millions of acres of private and public land in the Pacific Northwest 
(Whitson, et al. 1996).  S. jacobea is a tall (0.3 – 2 m.) biennial or short lived perennial 
with a taproot.  It flowers from July to September producing many heads of yellow 
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flowers, and its leaves are two to eight inches long and deeply lobed (Whitson, et al. 
1996).  Because Tansy ragwort is not particularly palatable, poisoning by this plant tends 
to be the result of seeds contaminating feeds, lack of other forage, or when animals 
cannot differentiate early rosettes from other plants (Stegelmeier 2011).   
S. jacobea tends to have a lower concentration of DHPA than S. douglasii var. 
longilobus or S. riddellii, but its invasive nature and palatability tend to make it more 
potently toxic (Johnson, et al. 1989).  A dose of 2.5 mg kg
-1
 for 18 days is toxic for cattle.  
Higher doses result in acute hepatocellular necrosis and liver failure, but these poisonings 
are rare due to the unpalatable nature of the plant (Stegelmeier 2011). 
S. douglasii var. longilobus (threadleaf or wooly groundsel) is a small perennial 
shrub that grows primarily in abused or degraded rangelands of the Southwestern United 
States in loamy to clay soils (Johnson, Molyneux et al. 1989).  It grows from 0.3 to 1 
meter tall and has numerous arching and branching stems (Whitson, Burrill et al. 1996).  
Threadleaf groundsel has long, thin leaves (less than 3/16 in x 3 in) that are covered with 
fine hairs giving it a gray appearance (Whitson, Burrill et al. 1996).  Approximately 750 
g of green plant for 15 days is lethal for cattle (Stegelmeier 2011). 
S. riddellii or Riddell’s groundsel is similar in appearance to S. douglasii var 
longilobus except that the leaves do not have hairs (Whitson, et al. 1996).  It grows 
primarily in the Midwestern and Southwestern United States, and tends to have a higher 
DHPA concentration than the previously discussed Senecio spp (Johnson, Molyneux et 
al. 1989).  S. riddellii has been found to contain up to 18% riddelliine on a dry matter 
basis  (Johnson, et al. 1989), although typically concentrations tend to be significantly 
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lower.  It is unique from most other DHPA containing plants in that it contains primarily 
one DHPA, riddelliine (Stegelmeier 2011). 
S. vulgaris or common groundsel, another Senecio spp. plant that has been involved 
in poisonings of animals is also used in some herbal medicines.  Unlike the previously 
discussed Senecio spp. plants, S. vulgaris is an annual, or sometimes a biennial (Whitson, 
et al. 1996).  S. vulgaris has wider (1 to 3 cm) leaves that are irregularly notched or 
toothed that range from one to four inches long.  Its stems are 8 to 40 cm tall and the 
leaves can be haired or hairless.  The approximate lethal dose for cattle is 250 g of green 
plant for 15 days (Stegelmeier 2011). 
S. douglasii var. longilobus (threadleaf or wooly groundsel) is a small perennial 
shrub that grows primarily in abused or degraded rangelands of the Southwestern United 
States in loamy to clay soils (Johnson, et al. 1989).  It grows from 12 to 40 inches tall, 
and has numerous arching and branching stems (Whitson, et al. 1996).  It has long, thin 
leaves (less than 3/16 in x 3 in ) that are covered with fine hairs giving it a gray 
appearance (Whitson, et al. 1996).  Approximately 750 g of green plant for 15 days is 
lethal for cattle (Stegelmeier 2011). 
Crotalaria spp. 
In an effort to improve soils, Crotalaria spp. were introduced into North America 
because of their ability to fix nitrogen (Stegelmeier 2011; Stegelmeier, et al. 1999).  
Initially used as a cover crop, several have escaped cultivation and grow as weeds along 
fence lines and ditch banks where they often invade pastures and fields (Stegelmeier 
2011).  They have a common name of “rattle pod” which comes from the long seed pods 
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containing 2-3 mm long seeds that tend to become detached as they mature and rattle 
(Stegelmeier, et al. 1999).  Crotalaria spp. have been involved in poisonings of horses  
(Stegelmeier, et al. 1999), and seeds have contaminated grains resulting in poisoning of 
livestock and poultry(Stegelmeier 2011). 
 Fletcher et al. found most DHPAs in Crotalaria spp. to be present in the N-oxide 
form with some exceptions (Fletcher, et al. 2009). 
Table 2-1 contains a list of plants containing known toxic DHPAs as well as the 
DHPAs that have been isolated from these plants, and the portion of the plant containing 
DHPAs. 
Studies on DHPA biosynthesis (Molyneux, et al. 2011) demonstrated that DHPAs 
are formed in the roots and transported to other parts of the plant such as leaves and 
reproductive organs where they accumulate as tertiary bases or N-oxides.  Johnson et al. 
(1985) compared different Senecio, Amsinkia, and Crotalaria species, and found that the 
ratio of N-oxides and tertiary bases varies with species, growth stage, and location within 
the plant.  They also determined that the maximum total DHPA content was present at the 
early bud or preflower stage of most plants (Johnson, et al. 1985).  
 
Table 2-1. Plants containing hepatotoxic pyrrolizidine alkaloids 
Plant Constituent Alkaloids Plant Part 
APOCYNACEAE   
Parsonsia eucalyptophylla lycopsamine AG 
P. heterophylla parsonsine 
heterophylline 
WP 
 
P. spiralis spiraline 
spiranine 
spiracine 
Lf 
P. straminea lycopsamine AG 
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Plant Constituent Alkaloids Plant Part 
Urechites karwinsky loroquin Rt 
BORAGINACEAE   
Amsinckia hispida intermedine 
lycopsamine 
echiumine 
WP 
A. intermedia intermedine 
lycopsamine 
echiumine 
sincamidine 
WP 
A. lycosoides intermedine 
lycopsamine 
echiumine 
WP 
Anchusa arvensis lycopsamine 
7-acetyllycopsamine (or diastereoisomer) 
WP 
A. officinalis lycopsamine 
7-acetyllycopsamine (or diastereoisomer) 
WP 
Asperugo procumbens amabiline (or diastereoisomer) WP 
Cynoglossum amabile amabiline 
echinatine 
7-acetylechinatine 
WP 
C. austral cynaustine 
cynaustraline 
WP 
C. creticum echinatine 
heliosupine 
AG 
C. glochidiatum amabiline WP 
C. lanceolatum cynaustraline 
cynaustine 
WP 
C. latifolium latifoline 
7-angelylretronecine 
AG 
C. officinale heliosupine 
echinatine 
acetylheliosupine 
7-angelylheliotridine 
AG 
Rt, AG 
AG 
C. pictum heliosupine 
echinatine 
pictumine 
Rt, AG 
 
AG 
C. viridiflorum viridiflorine 
heliosupine 
Rt 
Echium italicum echimidine WP 
E. plantagineum echiumine 
echimidine 
AG 
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Plant Constituent Alkaloids Plant Part 
E. vulgare heliosupine 
asperumine 
lycopsamine (or diastereoisomer) 
AG 
 
WP 
Heliotropium acutiflourm heliotrine AG 
H. amplexicaule indicine AG 
H. arbainense europine 
lasiocarpine 
heliotrine 
AG 
H. arborescens lasiocarpine AG 
H. arguzioides heliotrine 
trichodesmine 
AG 
AG, Rt 
H. curassavicum heliotrine 
lasiocarpine 
angelylheliotridine 
curassavine 
coromandaline 
heliovicine 
trachelanthamidine 
WP 
 
 
AG 
H. dasycarpum heliotrine AG, Rt, Sd 
H. eichwaldi heliotrine 
lasiocarpine 
7-angelylheliotrine 
WP 
AG 
H. europaeum heliotrine 
lasiocarpine 
europine 
supinine 
heleurine 
N-(dihydropyrrolizino-methyl)-heliotrine 
chloride 
acetyllasiocarpine 
WP 
H. indicum indicine 
acetylindicine 
indicinine 
echinatine 
supinine 
heleurine 
lasiocarpine 
heliotrine 
AG 
H. lasiocarpum heliotrine 
lasiocarpine 
AG 
H. maris mortui Europine 
Lasiocarpine 
AG 
18 
 
Plant Constituent Alkaloids Plant Part 
H. olgae Heliotrine 
incanine 
AG, Rt 
H. popovii heliotrine Sd 
H. ramosissimum heliotrine AG 
H. rotundifolium europine AG 
H. steudneri lycopsamine Lf 
H. supinum supinine 
heliosupine 
echinatine 
7-angelylheliotridine trachelanthic and 
viridifloric esters of 7-Angelylheliotridine 
Rt 
 
WP 
H. transoxanum heliotrine AG 
Lappula glochidiata echinatine AG 
L. intermedia lasiocarpine AG 
Lindelofia angustifolia echinatine 
amabiline 
AG 
L. spectabilis echinatine 
7-acetylechinatine monocrotaline 
AG 
L. stylosa viridiflorine 
echinatine 
lindelofine 
AG 
Sd 
L. tschimganica carategine 
echinatine 
viridiflorine 
AG 
Myosotis sylvatica viridiflorine 
9-angelylretronecine 
heliosupine 
acetylheliosupine 
WP 
ParaCynoglossum imeritinum heliosupine 
echinatine 
AG, Rt 
Rindera austroechinata echinatine Lf, St, Sd, Rt 
R. baldschuanica rinderine 
echinatine 
trachelanthamine 
turkestanine 
AG 
R. cyclodonta echinatine AG 
R. echinata ehinatine 
trachelanthamine 
AG 
R. oblongifolia carategine 
echinatine 
turkestanine 
AG 
Solenanthus circinnatus echinatine Sd, AG, Rt 
S. coronatus echinatine AG 
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Plant Constituent Alkaloids Plant Part 
Skarategenius carategine 
echinatine 
AG 
S. turkestanicus rinderine 
turkestanine 
AG 
Symphytum asperum asperumine 
echinatine 
heliosupine 
7-acetylechimidine (or diastereoisomer) 
WP 
S. caucasicum lasiocarpine 
asperumine 
echinatine 
echimidine 
AG, Rt 
S. officinale symphytine 
echimidine 
lasiocarpine 
heliosupine 
viridiflorine 
echinatine 
7-acetylllycopsamine (or diastereoisomer) 
7-angelylretronecine 
viridiflorate (or diastereoisomer) 
acetylechimidine (or diastereoisomer) 
Rt 
 
AG, Rt 
 
Rt 
 
WP 
S. orientale anadoline 
symphytine 
echimidine 
WP 
S. tuberosum echimidine 
anadoline 
WP 
S. xuplandicum symphytine 
symlandine 
echimidine 
7-acetyllycopsamine 
7-acetylintermedine 
uplandicine 
lycopsamine 
intermedine 
AG 
Tournefortia sarmentosa supinine Lf, St 
Trichodesma Africana europine 
intermedine 
WP 
T. incanum trichodesmine 
incanine 
AG 
Sd, AG, Rt 
T. zeylanicum supinine Sd 
Ulegbekia tschimganica uluganine  
COMPOSITAE   
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Plant Constituent Alkaloids Plant Part 
Adenostyles alliariae platyphylline 
seneciphylline 
Rt 
A.  rhomibifolia platyphylline 
seneciphylline  
AG 
Brachygloitis repanda senecionine 
senkirkine 
brachyglottine 
AG 
Cacalia floridaiia 
 
otosenine 
florosenine 
floridanine 
floricaline 
AG 
C. hastate Integerrimine Rt 
c. yatabei  yamataimine Rt 
Doronicum macrophyllum otosenine 
floridanine 
doronine 
Rt 
Emilia flammea otosenine 
emiline 
AG, Rt 
E. sonchifolia senecionine AG 
Erechtites hieracifolia senecionine 
seneciphylline 
AG 
Eupatorium cannabinum echinatine 
supinine 
AG 
E. maculatum echinatine 
trachelanthamidine 
Rt 
E. purpureum probably echinatine AG 
E. serotinum supinine 
rinderine 
AG 
E. stoechadosmum lindelofine 
supinine 
Rt 
Farfugium japonicum senkirkine Rt, Lf 
Ligularia brachyphylla clivorine 
ligularine 
ligudentine 
AG 
L. clivorum clivorine AG 
L. dentata clivorine 
ligularine 
ligudentine 
ligularidine 
AG 
 
 
Rt, AG 
L. elegans clivorine 
ligularine 
ligudentine 
AG 
Petasites hybridus senecionine Lf 
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Plant Constituent Alkaloids Plant Part 
P. japonicas fukinotoxin 
neopetasitenine 
senkirkine 
petasinine 
petasinoside 
AG 
 
St 
AG 
P. laevigalus platyphylline 
senkirkine 
senecionine 
AG 
Senecio aegypticus senecionine 
otosenine 
riddelliine 
WP 
S. alpines seneciphylline 
jacozine 
AG 
S. ambrosioides seneciphylline 
senecionine 
retrorsine 
riddelliine 
WP 
S. ampullaceus senecionine 
seneciphylline  
retrorsine 
WP 
S. antieuphorbium integerrimine 
senkirkine 
senaetnin 
isosenaetinin 
AG 
S. aquaticus seneciphylline AG 
S. auresu senecionine AG 
S. auricola neosenkirkine AG 
S. bipinnatisectus retrorsine AG, Rt 
S. borysthenicus seneciphylline AG, Rt 
S. brasiliensis senecionine 
seneciphylline 
jacobine 
integerrimine 
retrorsine 
Lf 
 
 
AG 
S. bupleuroides retrorsine AG 
S. cannabilfolius seneciphylline AG 
S. carthamoides senecionine 
seneciphylline 
WP 
S. chrysanthemoides seneciphylline  
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Plant Constituent Alkaloids Plant Part 
S. cineraria jacobine 
senecionine 
seneciphylline 
otosenine 
retrorsine 
AG 
Sd 
AG 
S. cruentus cruentine A 
cruentine B 
AG 
S. cymbalarioides senecionine  
S. desfontainei senecionine 
otosenine 
riddelliine 
seneciphylline 
AG 
S. discolor retrorsine 
senecionine 
Lf, AG 
S. doronicum doronenine 
bulgarsenine 
WP 
S. douglasii retrorsine 
riddelliine 
seneciphylline 
senecionine 
WP 
S. durieui integerrimine WP 
S. eremophilus senecionine 
seneciphylline 
retrorsine 
riddelliine 
WP 
S. erraticus senecionine 
otosenine 
erucifoline 
seneciphylline 
integerrimine 
AG 
 
 
Lf 
AG 
S. erucifolius senecionine 
seneciphylline 
erucifoline (base S-C) 
retrorsine 
AG 
S. fluviatilis seneciphylline 
otosenine 
florosenine 
AG 
S. formosus integerrimine 
retrorsine 
AG 
S. fremonti senecionine 
seneciphylline 
WP 
S. glabellus senecionine WP 
S. glaberrimus retrorsine AG 
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Plant Constituent Alkaloids Plant Part 
S. graminifolius retrorsine 
graminifoline 
AG 
S. grandifolia platyphylline 
seneciphylline 
Rt, Lf, St 
S. griesebachii retrorsine AG 
S. ilicifolius senecionine 
seneciphylline 
retrorsine 
AG 
S. incanus seneciphylline AG 
S. integerrimus integerrimine 
senecionine 
platyphylline 
neoplatyphylline 
AG 
S. isatideus retrorsine AG 
S. jacobea  seneciphylline 
senecionine 
jacobine 
jaconine 
jacoline 
jacozine 
otosenine 
senkirkine 
retrorsine 
AG 
S. kirkii senkirkine 
O-acetylsenkirkine 
Bk, Lf 
Lf 
S. kleinia integerrimine 
senkirkine 
St 
S. krylovii seneciphylline AG 
S. kubensis seneciphylline AG 
S. lampsanoides seneciphylline AG, Rt 
S. latifolius retrorsine 
seneciphylline 
platyphylline 
AG 
S. lautus senecionine WP 
S. longilobus seneciphylline 
retrorsine 
riddelliine 
WP 
S. magnificus senecionine 
integerrimine 
AG 
S. minimus seneciphylline AG 
S. morrisonensis integerrimine WP 
S. nebrodensis integerrimine 
senecionine 
WP 
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Plant Constituent Alkaloids Plant Part 
S. nemorensis var. bulgaricus bulgarsenine 
retroisosenine 
nemorensine 
Lf 
S. nemorensis var. 
subdecurrens 
nemorensine 
retroisosenine 
bulgarsenine 
AG 
Rt 
S. nemorensis ssp. fuchsia fuchsisenecionine 
senecionine 
AG 
S. othonnae otosenine 
onetine 
seneciphylline 
floridanine 
doronine 
AG 
Rt 
 
AG, Rt 
AG 
S. othonniformis bisline 
Isoline 
AG 
S. palmatus seneciphylline Rt 
S. paludosus seneciphylline 
jacobine 
Rt, AG 
S. paeanus senecionine AG 
S. paucicalyculatus paucicaline 
retrorsine 
WP 
S. paucifolius seneciphylline  
S. petasitis senecionine 
probably bisline 
AG 
S. platyphylloides platyphylline 
seneciphylline 
Rt 
S. platyphyllus platyphylline 
seneciphylline 
neoplatyphylline 
sarracine 
Rt, AG 
Lf 
Rt 
Rt 
S. pojarkovae sarracine 
seneciphylline 
Rt 
S. procerus var. procerus senkirkine 
procerine 
AG, Rt 
S. propinquus seneciphylline AG, Rt 
S. pseudo-arnica senecionine AG 
S. pterophorus senecionine 
seneciphylline 
setrorsine 
rosmarinine 
acetylseneciphylline 
pterophorin 
AG 
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Plant Constituent Alkaloids Plant Part 
S. quadridentatus senecionine 
seneciphylline 
retrorsine 
AG 
S. racemosus seneciphylline Rt 
S. renardii seneciphylline 
senkirkine 
otosenine 
AG 
S. retrorsus retrorsine AG 
S. rhombifolius sarracine 
platyphylline 
neoplatyphylline 
seneciphylline 
Rt 
Ag, Rt 
S. riddellii riddelliine WP 
S. riddellii var. parksii retrorsine 
riddelliine 
AG 
S. rivularis 7-angelyheliotridine AG 
S. ruderalis retrorsine AG 
S. ruwenzoriensis ruwenine 
ruzorine 
WP 
S. scandens senecionine 
seneciphylline 
WP 
S. sceleratus retrorsine 
sceleratine 
chlorodeoxysceleratine 
AG 
S. spartioides seneciphylline 
spartioidine 
senecionine 
retrorsine 
riddelliine 
AG 
S. spathulatus senecionine 
integerrimine 
seneciphylline 
AG, Rt 
S. squalidus senecionine 
integerrimine 
AG 
S. stenocephalus seneciphylline AG 
S. subalpinus senecionine 
seneciphylline 
Lf 
AG 
S. swaziensis retrorsine 
swazine 
AG 
S. tomentosus senecionine 
otosenine 
AG 
S. triangularis senecionine AG 
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Plant Constituent Alkaloids Plant Part 
S. uintahensis senecionine 
senkirkine 
AG 
S. venosus retrorsine AG 
S. vernalis senecionine 
senkirkine 
retrorsine 
senecivernine 
 
S. viscosus senecionine 
integerrimine 
Ag 
S. vulgaris senecionine 
seneciphylline 
retrorsine 
riddelliine 
AG 
S. werneriaefolius senecionine 
retrorsine 
 
Syneilesis palmata syneilesine 
acetylsyneilesine 
senecionine 
AG, Rt 
Tussilago farara senkirkine Fl, Lf 
LEGUMINOSAE   
Crotalaria aegyptica monocrotaline 
crosemperine 
7β-hydroxy-1-methylene-8β-pyrrolizidine 
AG 
 
 
 
C. agatiflora madurensine 
anacrotine 
7-acetylmadurensine 
6-acetylanacrotine 
7-acetyl-cis-madurensine 
6-acetyl-trans-anacrotine 
crotaflorine 
6-angelyl-trans-anacrotine 
AG 
C. anagyroides 1-methylenepyrrolizidine 
senecionine 
anacrotine 
Sd 
C. assamica monocrotaline Sd 
C. axillaris axillarine Sd 
C. barbata crobarbatine Sd 
C. brevifolia integerrimine 
usaramine 
Sd 
C. burhia orotalarine 
monocrotaline 
AG 
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Plant Constituent Alkaloids Plant Part 
C. crispata monocrotaline 
fulvine 
crispatine 
WP 
C. dura dicrotaline AG 
C. fulva fulvine AG 
C. globifera dicrotaline AG 
C. grahamiana monocrotaline 
grahamine 
monocrotalinine 
Sd 
 
WP 
C. grantiana grantianine 
grantaline 
1-hydroxymethyl-1β-2β-epoxypyrrolizidine 
Sd 
Sd 
C. incana integerrimine 
anacrotine 
usaramine 
Sd 
Ag 
Sd 
C. intermedia integerrimine 
usaramine 
Sd 
C. juncea senecionine 
seneciphylline 
riddelliine 
trichodesmine 
junceine 
Sd 
C. laburnifolia anacrotine 
1-methylenepyrrolizidine 
Sd 
C. laburnifolia subsp.eldomae madurensine 
anacrotine 
senkirkine 
hydroxysenkirkine 
crotafoline 
AG 
C. lechnaultii monocrotaline 
crispatine 
Sd 
C. leiloba monocrotaline Sd 
C. madurensis madurensine 
crispatine 
fulvine 
cromadurine 
isocromadurine 
Sd 
AG 
 
Sd 
Sd 
C. mitchellii monocrotaline 
retusamine 
WP 
C. mysorensis monocrotaline WP 
C. novae-hollandiae subsp. 
Lasiophylla 
monocrotaline 
retusamine 
WP 
28 
 
Plant Constituent Alkaloids Plant Part 
C. novaehollandiae subsp.  
Novae-hollandiae 
retusamine Sd 
C. pallida usaramine 
integerrimine 
mucronatine (usaramine?) 
nilgirine 
crotastriatine 
Sd 
 
 
Sd 
Sd 
C. paniculata  fulvine Sd 
C. quinquefolia monocrotaline Sd 
C. recta monocrotaline 
trichodesmine 
AG 
C. retusa monocrotaline 
retusine 
retusamine 
retronecine 
Sd 
Sd, AG 
C. rubiginosa junceine 
trichodesmine 
Sd 
C. sagittalis monocrotaline Sd 
C. semperflorens crosemperine Sd 
C. sericea monocrotaline 
spectabiline 
Sd 
C. spartioides retrorsine AG 
C. spectabilis monocrotaline 
spectabiline 
retusine 
Sd 
Sd, WP 
Sd 
C. stipularia monocrotaline Sd 
C. tetragona integerrimine 
trichodesmine 
Sd 
C. usaramoensis integerrimine 
usaramine 
senecionine 
retrorsine 
Sd 
Sd 
C. verrucosa 1-methylenepyrrolizidine 
anacrotine 
crotaverrine 
acetylcrotaverrine 
 
Sd 
Sd 
C. walker crotaverrine 
acetylcrotaverrine 
Sd 
C. Sp. Aff. Mitchellii retusamine WP 
RANUNCULACEAE   
Caltha biflora senecionine AG 
C. leptosepala senecionine AG, Rt 
SCROPHULARIACEAE   
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Plant Constituent Alkaloids Plant Part 
Castilleja rhexifolia senecionine  
Adapted from Smith and Culvenor 1981 
Abbreviations:  WP = whole plant   Bk = bark 
  AG = above ground parts of plant Lf = leaf 
  Rt = root    Fl = flower 
  St = stem    Sd = seed 
 
Chemistry/Biochemistry 
 
 
Structure 
Pyrrolizidine alkaloids are composed of two fused five ring structures containing a 
nitrogen atom in the center called a necine base, and associated acid moieties, which are 
termed necic acids (Roeder 2000).  The necine bases may be either saturated or 
unsaturated with a 1,2 double bond.  Pyrrolizidine alkaloids with the 1,2 double bond 
have the potential to be toxic/carcinogenic (Mattocks 1986).  Nearly all of the necine 
bases have a hydroxymethyl group at C-1, and most have a hydroxyl group at C-7 
(Roeder 2000).  Additional hydroxyl groups may also be present particularly at C-2, C-6 
or C-7, resulting in the formation of many different necine bases.  A large majority of 
DHPA related toxicity appears to be the result of DHPAs containing one of three necine 
bases (heliotridine, retronecine, and otonecine) (Fig. 2-1).   
 
 
Figure 2-1. Structures of three necine bases (A) retronecine, (B) heliotridine, (C) 
otonecine 
B C A 
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With the exception of acetic acid, necic acids contain from five to ten carbon atoms 
(Roeder 1995).  They may be branched or simple chains, and also commonly contain 
various substituents including:  hydroxyl, carboxy, methoxy, epoxy, or acetoxy groups.  
Consequently numerous structural variations can be derived, including various 
stereoisomers.  Necic acids can be esterified to the necine bases at these locations giving 
rise to monoester, open chain diester, and macrocyclic diester DHPAs (Roeder 2000) 
(Fig. 2-2).   
 
 
 
Figure 2-2. Structures of dehydropyrrolizidine alkaloids with A. monoester 
(echinatine), B. diester (echimidine) and C. macrocyclic diester (senecionine) side chains. 
 
 
DHPAs are generally referred to by their trivial names as opposed to their chemical 
names because the chemical names are long and difficult to use (Mattocks 1986).  Their 
trivial names are generally derived from the plants from which they were initially isolated 
(Mattocks 1986).  A different method for naming is used for macrocyclic diesters.  For 11 
membered ring structures such as monocrotaline, the stem name of crotalanine is used, 
and for 12 membered rings like senecionine, the stem name senacanine is given 
(Mattocks 1986). 
A B C 
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Biotransformation 
DHPAs are pro-toxins and not inherently toxic.  To illustrate this, Mattocks gives 
multiple points as evidence, including (Mattocks 1986):   
1.  DHPAs are not locally toxic at the site of injection, or when they are 
applied to the skin. 
2. The alkaloids do not injure some organisms, e.g. cinnabar moth larvae, 
even though these are able to accumulate relatively large amounts of 
DHPAs in their tissues (Aplin et al., 1968). 
3. The main organ damaged is usually the liver, regardless of the route of 
administration of the alkaloid; DHPAs are known to be metabolized in the 
liver. 
4. The susceptibility of animals to DHPA intoxication is considerably 
influenced by treatments which modify the activity of the hepatic drug 
metabolizing enzymes. 
5. Some animals are much more resistant than others to DHPA 
hepatotoxicity.  Guinea pigs can withstand 20 times the dose of retrorsine 
that is an LD50 for male rats; stimulation of their liver microsomal 
enzymes by pretreatment with phenobarbitone increases the susceptibility 
of guinea pigs fourfold (White et al., 1973).  Newborn rats given retrosine 
within 1 h of birth are more resistant to the chronic hepatotoxicity of the 
alkaloid than rats aged one day or more when their hepatic microsomal 
enzyme activity is much greater (Mattocks and White, 1973). 
6. DHPAs are chemically rather unreactive.  It is unlikely that they would be 
able to react with cell constituents under physiological conditions.  On the 
other hand, metabolites known to be formed from DHPAs in the liver are 
highly reactive and more cytotoxic than their parent alkaloids. 
 
As is evident from the points above, the need for bioactivation and the central role 
of the liver in DHPA-dependent toxicity was understood decades ago.  Miranda et al. 
(1991) determined that the major enzyme catalyzing both the bioactivation (formation of 
6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrollizine or DHP) and detoxification 
(formation of N-oxide) of senecionine in human liver microsomes was CYP3A4.  In a 
later study Huan et al. (1998a) also found that CYP3A isoenzymes played a major role in 
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bioactivation and detoxification sheep and hamsters, while CYP2B isoenzymes played a 
minor roll. 
Species variation exists in enzymes responsible for DHP formation as well as N-
oxidation.  Formation of DHP from senecionine in rats is reportedly primarily due to 
CYP3A2 and N-oxide formation is mainly catalyzed by CYP2C11 (Williams, et al. 
1989).  In guinea pigs, CYP2B isoenzymes are the main catalyst responsible for 
biotransformation of senecionine and CYP3A isoenzymes play a rather minor role  
(Chung and Buhler 1994). 
Biotransformation also varies by gender at least in some species.  Williams et al. 
(1989) found that liver microsomes from male rats were much more efficient at 
biotransforming senecionine than microsomes from female rats.  Both DHP production 
and N-oxidation was higher with microsomes from male rats.  The difference was much 
greater with N-oxidation than DHP production. 
 
Toxicology 
 
 
Absorption, Distribution, Metabolism and Excretion (ADME) 
Pharmacokinetic studies have been reported for a few DHPAs or DHPA N-oxides 
including riddelliine (Williams, et al. 2002), monocrotaline(Estep, et al. 1991), 
senecionine (Wang, et al. 2011), adonifoline (Wang, et al. 2011), and indicine N-
oxide(Ames, et al. 1982; Kovach, et al. 1979).  Williams et al. (2002) performed kinetics 
for riddelliine in both rats and mice, but unfortunately examined oral dosing only.  
Because no IV data are available for comparison, interpretation of the kinetics is 
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somewhat limited. Senecionine and adonifoline were tested in rats (Wang, et al. 2011) 
and this constitutes the only report of kinetics which includes both IV and oral data.  
Male Sprague-Dawley rats were used for kinetics testing of monocrotaline IV (Estep, et 
al. 1991).  Indicine N-oxide was tested in human adults (Kovach, et al. 1979) and 
children (Ames, et al. 1982) as part of a clinical trial to determine its usefulness as a 
chemotherapeutic agent.  Consequently, it was administered IV and no oral kinetics data 
are available. 
A shortfall in the literature evaluating DHPAs is that virtually all of the LD50 data 
were determined using IP or IV routes in spite of the fact that all natural exposure is oral 
(Mattocks 1986).  In order to more accurately extrapolate the IP and IV LD50 data, more 
information is needed about the kinetics of the various DHPAs in more species.  In spite 
of these limitations, much is known about the metabolism of DHPAs as it pertains to 
cytochrome P450s and different metabolites that result from their actions on DHPAs. 
Absorption 
As stated above, natural toxicity to DHPAs occurs following oral exposure.  After 
ingestion, DHPAs are absorbed into the portal circulation and carried to the liver.  Wang 
et al. (2011) determined that the absorption half-life of senecionine is between 115 and 
163 minutes depending on the dose administered.  The absorption half-life of adonifoline 
was somewhat longer, ranging from 95 to 207 minutes (Wang, et al. 2011).   
Distribution 
 
The distribution half-lives of senecionine and adonifoline were similar, ranging 
from 56 to 111 minutes depending on the dose (Wang, et al. 2011).  The distribution 
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phase of indicine N-oxide was less than 4 minutes for all but the highest dose given 
(Kovach, et al. 1979).  Both senecionine and adonifoline are macrocyclic diesters 
whereas indicine is a monoester.  It is unclear whether the variation present in these two 
studies is due to the difference in the chemical structures of the DHPAs or if there is 
some difference in the methodologies that may explain such vast differences. 
Estep et al. (1991) measured concentrations of 14C-labeled monocrotaline in 
erythrocytes, liver, kidney, lung, spleen, cardiac muscle, plasma, and skeletal muscle at 7 
hours and again at 24 hours post dosing.  At both time points they found the highest 
concentration of free base in erythrocytes followed by liver.  At 24 hours the spleen and 
lung both had slightly more free base present than the kidneys followed by cardiac 
muscle, plasma and lastly skeletal muscle (Estep, et al. 1991).  This group hypothesized 
that the high concentrations of monocrotaline in red blood cells could play a role in the 
extrahepatic toxicity seen more commonly with monocrotaline than other DHPAs. 
Metabolism 
Primary metabolism of DHPAs is achieved by a handful of enzymes belonging to 
the P450 superfamily.  As discussed under bioactivation, although there are multiple 
P450 enzymes that play a role in DHPA metabolism, the most consistent across species, 
and the most important from a toxicity standpoint appears to be CYP3A4.  Interestingly, 
both N-oxidation, which increases the water solubility and consequently allows for 
increased rate of excretion, and formation of the reactive metabolites are mediated 
through the activity of the same enzyme in some species (Miranda, et al. 1991; Williams, 
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et al. 1989).  Glutathione conjugation plays a major role in phase II metabolism of the 
reactive metabolite (Reed, et al. 1992; Yan and Huxtable 1995). 
DHPAs exist in plants in both free base and N-oxide forms (Fig. 2-3).  The N-oxide 
form can be converted to the free base in the gut via intestinal microflora.  In addition, 
hepatic microsomes are capable of metabolizing the N-oxide to the free base (Wang, et 
al. 2005b).  After ingestion, DHPAs are carried first to the liver where they are exposed 
to P450 enzymes, flavin-containing monooxygenases (FMOs), and esterases.  The 
relative action of each enzyme type is variable depending on the species.  In cattle and 
sheep FMOs had a greater influence on N-oxide formation from senecionine and P450s 
(CYP3A) had more influence in the formation of DHP (Duringer, et al. 2004). 
Free bases of retronecine, heliotridine, and otonecine all have the same basic 
potential metabolic pathways once they reach the liver.  They may be acted on by 
esterases forming non-toxic necine acids (Fig. 2-3 3b) and necine bases (Fig. 2-3 3a).  
P450 enzymes, particularly isoforms of CYP3A, may convert them to dihydropyrrolizine 
esters (Fig. 2-3 4), the initial toxic metabolites.  Dihydropyrrolizine esters are highly 
reactive electrophiles at the C-7 and C-9 position, which rapidly bind to tissue 
nucleophiles (Nu) such as NH, OH, or SH groups found on tissue proteins, nucleic acids 
or glutathione, forming adducts (Fig. 2-3 6) (Edgar, et al. 2011).  Dihydropyrrolizine 
esters may also be hydrolyzed to form dehydroretronecine or dehydroheliotridine (Fig. 2-
3 5).  Dehydroretronicine and dehydroheliotridine are also electrophilic and 
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Figure 2-3. Dehydropyrrolizidine Alkaloid Metabolism 
Dehydropyrrolizidine alkaloids are consumed in either the free base form (2a & 2b) or the N-
oxide form (1).  If consumed in the N-oxide form (1) some can be converted by intestinal 
microflora to the free base form (2a or 2b).  The free base is metabolized in the liver by one of 
several mechanisms.  It can be N-oxidized increasing its water solubility, acted on by esterases 
forming non-toxic necine acids (3b) and bases (3a), or bioactivated by P450 enzymes into 6,7-
dihydropyrolizine esters (4).  These esters either bind rapidly to nucleophiles forming adducts (6) 
or are hydrolyzed forming dihydroretronecine or dihydroheliotridine (5), which also have the 
propensity to bind to nucleophiles and form adducts (5).  
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readily bind to similar tissue nucleophiles.  Additionally over time, adducts may release 
dehydroretronecine or dehydroheliotridine, which are speculated to bind to other tissue 
nucleophiles forming new adducts, leading to chronic diseases such as sinusoidal 
obstructive syndrome, cirrhosis and neoplasia (Edgar, et al. 2011).  
The initial toxic metabolites (dehydropyrrolizine esters) are so highly reactive that 
only the alcohols (Fig. 2-3 5) and adducts (Fig. 2-3 6) are measured as products of P450 
activation in microsomal preparations (Jago, et al. 1970; Mattocks 1986).  The rapid 
nature of metabolism explains why the liver is the primary target organ in most DHPA 
intoxications.  Further metabolism of DHPAs in extrahepatic tissue could account for the 
presence of pulmonary and renal lesions with DHPAs such as monocrotaline given that 
CYP 3A activity does occur in both liver and lung (Molyneux, et al. 2011).  The rate of 
DHPA metabolism has been increased experimentally by pretreating animals with 
phenobarbitol, which induces P450s, and decreased with chloramphenicol or SKF 525A, 
which are P450 inhibitors (Allen, et al. 1972; White, et al. 1983). 
Excretion 
Studies using radio-labeled monocrotaline, lasiocarpine, senecionine and 
seneciphylline have shown that approximately 80% of ingested DHPAs are rapidly 
excreted unchanged in the urine and feces, and that the urine is the most prevalent route 
(Chan 2001; Eastman, et al. 1982).  Expiration with carbon dioxide also accounts for 
approximately 10% of the dose excreted (Chan 2001).  Excretion into milk was shown to 
be a very minor route with 0.04% of both senecionine and seneciphylline excreted in the 
milk of mice (Eastman, et al. 1982).  
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Clinical Signs and Pathology 
Clinical signs and pathologic lesions in DHPA-poisoned animals depending on 
multiple factors including:  the specific DHPA involved, the dose and route of exposure, 
and the species, age, and sex of the animal.  Most DHPAs are primary hepatotoxins, 
however certain DHPAs also affect other organs.  Differences in pathological responses 
between laboratory and natural exposure exist primarily because of variations in dose and 
route of exposure.  DHPA toxicoses in laboratory animals have been categorized as 
peracute, acute and chronic forms (Mattocks 1986), whereas naturally-occurring DHPA 
toxicity in domestic animals has been described as three pathologic expressions 
representing different types of exposure (Stalker and Hayes 2007).  Although similar 
toxic actions have been demonstrated in many animal species, the quantity of alkaloid 
required to reach toxic effect can be quite different in different species.  Younger animals 
as well as children tend to be more susceptible than adults, and in some species males 
tend to be more susceptible than females (Mattocks 1986).  
Most clinical signs in DHPA-poisoned animals can usually be attributed to a loss of 
hepatic function (Galey 1996).  The liver plays a major role in metabolism of proteins, 
lipids, and carbohydrates as well as conversion of excess nitrogen to urea.  When these 
functions are limited there is a lack of energy, clinically expressed as lethargy and weight 
loss/decreased weight gain, and a buildup of excess nitrogen in the blood resulting in 
central nervous system dysfunction.  The central nervous system dysfunction can result in 
disorientation leading to common names of DHPA toxicosis such as “walking disease” or 
“walkabout” (Galey 1996). 
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DHPAs are hepatotoxic primarily because they are bioactivated in the liver.  
Pathologic lesions range from zonal hepatic necrosis to fibrosis with or without 
regeneration depending on chronicity (Stalker and Hayes 2007).  Characteristic lesions of 
DHPA intoxication, such as megalocytosis, typically require more time to develop and 
are therefore present following more chronic exposures.   
Because DHPA metabolites can also affect other organs, death may also be due to 
renal or pulmonary damage (Stalker and Hayes 2007).  Alkaloids from Crotalaria affect 
the widest range of tissues in domestic animals (Stalker and Hayes 2007).  
Monocrotaline, in particular, is pneumotoxic as well as hepatotoxic (Mattocks 1968; 
Stalker and Hayes 2007).  Pulmonary symptoms have been described in horses, sheep 
and rats after consumption of various Crotalaria spp. plants, and in pigs after eating 
Senecio jacobea   (Stalker and Hayes 2007).  Crotalaria spp. plants are also severely 
nephrotoxic in pigs (Hooper 1978).  In horses and cattle Trichodesma incanum has 
similar effects to Crotalaria spp.  Crotalaria retusa, a plant found in northern Australia, 
is the one substantial exception.  C. retusa causes hepatotoxicity, but no pneumotoxicity 
(Hooper 1978).  Senecio jacobea has been reported to cause pulmonary disease in pigs, 
rats and mice, but not in horses, cattle, sheep, or chickens.  S. jacobea also causes renal 
tubular epithelial megalocytosis and occasional nephrosis in most species (Hooper 1978).  
Generally Heliotropium spp., Amsinkia spp., and Echium spp. are hepatotoxic, however 
they may cause renal tubular epithelial megalocytosis, and alkaloids extracted from these 
genera have been known to cause pulmonary disease in animals acutely poisoned 
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(Hooper 1978).  Sheep, rats, and mice exposed to high doses of Lasiocarpine developed 
necrotizing enteritis (Hooper 1975).  
Megalocytic hepatocytes have morphologic and structural changes when compared 
to normal hepatocytes.  In an ultrastructural study conducted by Allen et al. (1970) they 
found megalocytic hepatocytes to contain large multilobular nuclei with cytoplasmic 
invaginations.  There was a decrease in rough endoplasmic reticulum as well as the 
number of bound ribosomes.  The RNA and nitrogen concentration was the same as 
controls, but DNA was increased up to 200%.  There was also an increase in the size and 
distribution of Golgi complexes (Allen, et al. 1970).  These changes are the result of 
mitotic inhibition (Allen and Hsu 1974) coupled with continued DNA synthesis in some 
cells.  This results in cells with large polyploid nuclei termed megalocytes. 
 Resistance to chronic toxicity does not necessarily imply resistance to acute 
toxicity.  Sheep died soon after IP injections of senecionine (60 mg kg
-1
 BW), 
lasiocarpine (30 mg kg
-1
 BW) and fulvine (45 mg kg
-1
 BW) (Hooper 1978).  Exposure by 
the IP route may also have affected the sensitivity of these animals.  Several authors have 
noted that ovine rumen microflora has the ability to detoxify/metabolize DHPAs (Craig, 
et al. 1992; Lanigan 1970; Lanigan and Smith 1970; Wachenheim, et al. 1992).  
However, metabolism by rumen microflora does not appear to be the only factor that 
determines the resistance of sheep and goats to DHPA intoxication.  S. jacobea incubated 
in sheep rumen fluid was more toxic to rats than S. jacobea incubated in cattle rumen 
fluid (Shull, et al. 1976). 
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Mattocks (1986) discussed DHPA toxicity in laboratory animals and categorized 
observations into either peracute, acute or chronic forms of toxicity.  He defines peracute 
toxicity as rapidly fatal were death ensues within a few minutes to a few hours as a result 
of a large dose of DHPA (Mattocks 1986).  Peracute toxicity is typically due to an IP or 
IV injection of DHPA such that absorption is very rapid.  Consequently the more 
lipophilic DHPAs are more prone to causing this type of toxicity.  This type of toxicity is 
not considered to be related to the cytotoxic action of the DHPA.  It is associated with 
pharmacological actions of the compound and death may follow convulsions or coma 
(Mattocks 1986). 
 
Short-term toxicity (Acute) 
Acute toxicity as described by Mattocks (1986) is the result of the hepatotoxic 
actions of DHPAs. In most cases, acute toxicity is the result of a single exposure and 
death ensues in a few days as the result of hepatic necrosis.  At necropsy, the liver is 
typically firm and congested with a red granular appearance, and ascites is commonly 
present.  Microscopically there is zonal hemorrhagic hepatic necrosis.  Reportedly the 
zone affected can be different depending primarily on the species, but sometimes on the 
nutritional status or chemical pretreatment of the animal (Mattocks 1986).  Rats, mice, 
and guinea pigs treated with retrorsine developed centrilobular hepatic necrosis, whereas 
hamsters treated with retrorsine and monkeys treated with lasiocarpine developed 
periportal necrosis (Mattocks 1986). 
There are numerous studies using scores of DHPAs on numerous different species 
primarily to determine LD50 information.  Unfortunately, nearly all of these studies have 
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used either an IV or IP route of administration (Mattocks 1986).  In virtually all natural 
exposures, the route of exposure is oral (there are some herbal products marketed for 
topical use).  Some species which are susceptible to IP exposure are resistant to oral 
exposure, such as sheep (Hooper 1978), hamsters (Huan, et al. 1998b) and rabbits 
(Pierson, et al. 1977).  Other species such as rats, which are sensitive to oral exposure, 
are more sensitive to IP exposure (Mattocks and Driver 1987).  As a result, it may not be 
prudent to use only IP-derived data to determine the relative acute toxicity of DHPAs in 
many species of animals. 
 
Chronic Toxicity 
Chronic toxicity may be the result of a single sublethal dose or multiple small 
doses.  Grossly, the liver is atrophic, firm and nodular (Mattocks 1968; Stalker and Hayes 
2007).  Ascites may also be present.  DHPAs inhibit mitosis (Allen and Hsu 1974), but 
DNA synthesis continues in some cells resulting in cells with large polyploid nuclei 
termed megalocytes.  The characteristic histologic lesions consist of hepatic atrophy, 
nodular regeneration, megalocytosis, periportal fibrosis and biliary hyperplasia (Stalker 
and Hayes 2007).  Not all alkaloids produce identical lesions.  For example, chronic 
exposure exclusively to Heliotropium has been reported to produce firm atrophic livers 
without nodular regeneration (Stalker and Hayes 2007).   
In some cases, toxic or even lethal doses of DHPA may be consumed with mild to 
no acute clinical signs.  S. jacobea, S. longilobus, and S. riddellii, were fed to cattle at 
lethal doses over a duration of several days.  Initial signs of poisoning were absent, mild 
or transitory.  Signs of DHPA toxicosis developed many months after exposure.  Death 
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followed closely after clinical signs (Molyneux, et al. 1988).  One theory explaining this 
type of pathogenesis is that tissue-bound DHPA adducts remain a source of ongoing 
alkylation.  Thus, following a dietary exposure, tissue damage continues until the 
reservoir of labile tissue-bound adducts is eliminated (Edgar, et al. 2011)  
 
Species Variations 
Swine 
In pigs naturally and experimentally exposed to Crotalaria retusa, the major 
clinical signs were severe nephrosis and uremia, with interstitial pneumonia as the second 
most common development (Hooper and Scanlan 1977).  Both presentations were 
accompanied by microscopic liver disease.  Hepatic and renal megalocytosis were 
common histologic findings.  The clinical disease was most prevalent in growing pigs 
with a universal depression of appetite and weight.  Breeding animals had often did not 
develop clinical disease, but histologically there was advanced megalocytosis in both the 
liver and kidneys.  This subclinical disease can be highly fatal as 10 of 12 pigs died or 
were euthanized when moribund when fed diets with 0.02% Crotalaria retusa seeds 
(Hooper and Scanlan 1977). 
Poultry 
Outbreaks of DHPA toxicity in chickens and ducks have been characterized by 
decreased weight gain in growing animals and general ill thrift (Hooper and Scanlan 
1977, Pass et al. 1979).  Gross examination of deceased animals revealed ascites with 
fibrin frequently present on the surface of most livers (Hooper and Scanlan 1977).  In 
acutely affected animals the major gross finding was yellow to orange friable livers (Pass 
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et al. 1979).  Histologically, there was single cell to zonal necrosis of hepatocytes.  
Hepatocellular megalocytosis was present in chronic cases.  In animals exposed to 
Crotalaria retusa, no discernible lesions were present in kidneys of acutely affected 
animals, but in more chronically affected animals there was renal tubular epithelial 
megalocytosis (Hooper and Scanlan 1977).  In chickens and ducks exposed to 
Heliotropium europaeum renal lesions were mild but consistent and consisted of enlarged 
nuclei within tubular epithelial cells (Pass, et al. 1979).  Chickens fed Crotalaria retusa 
seeds at 0.5% of their diets all died, and five of eight of those fed at 0.1% of their diets 
died (Hooper and Scanlan 1977). 
Cattle 
Calves naturally (Baker, et al. 1989) or experimentally (Baker, et al. 1991) exposed 
to Cynoglossum officinale or experimentally exposed to Senecio erraticus (Araya and 
Fuentealba 1990) all developed hepatocellular megalocytosis if exposed chronically.  
Renal megalocytosis (Baker, et al. 1991) and biliary hyperplasia (Araya and Fuentealba 
1990) was also a feature of chronically-exposed animals.  Four calves fed C. officinale at 
a rate that provided an approximate daily dose of 60 mg kg
-1
 BW of total DHPA died 
within 48 hours after a single dose (Baker, et al. 1991).  All four of those animals had 
massive hepatocellular necrosis and hemorrhage, as well as intestinal hemorrhage most 
prevalent in the duodenal mucosa.  Mesenteric and subcutaneous edema were also 
common findings in this group (Baker, et al. 1991).   
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Horses 
Horses were experimentally exposed to C. officinale in a suspension at doses of 5 or 
15 mg kg
-1
 BW day
-1
 for 14 days (Stegelmeier, et al. 1996).  All of the high dose animals 
developed severe liver disease within one week which progressed until they were 
euthanized.  Histologically there was extensive hepatocellular necrosis, biliary 
hyperplasia, and mild periportal fibrosis.  The horses treated with 5 mg kg
-1
 DHPA day
-1
 
were depressed for several weeks after dosing and had elevated liver enzyme activities 
and bile acid concentrations in the serum that resolved within 6-8 weeks.  Biweekly liver 
biopsies of these animals revealed minimal periportal necrosis with fibrosis, which 
persisted and was accompanied by extensive megalocytosis by week 14.  Biliary 
epithelial cells had an increased mitotic rate commensurate with the other histologic 
changes (Stegelmeier, et al. 1996). 
Sheep and Goats 
As previously mentioned, sheep and goats are significantly more resistant to DHPA 
toxicosis than other livestock species.  Lactating dairy goats as well as goat kids were fed 
dried, ground S. jacobea as 25% of their diet (Goeger, et al. 1982).  Four of eleven 
animals died and had signs of chronic DHPA poisoning such as hepatocellular 
degeneration, hepatocyte swelling, megalocytosis, and bile duct proliferation.  The 
chronic lethal dose was determined to be between 1.2 and 4 kg of dried plant per kg of 
body weight.  Intakes of 0.05 to 0.20 kg/kg of body weight were found to be lethal in 
horses and cattle. 
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After an outbreak of acute DHPA intoxication in sheep presumably caused by 
Crotalaria retusa seeds, sheep were experimentally fed C. retusa seeds at doses of 2.5, 5, 
10, 20, and 40 g/kg BW (Nobre, et al. 2005).  The seeds contained 1.4% monocrotaline.  
Animals which received 5 g/kg BW or more died with signs of acute DHPA intoxication 
including anorexia, severe depression, mild jaundice, incoordination and recumbence.  In 
another study, three sheep per group were fed a single dose of monocrotaline at 205.2 and 
273.6 mg kg
-1 
BW (Anjos et al. 2010).  Two sheep from the 205.2 mg kg
-1
 BW and one 
from the 273.6 mg kg
-1
 BW groups died with signs of acute intoxication including 
apathy, abdominal pain, anorexia, increased respiratory and cardiac rates, and mild 
yellowish ocular or oral mucosa, followed by marked depression, recumbence and death 
within one to four days.  The two remaining sheep in the 273.6 mg kg
-1
 BW group 
initially showed clinical signs of anorexia during the first three to five days followed by a 
period of no clinical signs and then a rapid course leading to death at 12 and one at 68 
days post-treatment.  Acutely intoxicated sheep exhibited periacinar hepatic necrosis, and 
chronically intoxicated sheep had hepatic fibrosis and megalocytosis. 
 
Carcinogenicity 
 
Numerous studies have examined various aspects of DHPA carcinogenicity.  This 
review will examine those studies aimed at expounding the extent of primary DNA 
damage caused by DHPAs, including DNA cross-linking, DNA strand breakage, 
unscheduled DNA synthesis and DNA adduct formation.  Next we will review 
chromosomal damage induced by DHPAs through studies using the micronucleus assay, 
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chromosomal aberration and sister chromatid exchanges.  We will then examine 
mutations induce by DHPAs which have been extensively studied in bacteria, Drosophila 
and rodents.  Finally we will consider neoplastic conditions associated with DHPA 
exposure.   
 
Primary DNA Damage 
DNA cross-linking 
Due to the presence of two functional groups, one at C7 and one at C9, DHPAs 
have the capacity to bind protein or DNA at two different locations.  Petry et al. (1984) 
demonstrated DNA-DNA and DNA-protein cross-linking due to DHPA exposure.  
Sprague Dawley rats were injected with doses of monocrotaline ranging from 5 to 30 mg 
kg
-1
 BW IP. Using the alkaloid elution technique, it was determined that DNA-DNA 
intrastrand cross-linking increased in a doses dependent manner and peaked at twelve 
hours or less, and that after 96 hours additional cross-linking was statistically no different 
than the control.  These cross-links are thought to play a role in carcinogenicity, toxicity, 
and the antimitotic effect of some DHPAs (Coulombe, et al. 1999; Kim, et al. 1999; 
Pereira, et al. 1998; Petry, et al. 1984; Rieben and Coulombe 2004; Tepe and Williams 
1999; Wagner, et al. 1993; Weidner, et al. 1990).   
Studies focusing on DNA-protein cross-linking ability of DHPAs have been 
conducted using both cells and isolated nuclei.  Coulombe et al. (1999) used bovine 
kidney epithelial cells and human breast carcinoma cells to determine that 
dehydrosenecionine and dehydromonocrotaline cross-linked DNA with actin.  This 
combined with the previous work of Kim et al. (1993), suggesting that megalocytic and 
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antimitotic effects of DHPAs are directly proportional to their ability to cross-link.  These 
led to the conclusion that the ability of DHPAs to cross link DNA with actin may be at 
least partially responsible for the antimitotic effects of DHPAs.  Furthermore the ability 
to form DNA-protein crosslinks tended to coincide with the toxic potency of the DHPAs 
in animals, leading to the conclusion that DNA-protein cross-linking is likely involved in 
PA-related toxicity (Coulombe, et al. 1999; Kim, et al. 1993; Petry, et al. 1984). 
Monocrotaline has been used as a model cross-linking DHPA by several 
researchers.  After Petry et al. (1984) demonstrated that IP injections of monocrotaline 
induced DNA-DNA and DNA-protein cross-links in Sprague-Dawley rats, Tepe et al. 
(1999) used the pyrrolic metabolite of monocrotaline (dehydromonocrotaline) to 
demonstrate its ability to mediate DNA-DNA cross-linking.  Pereira et al. (1998) also 
used dehydromonocrotaline (DHM) to study different types of DHPA-induced DNA-
DNA cross-links.  By using electrophoresis and electron microscopy, they found that 
DHM produced piperidine and heat-resistant DNA crosslinks.  Based on their research 
they proposed that DHM undergoes a rapid polymerization forming a structure that 
allows it to cross-link multiple DNA fragments. 
There is some disagreement in the literature as to whether or not there is a 
preferential site for DNA-DNA cross-link formation.  Three different groups used DHM 
as their model to study DNA-DNA cross-linking.  Weidner et al. (1990) found a 
preference for cross-linking at 5’-CG sites using DHM and dehydroretrorsine with DNA 
duplex fragments and polyacrilamide gel electrophoresis (PAGE).  Pereira et al. (1998) 
found a predilection for 5’-GC and 5’GA sequences using a DNA alkylation method that 
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causes cleavage of DNA at N7 residue of guanine.  Rieben et al. (2004) assessed cross-
linking by electrophoretic mobility shift assay of 32P endlabeled oligonucleotides and by 
HPLC analysis of cross-linked DNAs enzymatically digested to their constituent 
deoxynucleosides.  In this study the degree of cross-linking was dependent on the 
concentration of DHM, but they found no base sequence preference. 
In a study using bovine kidney epithelial cells Hincks et al. (1991) tested DHPAs 
from three different classes, macrocyclic diesters, open chain diesters, and the 
pyrrolizidine base (retronecine).  All of the DHPAs they tested induced DNA-protein 
cross-links and DNA-DNA cross-links.  The relative ability to induce cross-links was 
determined as follows:  seneciphylline > riddelliine > retrorsine > senecionine > 
heliosupine > monocrotaline > latifoline > retronecine.  All but monocrotaline and 
retronecine tended to form more DNA-protein cross-links than DNA-DNA cross-links.  
DNA strand breakage 
DNA strand breaks were not detectable following treatment with senecionine, 
seneciphylline, riddelliine, retrorsine, monocrotaline, heliosupine, latifoline or jacobine 
using the alkaline elution assay (Hincks, et al. 1991; Petry, et al. 1984).  Using the more 
sensitive single cell gel electrophoresis assay (Comet assay) DNA strand breaks were 
detected in human hepatoma (HepG2) cells treated with isatidine (Uhl, et al. 2000) and 
human glioblastoma cells (GL-15) treated with monocrotaline (Silva-Neto, et al. 2010). 
Unscheduled DNA synthesis 
Unscheduled DNA synthesis (UDS) is any DNA synthesis that takes place outside 
of the S-phase of the cell cycle.  The UDS assay incorporates tritiated thymidine into the 
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DNA of cultured mammalian cells during repair which can be detected via 
autoradiography.  Therefore, this test measures the repair of primary DNA damage.  This 
method has been used to detect DNA damage induced by various DHPAs (Griffin and 
Segall 1986; Mirsalis 1987; Mirsalis, et al. 1993; NTP 2003a).  Riddelliine induced UDS 
in rat hepatocytes following in vitro treatment, however it required greater than an LD50 
equivalent dose to produce positive response (Mirsalis 1987).  In a prechronic (animals 
survive up to 30 days) toxicity test conducted for the National Toxicology Program, 
Mirsalis et al. (1993) found that riddelliine did not induce an increase in UDS in rat 
hepaotcytes after 5 or 30 days of dosing.  However, it did induce an equivocal response in 
male mice at both time points and a positive response in female mice after 30 days of 
dosing.  UDS was detected in hepatocytes cultured from male and female rats and mice 
following five days of riddelliine treatment by gavage.  UDS was also detected in 
cultured hepatocytes from all of the same groups except the female rats following a 30 
day gavage study with riddelliine (NTP 2003a).  Griffin and Segall (1986) detected a 
positive, dose-related increase in UDS in primary cultures of rat hepatocytes when treated 
with any of the following compounds: senecionine, retrorsine, seneciphylline, 19-OH-
senecionine, trans-4-OH-2-hexenal, trans-4-OH-2-nonenal, and nonenal. 
DNA adducts 
DNA adducts are formed when DHPAs are metabolized in vivo or in vitro.  After 
treating rats with tritiated senecionine and seneciphylline Candrian et al. (1985) collected 
protein and DNA from liver, lung and kidney six hours and four to five days post-
treatment.  Using HPLC and radioactivity analysis this group was able to show that both 
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alkaloids covalently bound to DNA, and that the binding persisted for at least four days 
post-treatment (Candrian et al. 1985).  Using a 32P-postlabeling/HPLC method, 8 DHR-
derived DNA adducts were identified in calf thymus DNA exposed to riddelliine that was 
metabolized by rat liver microsomes (Yang et al. 2001).  Similar DNA adduct profiles 
were detected in livers of female F344 rats fed riddelliine.  They were able to determine 
the structure of two of the eight adducts, which were epimers of DHR-3’-dGMP (Yang, 
et al. 2001). 
Chou et al. (2004) measured DHR derived adducts at 1,3,7, and 28 days post 
inoculation in both rats and mice.  The maximum concentration was higher in rats than 
mice and they were more persistent in rats than mice.  Concentrations of DHR derived 
DNA adducts were higher in hepatic endothelial cells of both mice and rats than in 
hepatic parenchymal cells.  Maximum concentration of DHR derived endothelial DNA 
adducts were higher in male mice than female mice, but they were more persistent in the 
female mice than male mice.  DHR derived DNA adducts tended to be more persistent in 
endothelial cells than in hepatic parenchymal cells. (Chou, et al. 2004) 
Employing the same 32P-postlabeling/HPLC method, the same eight DNA adducts 
have been isolated from calf thymus DNA incubated with rat liver microsomes and other 
DHPAs and DHPA containing plants (Chou and Fu 2006; Wang, et al. 2005a; Xia, et al. 
2006; Xia, et al. 2004; Xia, et al. 2008).  The DHPAs and DHPA containing plants tested 
include:  clivorine, heliotrine, lasiocarpine, monocrotaline, retrorsine, comfrey root 
extract, comfrey compound oil, coltsfoot extract, Flos farfara extract, and Ligularia 
hodgsonnii extracts.   
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In an effort to determine the relevance of this information obtained via use of 
experimental animals, a similar experiment was conducted using human liver 
microsomes and calf thymus DNA (Xia, et al. 2003).  When human liver microsomes 
were exposed to riddelliine the same major metabolites (dehydroriddelliine and 
riddelliine N-oxide) were isolated in similar concentrations to that obtained from rat liver 
microsomes under the same experimental conditions.  When metabolism was conducted 
in the presence of calf thymus DNA the same set of DHR-derived DNA adducts were 
isolated. 
Due to the lack of structural information about DNA adducts, the 32P-
postlabeling/HPLC method was limited.  As a result a more sensitive and specific liquid 
chromatography-electrospray ionization-tandem mass spectrometry method was 
developed (Fu, et al. 2010).  Using this new technique in combination with a technique 
for synthesizing larger quantities of DHR-derived DNA adducts, the full structures of all 
eight adducts were determined (Zhao, et al. 2012).  
More recently, female rats were gavaged with one of ten different alkaloids (Xia, et 
al. 2013).  Nine of these DHPAs contained the crucial C1-C2 double bond including: 
riddelliine, retrorsine, monocrotaline, lycopsamine, retronecine, lasiocarpine, heliotrine, 
clivorine and senkirkine.  The tenth, platyphylliine is a saturated pyrrolizidine alkaloid, 
and therefore is not tumorigenic.  They were able to demonstrate the presence of the four 
major DNA adducts (DHP-dG-3, DHP-dG-4, DHP-dA-3, DHP-dA-4) in rats treated with 
all of the pyrrolizidine alkaloids with the exception of retronecine and the saturated 
pyrrolizidine alkaloid platyphylliine.   
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As mentioned under the metabolism section DHPAs are conjugated by glutathione, 
and glutathione conjugation is considered a major detoxification mechanism (Reed, et al. 
1992, Yan and Huxtable 1995).  However, glutathione conjugated DHPAs may be 
somewhat unstable and can potentially act as a reservoir for DHP adduct formation.  
After incubating the DHPA glutathione conjugate 7-glutathionyl-(±)-6,7-dihydro-1-
hydroxymethyl-5H-pyrrolizine with purine nucleosides or calf thymus DNA the same 
major DNA adducts described previously were formed (Xia, et al. 2015).  Furthermore an 
in vivo study, where lasiocarpine was injected IP into sheep, rats, and mice resulted in 
severe intestinal lesions (Hooper 1975).  Conclusions were made that the most likely 
cause of the intestinal lesions was glutathione bound DHPA in the bile.   
Chromosomal Damage Induced by DHPAs 
 
Chromosomal damage as a result of exposure to DHPAs has been studied by 
numerous scientists beginning at least as early as 1972 (Martin, et al. 1972).  Three basic 
methods have been used, the micronucleus assay, chromosomal aberration, and sister 
chromatid exchange.  Increases in micronucleus formation, number of chromosomal 
aberrations and sister chromatid exchanges are indicative of chromosome damage. 
Micronucleus assay 
When a portion of a chromosome is not carried to opposite poles during anaphase 
of either mitosis or meiosis, a micronucleus is formed.  This chromosome or chromosome 
fragment will transfer to one of the daughter cells.  The daughter cell with the extra 
portion of a chromosome will have a nucleus and a second smaller nucleus or 
micronucleus.  An increase in micronucleus formation is indicative of chromosomal 
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damage.  The micronucleus assay typically uses bone marrow or peripheral blood to 
detect an increase in micronucleus formation.   
DHPAs extracted from Senecio brasiliensis in 1945 and stored for 23 years in an 
ambient environment in Brazil were used to determine the stability of DHPAs (Santos-
Mello et al. 2002).  During storage these DHPAs were exposed to variations in 
temperature and humidity as well as light.  The crude alkaloid contained integerrimine, 
retrorsine and several unidentified impurities.  This crude extract as well as a purified 
extract of integerrimine were injected IP into albino Swiss mice.  Both the purified 
integerrimine and the crude extract induced micronucleus formation in polychromatic 
erythrocytes from the bone marrow.   
Sanderson and Clark, (1993) evaluated the clastogenic activity of multiple 
chemicals including heliotrine and monocrotaline, in adult mice as well as transplacental 
exposure to fetal mice.  Both heliotrine and monocrotaline increased micronucleus 
formation in polychromatic erythrocytes found in bone marrow of adult mice and the 
liver of fetal mice.  Heliotrine exposure resulted in the largest increase which peaked 18 
hours post injection in adult bone marrow and 24 hours post injection in fetal liver 
(Sanderson and Clark 1993).  This suggests that heliotrine and monocrotaline are 
mutagenic to both adult and fetal mice. 
Monocrotaline or ground seeds from Crotalaria spectabilis containing 4.2% 
monocrotaline were administered in the diet to Swiss-Webster mice for six days.  
Polychromatic erythrocytes increased in peripheral blood and became constant after three 
days of treatment (MacGregor, et al. 1990).  Muller-Tegethoff et al. (1997) investigated a 
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host of compounds using the micronucleus assay, among which were isatidine, 
monocrotaline and retrorsine.  All three were found to induce micronucleus formation. 
Exposure to riddelliine did not increase micronucleus formation in mice or rat 
peripheral blood samples after 4 or 13 weeks at doses of 10 mg kg
-1
 for rats and 25 mg 
kg
-1
 for mice given daily as an oral gavage.  A much higher dose of 150 mg kg
-1
 did 
result in a weakly positive response in bone marrow and peripheral blood of male mice 
(Chan 1993; Mirsalis, et al. 1993).  To give some perspective to the doses used, the oral 
LD50 in male rats for riddelliine is about 80 mg kg
-1
 (Dalefield, et al. 2012). 
Chromosomal aberration 
The chromosomal aberration test is performed by analyzing cytologic preparations 
and counting the number of structural chromosomal aberrations present as a proportion of 
cells in metaphase.  Structural chromosomal aberrations include chromatid and 
chromosome gaps, breaks and fragments. 
The majority of studies linking DHPAs to chromosomal abnormalities have used an 
in vitro model of either V79 Chinese hamster cells (Muller et al., 1992; Takanashi et al. 
1980) or Chinese hamster ovary cells (Carballo et al., 1992; Chan 1993), or alternatively 
in vivo models, such as mouse bone marrow (Ribeiro et al., 1993; Gimmler-Luz et al., 
1990), rat peripheral blood (Martin et al., 1972), or peripheral blood from children 
recovering from veno-occlusive disease (Martin et al., 1972). 
Some studies used extracts from various parts of DHPA containing plants (Ribeiro 
et al., 1993; Carballo et al. 1992), while others used purified DHPAs (Martin et al., 1972; 
Muller et al., 1992; Takanashi et al. 1980; Chan 1993).  In all of these studies, every 
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DHPA tested resulted in chromosomal aberrations.  Ribeiro et al. 1993) found that 
extracts made from fruit obtained from Crotalaria retusa resulted in a dose-dependent 
increase in chromosomal aberrations while extracts made from the leaves of C. retusa 
and fruit from C. mucronata had no detectable effect on frequency of chromosomal 
aberrations. 
Sister chromatid exchanges 
Sister chromatid exchange is the exchange of DNA fragments between two 
identical or sister chromatids.  An increase in sister chromatid exchanges has been 
associated with chromosome damage and tumor induction (Chen et al. 2010).  Sister 
chromatid exchanges have been associated with dehydroretronecine, heliotrine, 
monocrotaline, riddelliine, seneciphylline, senkirkine and several synthetic DHPAs 
(Bruggeman and Van der Hoeven 1985, Ord et al. 1985, Chan 1993).  These studies have 
employed a variety of in vitro  models including human lymphocytes (Ord et al. 1985), 
V79 Chinese hamster cells co-cultured with chick embryo hepatocytes (Bruggeman and 
Van der Hoeven 1985), and CHO cells with and without S9 (Chan 1993).  
 
Mutations Induced by DHPAs 
Mutations in bacteria 
Earlier researchers had difficulty in testing DHPA mutagenicity using the 
Salmonella typhimurium/mammalian microsome test (Clark 1976; Wehner, et al. 1979), 
also known as the Ames test, presumably because they lacked a suitable activation 
enzyme system.  Subsequently, although it may lack sensitivity (Rubiolo, et al. 1992), the 
Ames test has been used extensively with suitable activation systems to evaluate the 
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mutagenic potential of various DHPAs.  The mutagenicity of retrorsine was measured 
using the Ames assay with four strains of Salmonella (TA98, TA100, TA1535, and 
TA1537) in the presence of S9 (liver cell fragment containing microsomes that can be 
obtained by taking the Supernatant of a cell homogenate after centrifugation at 9,000 g).  
It was determined to be mutagenic for TA1535 and TA1537 indicating that it induced 
both frame shift mutations and base pair substitutions (Wehner, et al. 1979).  Using 
TA100 with S9 the following DHPAs/DHPA containing plants have been determined to 
be mutagenic: clivorine, fukinotoxin, heliotrine, lasiocarpine, ligularidine, LX201, 
retrorsine, riddelliine, senecivernine, seneciphylline, senkirkine, and extracts from 
Senecio inaequidens, S. fuchsia, S. cacliastershowed, and S. jacobea (Chan 1993; 
Rubiolo, et al. 1992; White, et al. 1984a; Yamanaka, et al. 1979).  Similar tests using 
isatidine, monocrotaline, and senecionine were negative (Rubiolo, et al. 1992).  Repair 
deficient strains of E. coli have been used to test mutagenicity of heliotrine and 
monocrotaline, resulting in increased mortality of repair deficient bacteria (Green and 
Muriel 1975).   
Mutations in Drosophila 
Drosophila melanogaster has been used extensively to study the mutagenic 
potential of DHPAs via either the wing spot test or the sex-linked recessive lethal test.  
One group used the wing spot test to assess the genotoxic potential of 15 DHPAs and one 
DHPA N-oxide (Frei, et al. 1992a).  All of the DHPAs tested with the exception of 
supinine (a C9 monoester), were clearly genotoxic.  They determined that macrocyclic 
diesters were the most potently genotoxic, followed by the open chain diesters.  The open 
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chain diesters had a stronger effect than the corresponding C9 monoesters with a 
hydroxyl group at C7.  Supinine, the only DHPA that was not significantly genotoxic, is a 
C9 monoester that lacks a hydroxyl group at C7.  From this they determined that at least 
one ester linkage and one hydroxyl group appear to be necessary for genotoxicity in the 
DHPAs tested.  The same group also found that an increasing number of hydroxyl groups 
appeared to reduce genotoxic potency (Frei, et al. 1992a) 
Brink (1969) demonstrated chromosomal damage in Drosophila exposed to 
heliotrine by documenting increased frequency of dominant lethal, sex chromosome loss, 
and translocations and sex-ratio shifts.  Candrian et al. (1984) used milk from rats fed 
25mg kg
-1
 seneciphylline to feed drosophila resulting in a fourfold increase of sex-linked 
recessive lethals.  They also found senkirkine to be mutagenic in Drosophila.  
Integerrimine was also found to be genotoxic using the wing spot test (Campesato et al. 
1997). 
Mutations in Rodents 
The mutagenicity of comfrey (Symphytum officinale) as well as riddelliine has been 
studied using Big Blue transgenic rats (Mei, et al. 2004a; Mei, et al. 2005; Mei and Chen 
2007). Transgenic mutation assays were used to study induction of tissue-specific 
mutations, and measure mutation frequencies in target tissues.  In one study, female Big 
Blue Rats were exposed to 0.3 mg riddelliine kg
-1
 BW, 5 days per week for 12 weeks 
(Mei, et al. 2004a).  After the rats were euthanized they isolated endothelial cell fractions 
and liver parenchymal cell fractions.  They then measured the mutation frequency of the 
cII transgene in both fractions.  While the liver parenchymal cell fraction did not have a 
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significant difference in mutation frequency, the endothelial cell fraction had increased 
frequency.  Molecular analysis of the mutants in the endothelial cell fraction determined 
that 17% of mutations in riddelliine treated mice were G:C→T:A transversions, whereas 
G:C→T:A transversions accounted for only 9% of mutations in the controls.  The major 
mutation in control rats were G:C→A:T transversions, which accounted for 54% of their 
mutations.  This hepatic endothelial cell mutation specificity is interesting in light of the 
fact that riddelliine readily induces hemangiosarcoma in the liver of rats (Chan 1993), 
and hemangiosarcoma is a tumor originating from endothelial cells.  Riddelliine also 
induced an increase in tandem base substitutions in Big Blue Rats of GG→TT and 
GG→AT (Mei, et al. 2004b). 
The mutagenic effect of comfrey on rat lung was also studied using the Big Blue 
Rat as a model (Mei and Chen 2007).  CII gene mutation frequency from the lungs of Big 
Blue Rats fed 8% comfrey for 12 weeks was significantly greater than that of controls.  
Much like the riddelliine treated rats in their previous studies, the major mutation in the 
comfrey treated rats was a G:C→T:A transversion.  The major mutation in the control 
rats was a G:C→A:T transversion, which is also consistent with their previous studies. 
B6C3F1 mice were used to examine alterations in the K-ras proto-oncogene, the P53 
tumor suppressor gene as well as β-catenin (Hong et al. 2003).  They examined 12 
riddelliine induced hepatic hemangiosarcomas as well as 15 spontaneous subcutaneous 
hemangiosarcomas and found that 58% of riddelliine induced hemangiosarcomas 
contained a K-ras codon 12 G→T transversion mutation, and that 75% had a variety of 
P53 mutations.  The spontaneous hemangiosarcomas of the control mice had neither K-
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ras nor P53 gene mutations.  They determined that K-ras mutations and p53 protein 
expression in riddelliine-induced hemangiosarcomas likely resulted from the genotoxic 
effects of riddelliine. 
Neoplasms associated with DHPAs 
A large number of experiments beginning as early as the 1950s have been carried 
out to determine the carcinogenicity of different DHPAs.  Table 2-2 is a summary of 
those experiments organized by type of DHPA base (retronecine, heliotridine, or 
otonecine).  There is substantial variation between studies in route, dose, dosing 
interval/frequency, duration of dosing and duration of the experiment.  In spite of these 
differences, the majority of experiments concluded that whatever DHPA they were 
studying caused an increase in tumors within the liver, the majority of which were either 
hepatocellular or endothelial in origin.   
 
Table 2-2 Neoplasms associated with different dehydropyrrolizidine alkaloids and 
dehydropyrrolizidine alkaloid containing plants 
PA / Plant Species Study 
Duration 
Tumor type(s) Reference (route 
of administration) 
Retronecine type  
Amsinckia 
intermedia  
 (Lycopsamine / 
Intermedine) 
Rats 26 – 31.5 
Months 
Pancreatic Islet Cell 
Tumors (3/15), 
Exocrine Pancreatic 
Tumor (1/15) 
(Schoental, 
Fowler et al. 
1970) (gavage) 
Bladder papillary 
tumor (1/15) 
Pituitary tumor(1/15) 
Dehydroretronecine Rats 22 
Months 
Rhabdomyosarcoma 
(31/60) 
(Allen et al. 
1975) 
(Subcutaneous 
injection) 
Isatididine Rats Until 
death (2 
½ years) 
Liver Tumors  (4/6) (Schoental and 
Head 1957) 
(water + IP) 
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PA / Plant Species Study 
Duration 
Tumor type(s) Reference (route 
of administration) 
Liver Tumors (10/22), 
(6/7) 
(Schoental et al. 
1954) (water) 
Liver Tumor (1/5) (Schoental et al. 
1954) (water + 
IP) 
Monocrotaline Rats 22 
Months 
Rhabdomyosarcoma 
(2/60), Hepatocellular 
carcinoma (2/60), 
Acute myelogenous 
leukemia (2/60) 
(Allen et al. 
1975) 
(subcutaneous 
injection) 
500 Days Insulinoma (16/23) (Yuzo et al. 
1977) 
(subcutaneous 
injection) 
2 Years Pulmonary Adenoma 
(10/60), 
Hepatocellular 
Carcinoma (5/60), 
Rhabdomyosarcoma 
(4/60) 
(Shumaker et al. 
1976) 
(subcutaneous 
injection) 
55 
Weeks 
Hepatocellular 
Carcinoma 
(10/42)&(14/35) 
(Newberne and 
Rogers 1973) in 
(Mattocks 1986) 
(gavage) 
Retrorsine Rats Until 
death 
Liver Tumors (2/4) 
 
(Schoental and 
Head 1957) 
(injection) 
Hepatomas (4/14) (Schoental et al. 
1954) (water) 
Riddelliine Rats 
(F344) 
male 
2 Years Hemangiosarcoma 
(43/50), 
Hepatocellular 
adenoma (4/50), 
Mononuclear Cell 
Leukemia (9/50) 
(Chan et al. 
2003) (gavage) 
female Hemangiosarcoma 
(38/50), 
Hepatocellular 
adenoma (7/50), 
Mononuclear Cell 
Leukemia (14/50) 
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PA / Plant Species Study 
Duration 
Tumor type(s) Reference (route 
of administration) 
Mice 
(B6C3F1) 
male 
2 Years Hemangiosarcoma 
(31/50) 
(Chan et al. 
2003) (gavage) 
female Alveolar/bronchiolar 
adenoma or carcinoma 
(13/50) 
Senecio 
cannabifolius 
Rats 240 Days Hemagioendothelial 
Sarcoma  (female 
1/11), Liver Cell 
Adenoma (male 6/10, 
female 7/11), Other 
Tumors (male 5/10, 
female 2/11) 
(Hirono et al. 
1983) 
240 Days Hemagioendothelial 
Sarcoma (male 2/12, 
female 6/12),  Liver 
Cell Adenoma 
(male1/12, female 
2/12), Other Tumors 
(male 8/12, female 
3/12) 
Senecio longilobus Rats >200 
Days 
Hepatocarcinoma 
(16/47), 
Angiosarcoma (3/47) 
Harris and Chen 
1970 in 
(Mattocks 1986) 
(feed) 
Senecio jacobea  Chickens  Liver Tumors (4/43) (Campbell 
1956)(feed) 
Senecio nemorensis 
(senecionine & 
Fuchsisenecionine) 
Rats 114 
Weeks 
Hepatocellular tumors 
(4/11 & 13/29), 
Cholangiogenic 
tumors  (male 1/2 & 
2/5) (female 2/11 
&11/29), 
Hemangiogenic (male 
2/10)(female 5/11 
&5/29) 
(Habs et al. 1982) 
(gavage) 
Symphytine Rats >330 
days 
Hemangiosarcoma 
(3/20), Liver adenoma 
(1/20) 
(Hirono et al. 
1979) (IP) 
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PA / Plant Species Study 
Duration 
Tumor type(s) Reference (route 
of administration) 
Symphtum 
officinale 
Rats 600 Days Hepatocellular 
adenoma (24/88), 
Hemangioendothelial 
Sarcoma (1/88) 
(Hirono et al. 
1978) (feed) 
280 Days Hepatocellular 
adenoma (57/87), 
Hemangioendothelial 
Sarcoma (2/87) 
Heliotridine Type  
Heliotropium 
supinum L. 
(Supinine, 
Echinatine, 
Trachelanthyl-7-
angelylheliotridine, 
Viridofloryl-7-
angelylheliotridine, 
Heliosupine) 
Rats 26 – 31.5 
Months 
Pancreatic Islet Cell 
Tumors (1/6, 1/2) 
(Schoental et al. 
1970) (gavage) 
Lasiocarpine Rats Until 
moribund 
or 
palpable 
tumor 
Hepatocellular 
Carcinoma (11/18), 
Squamous Cell 
Carcinoma (6/18), 
Pulmonary Adenoma 
(5/18), Small 
Intestinal 
Adenocarcinoma 
(2/18), 
Cholangiocarcinoma 
(1/18), Adenomyoma, 
ileum (1/18) 
(Svoboda and 
Reddy 1972) (IP) 
59 
Weeks 
Hemangiosarcoma 
(9/20) 
Hepatocellular 
Carcinoma (7/20), 
Lymphosarcoma 
(1/20), Malignant 
Adnexal Tumor (1/20) 
(Rao and Reddy 
1978) (feed) 
Heliotrine + 
Nicotinamide 
Rats 2 Years Pancreatic Islet Cell 
Tumor (3/6), 
Interstitial Cell 
Tumor, Testicle (1/6), 
Hepatoma (1/6) 
(Schoental 1975) 
(gavage) 
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PA / Plant Species Study 
Duration 
Tumor type(s) Reference (route 
of administration) 
Heliotrine Rats 2 Years Pancreatic Islet Cell 
Tumor (1/1) 
Otonecine Type  
Clivorine Rats 480 Days Hemangiosarcoma 
(2/12), Liver Tumor 
(6/12), Interstitial Cell 
Tumor, Testicle 
(4/12), Pancreatic 
Acinar Cell Tumor 
(1/12), Pituitary 
Adenoma (1/12) 
(Kuhara et al. 
1980) (water) 
Farfugium 
japonicum 
(Senkirkine & 
Petasitenine) 
Rats 240 Days Hemangiosarcoma 
(6/29), Liver 
Adenoma (7/29), 
Adrenal cortical 
adenoma (7/29), Other 
Tumors (6/29) 
(Hirono et al. 
1983) (feed) 
Tussilago farfara 
(Senkirkine) 
Rats >380 
Days 
Hemagioendothelial 
Sarcoma (8/12) 
(Hirono et al. 
1976) (feed) 
 
Some researchers also concluded that there were gender related differences (Chan, 
et al. 2003; Habs, et al. 1982; Hirono, et al. 1983).  Perhaps the most profound is the 
NTP funded carcinogenicity study using B6C3F1 mice.  When comparing male and 
female mice at an oral dose of 3 mg kg
-1
 BW day
-1
 of riddelliine for 105 weeks, 31 of 50 
male mice developed hemangiosarcoma in the liver compared to 1 of 50 female mice 
(Chan, et al. 2003).  Also of interest in this study is a significant decrease in tumors of 
hepatocellular origin in both genders when compared to controls.  In the male mice, 3 of 
50 developed tumors of hepatocellular origin compared to 36 of 50 controls.  Female 
mice followed a similar trend with 0 of 50 compared to 16 of 49 hepatocellular adenomas 
or carcinomas in controls (Chan et al. 2003).  This work was supported as the same group 
also found increased incidence of hepatocellular and endothelial neoplasia in both male 
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and female F344 rats that were treated with riddelliine at a dose of 1 mg kg
-1
 BW day
-1
 
for 105 weeks.   
 
Factors Influencing Toxicity 
 
 
Species 
Vast variations in susceptibility exist between species.  Sheep have been used in 
many parts of the world to graze pastures that are considered too dangerous for other 
species.  One study compared the susceptibility of pigs and chickens to Crotalaria retusa 
and found that chickens required from 5 to 10 times more Crotalaria retusa per body 
weight than pigs to result in lethality (Hooper and Scanlan 1977).  In general it appears 
that horses are similar to cattle and sheep are similar to goats in their susceptibility to 
DHPAs.  Hooper (1978) approximates the ratios of DHPA containing plant required to 
poison different species as follows:  pigs = 1, chickens = 5, cattle and horses = 14, rats = 
50, mice = 150, and sheep and goats = 200.  Extreme ranges for acute toxicity have also 
been reported (Mattocks 1986). 
Numerous studies have reported variations in susceptibility of different animals to 
the effects of DHPAs (Chesney and Allen 1973; Huan 1995; Huan, et al. 1998a; 1998b; 
Shull, et al. 1976; Swick, et al. 1982; White, et al. 1973; Winter, et al. 1988).  Cheeke 
(1998) divided species into susceptible and resistant groups.  Resistant species included 
sheep, guinea pigs, gerbils, rabbits, hamsters and Japanese quail, whereas rats, cattle, 
horses, and chickens were reported to be highly susceptible (Huan, et al. 1998a).  The 
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difference in susceptibility between species appears to be primarily due to differences in 
hepatic DHPA metabolism (Huan, et al. 1998a).  
 
Individual (Animal or Human) 
Some individual animals are able to develop resistance to DHPA intoxication over 
time.  Two of three and three of three sheep fed single doses of Crotalaria retusa 
containing 205.2 and 273.6 mg kg
-1
 BW of monocrotaline respectfully, died.  However, 
three sheep fed 136.8 mg kg
-1
 BW day
-1
 for 20 days followed by seven days of 273.6 mg 
kg
-1
 BW day
-1
 developed no clinical signs (Anjos, et al. 2010). The authors concluded 
that chronic poisoning at least in sheep is unlikely to occur as a result of repeated non-
acutely toxic doses, but is most likely the result of a single toxic dose.  It is unclear 
whether this is due to induction of detoxification enzymes or some other mechanism.   
 
Extent of bioactivation 
In one study researchers measured pyrrolic metabolites and N-oxide formation in 
hepatic microsomal incubations from eight different species (sheep, cattle, gerbils, 
rabbits, hamsters, Japanese quail, chickens, and rats) (Huan, et al. 1998b).  In this study 
microsomes from hamsters produced far more DHP than N-oxide, whereas sheep, 
another resistant species, produced much more N-oxide than DHP.  They determined that 
at least in their model, there was not a strong correlation between production of pyrrolic 
metabolites and susceptibility of animals to DHPA toxicity.   
Another study using a similar design compared the metabolism of senecionine in 
guinea pig, rat, cattle, horse, and sheep hepatic microsomes (Winter, et al. 1988).  They 
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found that DHP production by guinea pig hepatic microsomes was higher than the other 
species.  Taken together these two studies suggest that at very least bioactivation is not 
the sole determinant of species susceptibility. 
 
Detoxification processes 
Several investigators have examined the effects of glutathione (GSH) conjugation 
on DHPA metabolism.  In vitro methods were used to determine that GSH forms 
conjugates with metabolites of monocrotaline (Robertson, Seymour et al. 1977, Yan and 
Huxtable 1995), senecionine (Reed et al. 1992) and Jacobine (Dueker, Lamé et al. 1994).  
In vivo methods have also been used to isolate and identify a pyrrolic glutathione 
conjugate metabolite of monocrotaline (Lamé, Morin et al. 1990). 
Using hepatic microsomes from hamsters and sheep, the effect of GSH conjugation 
on formation of DHP and N-oxide was determined by adding the reduced form of GSH to 
the incubation mixture and comparing the formation of DHP and N-oxide with controls 
(Huan, et al. 1998b).  When they added 2.0 mM GSH to the incubation mixture, the 
occurrence of DHP was reduced by 79% and 63% in sheep and hamsters respectively.  
They found little effect on formation of N-oxide. 
Yan and Huxtable (1995) used isolated perfused rat liver to determine the 
relationship of GSH concentration and metabolism of monocrotaline.  When GSH was 
depleted, although there was no effect on the total release of pyrrolic metabolites, the 
pattern of pyrrole release was markedly affected.  Release of the GSH conjugated DHP in 
the bile was reduced 72%, protein bound pyrrole concentration in the liver increased, and 
there was double the release of dehydromonocrotaline into the perfusate.  Increase of 
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GSH resulted in a 54% increase of total pyrrolic metabolites.  Release of GSH conjugated 
DHP in the bile, release of dehydromonocrotaline in the perfusate, and DHP were all 
increased.  They concluded that hepatic GSH concentration regulates the metabolism of 
monocrotaline and dehydromonocrotaline.  Depletion of GSH results in a switch from 
biliary release of glutathione conjugated DHP to the perfusate release of the highly toxic 
dehydromonocrotaline.  Furthermore, depletion of GSH allows more 
dehydromonocrotaline in the liver to remain available for macromolecular alkylation 
(Yan and Huxtable 1995). 
 
Environmental copper and other factors 
Interactions between DHPAs and various dietary constituents have been identified.  
Some have an additive or symbiotic effect with DHPAs increasing the toxicity of the 
DHPA.  Others have a protective effect, and have been used in an attempt to mitigate the 
effects of DHPAs.  In some cases DHPAs have an effect on the absorption or metabolism 
of dietary constituents, but there is no observable impact on the toxicity of the DHPA. 
Interrelationships between minerals and DHPAs are of particular importance.  In 
Australia, enzootic copper poisoning was observed in areas were the copper 
concentration of the forage was normal (Cheeke, et al. 2011).  Consumption of DHPA 
containing plants (Heliotropium europaeum  and Echium lycopsis) predisposed sheep to 
the hemolytic effects of chronic copper poisoning (Bull, et al. 1956).  The relationship 
between DHPA consumption and copper toxicosis in sheep is now well documented 
(Cheeke, et al. 2011).  Copper accumulation appears to be related to both the intakes of 
copper and DHPA and according to Cheeke et al. (2011) probably also dependent on the 
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pattern of DHPA intake.  Pair-fed rats were given a diet containing 250 ppm added 
copper with and without 5% Senecio jacobea (Swick et al. 1982).  At five weeks the rats 
fed S. jacobea had a 7.5 fold increase in hepatic copper concentration when compared to 
controls.  Serum zinc concentration was decreased in the same animals.  Another study 
also using S. jacobea in sheep concluded that sheep fed S. jacobea do not preferentially 
accumulate copper in their livers, but that interactions with molybdenum were 
responsible for increased sensitivity to Tansy ragwort (White, et al. 1984b). 
Dietary proteins can have the opposite effect on DHPA-induced toxicity.  Cheeke 
and Garmin (1974) found that toxic effects of DHPAs were increased with restricted 
dietary protein.  They observed no gross signs of DHPA toxicity in rats fed 25% dietary 
protein, but rats fed only 8% dietary protein exhibited severe signs of toxicosis even 
though their consumption of S. jacobea was only 68% of the amount consumed by the 
high protein group (Cheeke, et al. 2011).  The protective effects were specifically 
associated with sulfur containing amino acids.  In a later study which compared the 
effects of cysteine and methionine in rats fed S. jacobea, it was determined that the 
protective effects were due primarily to cysteine (Buckmaster, et al. 1976).  Rats fed 1% 
cysteine had double the survival time of controls, and they consumed 300% more total 
plant resulting in 3X higher DHPA doses.  There was no perceptible advantage in those 
fed methionine.  Partial protection against DHPA toxicity by cysteine supplementation 
has been shown in a number of studies (Buckmaster, et al. 1976; Garrett, et al. 1984; 
Miranda, et al. 1981).  It is presumed that the protective effects of cysteine are due to its 
effects as a constituent of glutathione (Cheeke, et al. 2011).  Glutathione conjugates 
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DHPAs and DHPA metabolites for excretion as mercaptans (Robertson, et al. 1977).  
Simultaneously administering synthetic antioxidants has been found to potentiate the 
protective effect of dietary cysteine (Cheeke, et al. 2011). 
The studies demonstrating protective effects of cysteine were carried out in 
laboratory animals and results may be different in other species.  When ponies were fed 
S. jacobea along with a 1% cysteine and .75% butylated hydroxyanisole (a synthetic 
antioxidant), no beneficial effect was noted (Garrett, et al. 1984).  A similar study a diet 
providing methionine hydroxyl analog (a source of rumen nondegradable sulfur amino 
acid) and ethoxyquin did not alter the toxicity of S. jacobea in Hereford steers (Cheeke, 
et al. 1985). 
Although in some situations a high protein diet can be protective against DHPA 
intoxication, such a diet can exacerbate clinical signs in an animal that has already been 
poisoned (Cheeke, et al. 2011).  This is particularly true with respect to animals with 
hepatic encephalopathy.  Hepatic encephalopathy is the result of high blood ammonia 
concentrations affecting the central nervous system.  Hyperammonemia is the result of 
impaired ability of the liver to convert ammonia (an amino acid degradation product) to 
urea.  Consequently, a high protein diet is contraindicated in such situations. 
Other nutrients affected by DHPA toxicosis include vitamins A and E and possibly 
B12.  It is not surprising that hepatotoxic agents such as DHPAs effect metabolism of 
nutrients that are primarily metabolized or stored in the liver such as vit. A.  In rats fed 
Senecio jacobea, liver and plasma concentrations of vitamin A were reduced to 50% that 
of control rats (Moghaddam and Cheeke 1989).  Similarly, Vitamin E concentrations 
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were decreased in broiler chickens fed Senecio jacobea  (Lulay, et al. 2007).  This group 
concluded that the decrease was likely due to reduction in Vitamin E transport proteins.  
Some reports suggest a possible beneficial effect of vitamin B12 with respect to ruminal 
detoxification of DHPAs (Cheeke, et al. 2011), but no beneficial effect has been shown 
in other studies when vitamin B12 has been added to diets of ponies (Garrett, et al. 1984) 
and cattle (Cheeke, et al. 1985). 
 
Compound 
Dose, rate 
Edgar et al. (2011) point out that DHPA exposures in pigs, poultry, rodents and 
non-human primates as well as in human cases, resulted in pulmonary hypertension 
followed by right heart failure with limited liver damage.  They present an argument that 
if the liver has sufficient capacity for repair, it is likely that at some low-doses with slow 
rates of exposure that liver lesions would be minimal while lung damage could progress 
until the main lesions seen would be confined to the pulmonary vascular system (Edgar, 
et al. 2011).  Intermittent exposure to DHPAs has been shown to allow recovery from 
antimitotic effects and allow for repair processes to start (Edgar, et al. 2011; Hirono, et 
al. 1978; Svoboda and Reddy 1972).  Once free from the antimitotic effects, those 
diseases that require cellular proliferation (such as neoplasia) begin to develop (IPCS 
1988; Jago, et al. 1969; Mattocks 1986).  As a result, Edgar et al. (2011) suggests that 
sporadic small doses, such as those known to exist in foods, may be expected to produce 
cancer and pulmonary hypertension rather than liver damage (Edgar, et al. 2011). 
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Chemical Structure 
There are certain structural features necessary for a DHPA to be potentially 
hepatotoxic.  They must have an unsaturated ring and at least one hydroxyl group 
attached to the pyrrolizine ring by one carbon (Mattocks 1986).  At least one hydroxyl 
must be esterified, and the acid moiety needs a branched chain.  Diesters tend to be more 
toxic than monoesters (Culvenor, et al. 1976; Mattocks 1986). 
Once these minimum requirements have been met, there are several other factors 
that appear to determine the relative toxicity of individual DHPAs.  These factors include 
lipid solubility, base strength, the acid moiety, the necine moiety, and the total alkaloid 
structure.  These factors are often interdependent. 
DHPAs which are more lipid soluble are more susceptible to activation in the liver, 
whereas DHPAs with higher water solubility are more readily excreted and consequently 
have a lower toxicity (Mattocks 1986).  Base strength is closely related to lipophilicity.  
Generally those DHPAs which are weakly basic tend to be more lipophilic and as a result 
they also tend to be among the more toxic DHPAs   
As noted above, all hepatotoxic DHPAs are esters, or have an acid moiety, and 
those with two ester groups are substantially more toxic than those with one (Culvenor, et 
al. 1976; Mattocks 1981).  Mattocks (1986) hypothesized that the reason for this increase 
in toxicity is likely a combination of increased lipophilicity as well as greater resistance 
to hydrolysis.  Because hydrolysis increases water solubility and consequently increases 
the rate of excretion, it is considered a detoxification pathway.  Therefore, resistance to 
hydrolysis enhances the toxicity of DHPAs (Mattocks 1986).  Hydrolysis is inhibited by 
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steric hindrance, which in the case of DHPAs, can be due to bulky carbon groups, acyl 
substituents, α, β-unsaturation in the acid moiety, or two acid moieties that are 
sufficiently close together (Mattocks 1986).  Additionally, the structure of the acid 
moiety may also effect chemical changes, such as the opening of the second ester linkage 
in a macrocyclic diester (after hydrolysis of the primary ester) (Mattocks 1986). 
The necine moiety must have an unsaturated (3-pyrroline ring) with associated 
hydroxyl group(s).  The location of the hydroxyl groups is of significant importance.  As 
previously mentioned two closely associated ester groups can inhibit hydrolysis, 
increasing the potential toxicity of the DHPA (Mattocks 1986).  Similar to the discussion 
of the acid and necine moieties, the total alkaloid structure and conformation largely 
determine the balance between different routes of metabolism, specifically hydrolysis, N-
oxidation, and pyrrole formation by controlling access to necessary enzymes. 
Culvenor et al. (1976) tested 62 DHPAs and DHPA derivatives on 14 day old rats 
using a single IP injection.  In this study they made multiple conclusions with regard to 
hepatotoxicity of DHPAs.  First they determined that diesters of heliotridine and 
retronecine were approximately four times as toxic as the respective monoesters.  
Heliotridine esters were two to four times as toxic as retronecine esters (Culvenor, et al. 
1976).  They also found that most compounds that produced chronic liver lesions also 
produced chronic lung lesions (although in some cases a higher dose was required).   
Mattocks and Bird (1983) tested 13 DHPAs using hepatic microsomes from 
phenobarbitone-pretreated rats.  Their results did not support the hypothesis that 
heliotridine esters are generally more hepatotoxic than retronecine esters.  They 
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concluded that the structure of the acid moiety was likely to have at least as much 
influence on toxicity as the configuration of the base (Mattocks and Bird 1983). 
N-oxides are hepatotoxic but less so than the free base alkaloids when administered 
intraperitoneally in experimental mammals. There may be no difference, however, 
following application PO, because microorganisms contribute to the reduction of N-
oxides in the gastrointestinal tract of rodents.(Frei, et al. 1992a) 
 
Human Exposure and Disease 
 
 
Human exposure has recently been reviewed in two articles (Edgar, et al. 2011; 
Molyneux, et al. 2011).  Exposure in humans differs from animals, particularly grazing 
animals.  In humans exposure tends to be due to contamination of foodstuffs such as 
cereal grains, milk, eggs, honey and pollen (Edgar, et al. 2011) or the result of 
consumption of DHPA containing herbal remedies (Roeder 1995).  Molyneux et al. 
(2011) emphasizes this point, because of the potential difference in resulting clinical 
signs.  In a given herd or flock of animals, exposure is generally a point source such as a 
particular species of poisonous plant.  Humans on the other hand may be exposed to 
small amounts of DHPAs from multiple sources and therefore one might expect to find 
quite a variation in exposure in a given population due to dietary preferences.  Because of 
this difference in exposure, one might expect the majority of animals in an affected herd 
to show clinical signs.  Conversely, in a human population few may consume a sufficient 
dose at a rate that will be overtly toxic.  Others may consistently consume a small dose 
over a long period of time.  Still others may be exposed to low-doses in a sporadic nature.  
This variation can be further compounded by the use of DHPA containing herbal 
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remedies (Molyneux, et al. 2011). As a result it can be exquisitely challenging to 
understand the true impact of DHPAs on human populations.   
In less developed countries in arid environments, diets often rely on a single source 
of grain which may be the major source of nutrition for the entire population for a period 
of time.  Such situations have resulted in exposure more similar to what is observed in 
grazing livestock where a large portion of the population is affected.  Several large point 
source outbreaks affecting humans have occurred and are well documented (Molyneux, et 
al. 2011; Roeder 1995). 
 
Food Contamination 
Grain 
Large scale DHPA poisonings in humans are typically the result of contamination 
of staple grains by seeds or other parts of DHPA containing plants.  These typically occur 
in developing countries with arid climates resulting in heavy infestation of fields with the 
more drought resistant weeds containing DHPAs (Molyneux, et al. 2011).  When the 
wheat or other cereal grains are harvested they are contaminated with DHPAs, and the 
DHPAs are incorporated into the flour during milling.   
Outbreaks resulting from cereal grain contamination have occurred in Africa, 
central Asia and India (Molyneux, et al. 2011).  One particularly devastating outbreak, in 
which an estimated 35,000 people were exposed, occurred in northwestern Afghanistan 
in the 1970s following a two year drought (Mohabbat, et al. 1976).  A clinicopathological 
study examined 7,200 people from affected villages and found that 22.6% of them had 
evidence of liver disease.  The disease was typically fatal with death occurring 3 – 9 
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months after the onset of abdominal distension (Mohabbat, et al. 1976).  The outbreak 
was caused by contamination of bread with seeds from Heliotropium spp. plants. 
 Another similar outbreak occurred in Tadjakistan in 1993 (Chauvin, et al. 1994).  
A military blockade resulted in a delay of the wheat harvest, allowing time for 
Heliotropium lasiocarpium to mature in the fields.  Contaminated wheat was then 
distributed to the population who milled it and made bread.  The result was 3,906 
reported cases of hepatotoxicity with a case fatality rate of 1.3% (Chauvin, et al. 1994).   
Honey and Pollen 
Honey and pollen have been shown to be a source of DHPA exposure (Edgar, et al. 
2011; Molyneux, et al. 2011).  DHPA content in honey has been measured and reported 
by several investigators at concentrations ranging from 1 to over 3900 g kg-1 of honey 
(Edgar, et al. 2011).  The primary source for DHPAs in honey has been determined to be 
pollen from DHPA containing plants such as Echium vulgare and species of Senecio, 
Eupatorium, Heliotropium, Borago, Myosotis, Chromolaena, Petasites, Ageratum, 
Cynoglossum, Tussilago  and Symphytum  (Edgar, et al. 2002).  Undocumented sources 
of contamination probably exist as honey attributed to sources of plants that do not 
contain DHPAs have also been found to contain up to 800 g of DHPA kg-1 of honey 
(Edgar, et al. 2011).   
Pollen can contain concentrations of DHPAs several thousand times higher than in 
honey (Edgar, et al. 2011).  Floral pollen from Echium vulgare  was found to contain 
from 8,000 to 14,000 g kg-1 and pollen from commercial sources was found to contain 
as much as 16,350 g kg-1 (Edgar, et al. 2011; Kempf, et al. 2010).  Kempf et al. (2010) 
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calculated an approximate daily DHPA intake for pollen consumers based on 30% DHPA 
contamination of pollen and an average DHPA concentration of 5.17 g g-1.  They 
calculated the average DHPA consumption at 15 g (retronecine equivalents) day-1.  This 
group further compared this DHPA exposure to the maximum daily allowance from 
German authorities of 1 g day-1, and concluded that individuals who regularly use 
pollen products (more than 6 weeks per year) are exposed to at least 300 times this 
recommended maximum daily dose (Kempf, et al. 2010). 
Milk 
The ability of DHPAs to transfer into milk has been well documented (Candrian, et 
al. 1984; Deinzer, et al. 1982; Dickinson 1980; Dickinson, et al. 1976; Eastman, et al. 
1982; Goeger, et al. 1982; Hoogenboom, et al. 2011; Johnson 1976; Lüthy, et al. 1983; 
Panariti, et al. 1997; Schoental 1959; White, et al. 1984a).  The quantity of DHPA that 
transfers into milk tends to be quite low.  Some researchers measure or estimate it as a 
percentage of the total DHPA administered to the lactating female in the neighborhood of 
0.1% (Hoogenboom, et al. 2011) or 0.04% in 16 hours (Eastman, et al. 1982).  Others 
have simply measured the DHPA concentration in the milk for example 9.4 to 16.7 g 
100 mL
-1
 of milk  (Dickinson, et al. 1976).  In these studies unfortunately there is no 
standard time point used, which makes it difficult to compare.  In one study, 32.4 mg of 
14C-seneciphylline was administered to sheep daily for five days  (Panariti, et al. 1997).  
The maximum concentration in the milk (987 ng mL
-1
) was higher than the maximum 
concentration in the blood (518 ng mL
-1
). 
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In order to determine the toxic potential of DHPAs transferred in milk, models 
ranging from the Salmonella/mammalian microsome test (White, et al. 1984a), through 
Drosophila melanogaster (Candrian, et al. 1984) to rats (Goeger, et al. 1982; Johnson 
1976) rat pups (Aston, et al. 1996; Schoental 1959)  and calves (Goeger, et al. 1982; 
Johnson 1976) have been used.  Milk from goats fed S. jacobea resulted in both negative 
and marginally positive results for different combinations of tester strains and microsome 
preparations using the Salmonella/mammalian microsome test (White, et al. 1984a).  
Drosophila fed with milk from rats fed senkirkine showed an increase in sex-linked 
recessive lethal mutations (Candrian, et al. 1984).  Models using rat pups have 
demonstrated results attributed to DHPA intoxication such as accumulation of hepatic 
copper (Aston, et al. 1996) and death with severe liver lesions (Schoental 1959).  Those 
using rats had mixed results ranging from swollen hepatocytes, biliary hyperplasia 
megalocytosis, fibrosis (Goeger, et al. 1982) to no gross or histologic abnormalities 
(Johnson 1976).  Feeding milk from cows fed with DHPAs has not resulted in grossly or 
histologically detectable abnormalities (Goeger, et al. 1982; Johnson 1976) even when 
the cows were clinically intoxicated (Goeger, et al. 1982).  The potential toxicity of 
DHPA metabolites, and their possible transfer to milk, has yet to be investigated and is 
therefore unknown  (Hoogenboom, et al. 2011).   
In a study exploring the hypothesis that a second xenobiotic agent is required with 
excess copper to produce “Indian Childhood Cirrhosis,” retrorsine was fed to female rats 
during the period when their pups were suckling (Aston, et al. 1996). 
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They measured changes in neonatal copper concentrations, serum ceruloplasmin 
concentrations and hepatic metallothionein concentrations.  They found that those pups 
whose mother received retrorsine had significantly increased hepatic copper 
concentrations, decreased serum ceruloplasmin concentrations (interpreted to indicate a 
decline or failure of copper incorporation into the apo-protein), decreased hepatic 
metallothionein and serum albumin concentrations (again interpreted to indicate reduced 
protein synthesis) and reduced hepatic DNA (interpreted to indicate an increase in cell 
size with a decrease in cell number).  This study suggests that even though the 
concentration of DHPA that transfers into milk tends to be low, it could still pose a threat 
to humans (particularly pregnant or nursing females). 
Eggs, Meat, and Vegetables 
DHPAs have been isolated from eggs at concentrations far exceeding German 
standards for DHPAs in herbal medicines (Edgar and Smith 2000).  In this case, three 
flocks of laying hens were inadvertently poisoned with seeds from Heliotropium 
europium as well as lesser amounts of other DHPA containing plants.  Concentrations of 
DHPAs ranged from 1.15 µg egg
-1
 to 9.7 µg egg
-1
.  Another group isolated europine, 
heliotridine, and senecionine from eggs of experimentally infected Japanese quail 
(Eröksüz, et al. 2008).  Concentrations of these DHPAs varied depending on the doses 
given to the quail, but the range was between 1.46 µg g
-1
 and 19.05 µg g
-1
.   
Numerous meat producing livestock are exposed to DHPA containing plants each 
year, but it is unclear whether residues of DHPAs enter the human food chain in meat 
(Wiedenfeld, et al. 2008).  Experiments using radiolabeled DHPAs have demonstrated 
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that the majority of radioactivity (80%) is eliminated within the first 24 hours (Candrian, 
et al. 1985; Eastman, et al. 1982).  The remaining radioactivity is presumed to be in the 
form of DHPA adducts (Wiedenfeld, et al. 2008).  The potential danger of adducts is not 
yet understood, but there is concern that these adducts can form in vivo reservoirs 
resulting in continued damage to adjacent cellular components as well as a source of 
subsequent exposure to reactive DHPA metabolites via secondary poisoning (Edgar, et 
al. 2011; Wiedenfeld, et al. 2008). 
Leafy DHPA producing plants such as comfrey are sometimes used intentionally in 
salads (Edgar, et al. 2011).  There are also reports of DHPA producing plants being found 
as unintentional contaminants of foods such as salads and spices (Edgar, et al. 2011; 
Molyneux, et al. 2011).  In one case a family used DHPA contaminated spices liberally 
during a time when the mother was pregnant (Rasenack, et al. 2003).  The baby was 
delivered pre-term via cesarean section suffering from hepatic veno-occlusive disease, 
and subsequently died. 
Herbal Medicines 
 A complete review of DHPA toxicity with relation to herbal medicine is far 
beyond the scope of this review.  The following examples are intended to provide some 
insight into what is a much broader and more complex situation than can be fully 
explored here. There are an abundance of case reports in multiple countries with different 
ages and genders of patients.  Invariably, those responsible for a patient taking a 
medicine/herb intended for the medicine/herb to have a beneficial effect on the patient. 
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 As has been shown with other animal species, the very young tend to be the most 
susceptible in humans as well.  A five day old infant was referred to a neonatal intensive 
care unit with jaundice, hepatomegaly and ascites (Roulet, et al. 1988).  The cause was 
determined to be consumption of herbal tea containing senecionine by the mother during 
pregnancy.  In this case the total DHPA consumption was calculated to be 0.6 mg kg
-1
.  
There is no report of clinical signs in the mother, but the infant died. 
Adults tend to be less susceptible, but have also been poisoned by consumption of 
herbal medicines.  Four young Chinese women used “Indian” herbal tea as a treatment 
for psoriasis (Kumana, et al. 1985).  Three developed symptoms of veno-occlusive 
disease (VOD) including ascites and hepatomegaly as well as serum biochemical 
abnormalities within 19 to 45 days.  The remaining patient stopped taking it after 21 days 
due to the development of a skin rash.  The average DHPA consumption of the three 
women was estimated to be 18 mg kg
-1
.  One of the three women died.  
Any DHPA containing plant has the potential to result in poisoning, but due to 
frequency of use some are more commonly reported than others.  Comfrey has been the 
source of poisoning in multiple reports.  A thirteen year old boy developed hepatomegaly 
and ascites after taking comfrey tea as a treatment for Crohn’s disease (Weston, et al. 
1987), and a 47 year old woman also developed VOD as a result of consuming comfrey 
tea (Bach, et al. 1989).  DHPA containing plants have been and continue to be common 
in various herbal teas, consumption of which has resulted in adverse clinical signs in 
humans from infants (Sperl, et al. 1995) to adults (Ridker, et al. 1985). 
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Associated Diseases 
Hepatic Veno-occlusive Disease (Sinusoidal Obstructive Syndrome) 
One of the most common clinical signs in the large point source outbreaks is 
hepatic VOD, more recently termed sinusoidal obstructive syndrome (SOS).  In the 1993 
Tadjakistan outbreak four different stages of illness were described (Chauvin, et al. 
1994).  The first stage consisted of abdominal pain, nausea or vomiting, and asthenia.  
Patients suffering from stage one symptoms universally recovered.  Stage two consisted 
of stage one symptoms with the addition of hepatomegaly.  Patients who developed 
ascites in addition to stage two symptoms were classified as stage three.  Stage four 
included all previous symptoms as well as altered consciousness (Chauvin, et al. 1994).   
VOD is the result of toxic injury to sinusoidal endothelium (Crawford 2004), and is 
characterized clinically by hepatomegaly, ascites, weight gain and jaundice (Chen and 
Huo 2010).  The injured cells round up and slough off the sinusoidal wall, resulting in 
downstream embolization and obstruction of sinusoidal blood flow.  It is characterized 
histologically by obliteration of the hepatic vein radicals with various amounts of 
reticulated collagen.  Acutely there is profound centrilobular congestion and 
hepatocellular necrosis.  Over time there is progressive obliteration of the lumen of the 
hepatic venule.  Chronic lesions are characterized by fibrosis radiating out into the 
parenchyma, with frequent total obliteration of the venule.  At this point congestion has 
been replaced by hemosiderin deposition (Crawford 2004). 
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Other Associated Diseases/Syndromes 
The liver is the major target organ for acute DHPA toxicity and in humans 
primarily results in sinusoidal obstructive syndrome as described above.  Other 
diseases/syndromes associated with DHPA toxicity include pulmonary hypertension and 
various forms of cancer.  Neither of these has been definitively associated with DHPA 
exposure in humans up to this point.  However, there is at least one case of pulmonary 
hypertension where DHPA exposure was present and suspected as the possible cause 
(Gyorik and Stricker 2009).  As described previously DHPAs (riddelliine and 
lasiocarpine) have been listed by the IARC as class 2b carcinogens (IARC 1987; 2002).   
Exposure to monocrotaline as well as fulvine have both been associated with 
pulmonary hypertension particularly in rats (Kay, et al. 1971; Wilson, et al. 1992).  
Monocrotaline has also been associated with pulmonary arterial hypertrophy and cor 
pulmonale in young stump tailed macaques (Allen and Chesney 1972).  Monocrotaline 
pyrrole injected IV into rats produced pulmonary hypertension and right heart 
hypertrophy in vivo and resulted in DNA cross-linking of pulmonary endothelial cells in 
vitro (Wagner, et al. 1993).  Donkeys fed C. retusa  as well as C. juncea developed 
pulmonary lesions including interstitial fibrosis and Clara cell proliferation (Pessoa, et al. 
2013). 
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CHAPTER III 
COMPARATIVE TOXICITY OF SELECT DEHYDROPYRROLIZIDINE 
ALKALOIDS AND N-OXIDES IN CHICKS (GALLUS GALLUS DOMESTICUS) 
 
Abstract 
 
 
Dehydropyrrolizidine alkaloids (DHPAs) are a large, structurally diverse group of 
plant-derived pro-toxins that are potentially carcinogenic.  With worldwide significance, 
these alkaloids can contaminate or be naturally present in the human food supply.  Due to 
the difficulty in obtaining large quantities of purified DHPAs, the majority of research 
has been done using intraperitoneal injections in rodent models, which is often very 
different than results via normal exposure of ingestion.  Furthermore, few studies 
compare more than a couple of DHPAs, consequently comparisons must be done 
between studies with differences in age, strain and dosing strategies.  To assess the 
relative toxicity of structurally diverse DHPAs in a biologically relevant manner, chicks 
were dosed orally with 0.01, 0.04, 0.13 or 0.26 mmol of riddelliine, senecionine, 
seneciphylline, echimidine, lycopsamine, lasiocarpine, heliotrine, riddelliine N-oxide, 
senecionine N-oxide or lasiocarpine N-oxide kg
-1
 bodyweight for 10 days.  After another 
7 days, chicks were euthanized.  Based on clinical, serum biochemical, and 
histopathological evaluations as well as “pyrrole” (a DHPA metabolite) tissue adduct 
accumulation rate, these different DHPAs are grouped in relation to their toxicity.  In this 
model heliotrine, lasiocarpine, and the three macrocylic diesters (seneciphylline, 
senecionine and riddelliine) appear to be most toxic followed by the three N-oxides 
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(riddelliine N-oxide, senecionine N-oxide and lasiocarpine N-oxide).  Echimidine was 
next and lycopsamine appear to be the least toxic of the compounds tested in this model.  
This model is sensitive for comparison of DHPA toxicity, and data obtained from this 
research can be used to validate previous research in a more biologically relevant 
exposure. 
  
101 
 
Introduction 
 
Dehydropyrrolizidine alkaloids (DHPAs) are a large and structurally diverse group 
of pro-toxins produced by plants assumedly as a protection against herbivory.  Present 
worldwide (Stegelmeier, et al. 1999), and estimated to be produced by approximately 
three percent of flowering plants  (Smith and Culvenor 1981); they are likely the most 
economically important plant toxins.  Not only do DHPAs effect livestock, poultry, swine 
and most likely wildlife, they are also present in numerous herbal preparations, and 
are potential contaminants of foods, such as grains (Chauvin, et al. 1994; Mohabbat, et 
al. 1976), eggs (Edgar and Smith 2000), honey (Edgar, et al. 2002), milk (Dickinson, et 
al. 1976), and occasionally fresh salads (Edgar, et al. 2011).  After they are eaten and 
absorbed into the body they are metabolized, primarily by CYP3A family enzymes, 
producing highly reactive dihydropyrrolizine esters.   
Even though reported natural exposure is exclusively oral, the vast majority of 
research devoted to determining the relative toxicity of DHPAs has been done by using a 
single intraperitoneal injection (IP) in rodents (Mattocks 1986).  Although potentially 
useful as a baseline, data obtained by using this method presupposes that between 
different DHPAs there are no significant differences in absorption, no significant toxic 
effects produced by DHPAs prior to reaching the liver, and that absorption rates into the 
liver either are the same as oral exposure or the rate does not affect the toxicity.  
Additionally, different studies used relatively resistant rodents with different 
varieties/strains, strains, and sexes, making comparisons difficult.  Using this single 
injection IP method it has been determined that DHPAs with the heliotridine base are 
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approximately two times more toxic than those with a retronecine base (Culvenor, et al. 
1976) (Fig. 3-1).  Side chains were also determined to affect the toxicity.  Those with two 
ester linked side chains were found to be more toxic than those with a single ester linked 
side chain, and those with two ester side chains that connect with each other (macrocyclic 
diesters) were found to be more toxic than open chain diesters (Culvenor al. 1976, 
Mattocks 1986) (Fig. 3-2).  Based on these guidelines Senecio douglasii var longilobus 
(which contains primarily macrocyclic diesters) would be expected to be more toxic than 
Cynoglossum officinale (which contains a mixture of mono and open chain diesters).  
This does not correlate well with oral exposure studies where they have very similar 
toxicities.  The LD50 for Cynoglossum officinale was less than 15 mg kg
-1
 for 14 days in 
horses (Culvenor, et al. 1976; Mattocks 1986; Stegelmeier, et al. 1996) and cattle (Baker 
et al. 1989), whereas the LD50 for Senecio douglasii var longilobus was 13 mg kg
-1
 for 
15 days (Johnson and Molyneux 1984) when orally dosed to cattle.  N-oxides are less 
hepatotoxic than their associated free base when administered IP in experimental animals, 
but there may be no difference when administered (Frei, et al. 1992b).  Due to these 
shortcomings as well as some contradictory experience in the laboratory (Stegelmeier, 
unpublished data), it was determined that a more biologically relevant model was needed 
to test relative toxicity of DHPAs.   
 
 
Figure 3-1. Necine bases (A) retronecine & (B) heliotridine 
A B 
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Figure 3-2. Necine bases with A. monoester (echinatine), B. diester (echimidine) and C. 
macrocyclic diester (senecionine) side chains. 
 
Due to the difficulty of obtaining purified DHPAs it was essential that a small 
sensitive model would be necessary.  Hooper (1978) reported the relative species 
sensitivity to DHPAs as follows: pigs = 1, chickens = 5, cattle and horses = 14, rats = 50, 
mice = 150, and sheep and goats = 200.  It is also well documented that younger 
individuals are much more sensitive to DHPA intoxication than adults (Mattocks 1986), 
and that in at least some species males are more sensitive than females.  As a result, we 
used male chicks as a model for DHPA toxicity testing. 
 
Materials and Methods 
 
 
Animals 
Three-day-old male, California White chicks (GALLUS GALLUS DOMESTICUS) 
were purchased from Privett Hatchery (Portales, New Mexico) through Intermountain 
Farmers Association (Hyde Park, Utah).  All animals were acclimated for three days prior 
to initiation of treatment.  Chicks were housed in brooder cages that contained heaters, 
providing a thermal gradient within their microenvironment which ranged from roughly 
A B C 
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16 to 25ᵒC.  All animals had free access to fresh water and 20% protein poultry starter 
purchased from Intermountain Farmers Association (Salt Lake City, Utah).  The brooder 
cages were housed in a room with access to ambient sunlight.  Because this study was 
divided into multiple sections and performed at various times throughout the year, room 
lights were left on if ambient light was less than 12 hours per day, such that the total 
lighting was at least 12 hours per day.  Humidity in the brooder cages was essentially 
ambient humidity which ranged from approximately 30% to 60% during the course of 
this study.  This research was conducted with the approval of the Utah State University 
animal care and use committee (IACUC Protocol #2055). 
 
Purified Alkaloids 
All of the DHPAs and N-oxides used were from the USDA ARS Poisonous Plant 
Research Laboratory’s collection of dehydropyrrolizidine alkaloids.  They were all 
authenticated using liquid chromatography mass spectrometry and NMR, and estimated 
to be at least 98% pure. 
 
Experimental Design 
Male, California White chicks were randomly divided into groups of five, assigned 
to a treatment group, and dose with one of the following:  Riddelliine, riddelliine N-
oxide, senecionine, senecionine N-oxide, seneciphylline, lasiocarpine, lasiocarpine N-
oxide, heliotrine, lycopsamine, or vehicle control.  Because these compounds differ in 
molecular weight, the dosages were calculated and dosed in mmols.  The doses for all 
except those animals receiving lycopsamine, or vehicle control were 0.01, 0.04, 0.13, and 
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0.26 mmol kg
-1
 body weight (BW) day
-1
.  The vehicle control animals received a volume 
equivalent to the largest volume received by any group.  Because previous IP studies 
suggested that lycopsamine is less toxic than the other DHPAs used in this study, the 
animals receiving lycopsamine received 0.04, 0.13, and 0.26 mmol kg
-1
 BW day 
-1
.  
Riddelliine is comparatively easier to extract and purify, has been widely studied and was 
tested for the pilot study for this project, hence riddelliine was used as a positive control 
and was dosed at 0.13 mmol kg
-1
 BW day
-1
 for each individual trial.  Positive and vehicle 
control groups consisted of five chicks for each trial.  All daily doses were divided into 
two equal portions, and water was added to all doses such that the total volume was 0.5 
mL.  One half of each daily dose was given in the morning and one half was given in the 
afternoon by gavage.  Animals were weighed three times per week, and doses were 
recalculated immediately after weighing and dosages were adjusted ensuring proper 
treatment.  All animals were dosed for 10 days after which they were maintained on the 
above mentioned commercial chick ration for the following seven days prior to 
euthanasia with carbon dioxide to allow histologic lesions to fully develop.  Animals 
were monitored at least twice daily, and animals which became moribund were humanely 
euthanized and necropsied. 
 
Tissue Preparation 
After euthanasia, necropsies were performed on all animals.  Gross abnormalities 
were recorded, and tissues including the entire brain, heart, lung, right liver lobe, and 
spleen, and representative samples of kidney, testicle, crop, proventriculus, ventriculus, 
small intestine, colon, cecum, and bursa of Fabricius, were collected in 10% neutral 
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buffered formalin for histopathological analysis.  The right liver lobe was sectioned 
randomly to facilitate morphometric study.  This was done by using a random number 
chart to determine the start location (mm 0-3) and the entire  right liver lobe was 
sectioned every 3 mm transversely along the long axis, laid left face down in the cassette 
and embedded, sectioned, fixed on glass slides  and stained.  Blood samples were taken 
immediately after euthanasia via cardiac puncture, divided into serum and packed cells, 
and frozen.  The left liver lobe of the liver was collected and stored at -80 degrees C for 
subsequent analyses including DHPA adduct evaluation. 
 
Hepatocellular Necrosis Scoring 
Due to the large variation in liver size between animals, all sections of the right 
liver lobe could occupy from one to four slides.  Each slide was graded by examining all 
sections on that slide and scored for necrosis as follows:  0 - no observed hepatocellular 
necrosis; 1 - scattered individual cell death; 2 - multifocal areas of necrosis which 
encompassed up to 25% of the sections on that slide; 3 - larger areas of necrosis were 
present accounting for between 25 and 50% of the sections; and 4 - greater than 50% of 
the observed sections were necrotic (Fig. 3-3).  The hepatic necrosis score for each 
animal was computed by taking the average of the necrosis scores for each slide of liver 
tissue from that animal. 
 
Protein “Pyrrole” Adduct Detection 
Procedures for “pyrrole” adduct detection were identical to those described in 
Brown et al. 2015.  Briefly, frozen liver lobes were freeze dried and crushed into fine 
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powder.  A 25 mg portion of the crushed, freeze dried, chicken liver was mixed with 
ethanolic silver nitrate and trifluoroacetic acid overnight, centrifuged, mixed with 
Erlich’s solution (ρ-Dimethylaminobenzaldehyde or DMABA), and analyzed with an 
HPLC-esi(+) MS/MS system.  The pyrrole-DMABA compound eluted with a retention 
time of 4.4 min and the resulting MS/MS spectrum contained major fragment ions at m/z 
252 and 296.  The detected “pyrrole” peak area was measured from the reconstructed ion 
chromatogram (m/z = 296) and quantified based on an external calibration curve 
established from control standards.  The resulting “pyrrole” concentration (nmol mL-1) of 
the injected sample was converted to nmol g
-1
 of liver.  
Reagents and solvents 
 Monocrotaline (crotaline) (used to make the positive control standard), 
tetrachlorobenzoquinone (ο-chloronil, 97%), boron trifluoride diethyl etherate 
(BF3·O(C2H5)2) and silver nitrate were purchased from Sigma-Aldrich.  ρ-
Dimethylaminobenzaldehyde (DMABA, Erlich’s reagent) was from ICN Biochemical 
(Cleveland, Ohio). Acetonitrile was HPLC grade (Sigma-Aldrich) and absolute ethanol 
was reagent grade.  0.1% formic acid for HPLC was prepared with Milli-Q-purified (18.2 
MΩ cm-1) water. 
Ethanolic silver nitrate, “pyrrole” calibration standards, and Erlich’s solution were 
prepared as described in Brown et al. 2015. 
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Figure 3-3. Sections of livers from chicks exposed to dehydropyrrolizidine alkaloids.  A-
E H&E.  A. Hepatocellular necrosis score = 0 (Control) 200X  B. Hepatocellular necrosis 
score = 1 There is a single hepatocytes with a pyknotic nucleus (arrow), and multiple 
hepatocytes are swollen with vacuolated cytoplasm (open arrow) (Riddelliine N-oxide 
0.04 mmol kg
-1
) 200X.  C.  Hepatocellular necrosis score = 2 The inset shows the border 
of a necrotic area.  Hepatocytes are surrounded by hemorrhage.  (Lasiocarpine N-oxide 
0.13 mmol kg
-1
) 40X with 200X insert.  D.  Hepatocellular necrosis score = 3 Larger 
areas of necrosis are present occupying (senecionine 0.26 mmol kg
-1
) 100X.  E.  
Hepatocellular necrosis score = 4 The majority of this section is composed of necrosis 
and hemorrhage.  The inset contains hepatocytes with fragmented, pyknotic nuclei 
(arrow) as well as individualized hepatocytes surrounded by hemorrhage (open arrow).  
(Heliotrine 0.26 mmol kg
-1
) 100X with 400X insert.  
A B 
C D 
E 
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“Pyrrole” Accumulation Rate Analysis 
 
Comparison of “pyrrole” concentration between compounds and doses was 
challenging due to the fact that chicks died at different time points and consequently 
received different total amounts of DHPA and clearance times.  In an effort to account for 
this difference,a comparison was performed by calculating a “pyrrole” accumulation rate.  
In any diagnostic test as sensitivity increases, the possibility of false positive results 
increases.  In the present study, a trace amount of “pyrrole” was detected in two of the 
negative control animals.  In order to account for this, the average negative control 
“pyrrole” concentration was subtracted from each individual “pyrrole” concentration to 
give a control adjusted “pyrrole” concentration.  The control adjusted “pyrrole” 
concentration was then divided by the number of days the animal survived to account for 
the differences in total DHPA administered to each animal based on survival time.  This 
control adjusted “pyrrole” accumulation rate was used in a log transformed model to 
predict the “pyrrole” accumulation rate for each alkaloid at each dose.  The data shown in 
Table 3-3 was back transformed.  This data should be used with caution because little is 
currently known about the potential clearance rate of the pyrrole from the liver.  If chicks 
are able to remove the pyrrole from the liver at a rate relevant to the present study 
timeline, then this approach for comparison may not be appropriate. 
 
Weight Analysis 
With the animal numbers used for each group, there was not sufficient power to 
determine differences in average daily gain between groups and doses.  A repeated 
measures comparison of weights provides more statistical power.  Directly comparing 
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actual weights would be the preferred method, but because chicks died at different time 
points throughout the study, this method would preclude comparisons at higher doses of 
more toxic compounds.  In order to account for these challenges, repeated weights were 
used to create a model estimate for each compound at each dose at the average number of 
survival days (10 days).  There was some difference in initial weights which can affect 
the weights as measured over time.  Consequently, initial weight was used as a covariate.  
SAS 9.4 was used to create the model estimate.  Controls for weight were randomly 
selected from all of the controls and assigned to each dose for comparison. 
 
Serum Biochemistry Analysis 
 
Frozen serum was sent to a commercial laboratory (Antech Laboratories, 
Indianapolis, Indiana) for analysis of total protein, glucose, triglycerides, cholesterol, 
gamma glutamyl transferase (GGT), aspartate aminotransferase (AST), lactate 
dehydrogenase (LDH), sorbitol dehydrogenase (SDH), bile acid, and creatine 
phosphokinase (CPK).  Principle component analysis of serum biochemistries was 
performed on standardized variables.  Three components were used, which explain 77% 
of the variation in the model.  The first component corresponds to hepatic metabolic 
products.  The major contributing variables of the first component are total protein, 
glucose, cholesterol, and triglycerides.  The second component corresponds to 
hepatocellular damage and is composed of the two hepatocellular leakage enzymes 
aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) along with a lesser 
contribution from bile acid.  Principle component three is composed primarily of gamma 
glutamyl transferase (GGT) with a smaller contribution from bile acid. Controls for 
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principle component analyses were randomly selected from all of the controls and 
assigned to each dose for comparison. 
 
Statistical Analysis 
 
  All statistical analyses were performed using SAS version 9.4 in PROC GLIMIX 
except for the survival analysis which was performed using PROC LIFETEST.  
Hepatocellular necrosis scores were compared as multinomial outcomes with alkaloid 
and dose as fixed factors in the model.  A survival analysis was performed using PROC 
LIFETEST with initial weight as a covariate. 
 
Results 
 
 
Weight 
  Within a given alkaloid group, model estimated chick weights decreased as dose 
increased for all alkaloids except for lycopsamine (Table 3-1).  Within the two 
heliotridine base alkaloids (heliotrine and lasiocarpine), each successive dose resulted in 
a significant decrease in the projected ten day weight.  An estimated weight for the 
heliotrine 0.26 mmol Kg
-1
 group was not calculated because all animals in this group died 
within one day of initial dose.  The three macrocyclic diesters (seneciphylline, 
senecionine, and riddelliine) all showed a difference between the two lower doses and the 
two upper doses.  There was also a difference between the lower two doses in both 
senecionine and riddelliine.  The three N-oxides (senecionine N-oxide, riddelliine N-
oxide, and lasiocarpine N-oxide) animal groups began to become lighter at the 0.13 mmol 
kg
-1
 dose and all three are significantly lighter at 0.26 mmol kg
-1
 than at 0.13 mmol kg
-1
.  
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Echimidine is similar to the N-oxides in that the lower two dosed animal groups are 
heavier than the higher two doses.  There is no difference however, between the two 
higher doses.  There was no difference in weight projections between any doses of 
lycopsamine. 
 
Table 3-1.  Projected Weight comparison at the average number of survival days (10) for 
California White chicks exposed to dehydropyrrolizidine alkaloids.  Weights were 
derived in a mixed model, using initial weight as a covariate.  Superscript letters denote 
statistical differences within a row, and superscript numbers denote statistical differences 
within a column.  A p-value of < 0.05 was considered significant.  Explanations for 
abbreviations are as follows:  CNT – control, HEL – heliotrine, LAS – lasiocarpine, SPH 
– seneciphylline, SEN – senecionine, RID – riddelliine, RNO – riddelliine N-oxide, SNO 
– senecionine N-oxide, LNO – lasiocarpine N-oxide, ECH – echimidine, LYC – 
lycopsamine, and NA - not available. 
 
Dose  
(mmol 
kg
-1
) 
CNT 
(g) 
HEL 
(g) 
LAS 
(g) 
SPH 
(g) 
SEN 
(g) 
RID 
(g) 
RNO 
(g) 
SNO 
(g) 
LNO 
(g) 
ECH 
(g) 
LYC 
(g) 
0.01 105
abc 
99
1bc 
109
1ab 
92
1c 
92
1c 
99
1bc 
96
1bc 
97
1bc 
97
1bc 
120
1a 
 NA 
0.04 103
def 
67
2a 
84
2bc 
78
1ab 
77
2ab 
78
2ab 
92
1bcde 
87
1bcd 
97
1cdef 
110
1f 
108
ef 
0.13 105
e 
48
3ab 
49
3ab 
46
2a 
59
3abc 
53
3ab
 73
2bc 
63
2bc 
75
2bc 
85
2d 
102
e 
0.26 105
d 
 NA 20
4a 
22
2ab 
36
3ab 
35
3ab
 58
3b 
38
3ab 
56
3b 
78
2c 
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There were some individual differences in weight projections between alkaloids at 
0.01 mmol kg
-1
, but at the 0.04 mmol kg
-1
 dose alkaloids began to separate somewhat into 
groups.  At the 0.04 mmol kg
-1
 dose the two heliotridine based alkaloids as well as the 
three macrocyclic diesters had significantly lower projections than the controls.  This 
group (the heliotridine based alkaloids and the three macrocyclic diesters) remains the 
lightest throughout all higher doses, although there is substantial overlap, and in most 
cases few differences were found between the most toxic group and the three N-oxides.  
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The three N-oxide groups had lower projections than controls beginning at the 0.13 mmol 
kg
-1
 dose, and with the exception of lasiocarpine N-oxide at 0.04mmol kg
-1
 that had 
significantly lower projections than echimidine.  Echimidine, the only open chain diester 
with a retronecine base, formed its own group.  Echimidine exposed chicks were 
projected heavier than all but the controls and lasiocarpine at the 0.01 mmol dose, and 
heavier than all but controls, lasiocarpine N-oxide, and lycopsamine at the 0.04 mmol 
dose. The projected weight of the top two doses of echimidine exposed chicks was less 
than lycopsamine exposed chicks and controls, but higher than all other groups.  
Lycopsamine was not different than control at any of the doses used in this study.   Based 
on weight, the rough order of toxicity with the most toxic first is:  seneciphylline, 
heliotrine, lasiocarpine, senecionine riddelliine, senecionine N-oxide, riddelliine N-oxide, 
lasiocarpine N-oxide, echimidine, and lycopsamine (Table 3-1). 
 
Survival Analysis 
  Using PROC LIFETEST a survival analysis was performed and the output is 
shown in Table 3-2.  Because this study was designed primarily to maximize the 
histologic lesions and facilitate their grading, it functions poorly to test survival.  The 
doses, animal numbers and incubation time to set the histologic lesions were not 
calculated to maximize power in this area.  Although perhaps not as sensitive as the 
weight comparisons the same trends still apply.  Heliotrine is the alkaloid that ranks 
highest in likelihood to result in death.  It groups with the macrocyclic diesters and the 
other heliotridine base, lasiocarpine.  Although substantial overlap is present, the next 
group is made up of the N-oxides followed by echimidine and then lycopsamine.  For the 
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survival analysis the initial weight affected the outcome, and consequently initial weight 
was used as a covariate. 
 
Table 3-2.  Survival analysis of California White chicks exposed to dehydropyrrolizidine 
alkaloids. A higher number denotes an increased likelihood of dying.  The key to 
abbreviations for alkaloids is as follows:  HEL – heliotrine, SPH – seneciphylline, RID – 
riddelliine, LAS – lasiocarpine, SEN – senecionine, SNO – senecionine N-oxide, RNO – 
riddelliine N-oxide, LNO – lasiocarpine N-oxide, ECH – echimidine, and LYC – 
lycopsamine.  Superscript letters denote statistical significance at p <0.05 
 
Survival Analysis  
 
 
 
 
 
Alkaloid Log-Rank 
HEL 8.782
a 
SPH 5.406
ab 
RID 5.077
abcd 
LAS 4.842
abc 
SEN 3.623
abc 
SNO -0.571
bcd 
RNO -1.254
bcde 
LNO -4.905
cde 
ECH -7.333
de 
LYC -13.666
e 
 
Tissue “Pyrrole” Accumulation Rate 
DHPA adducts or “Pyrroles” were detected in the livers of chicks treated with every 
alkaloid at every dose (Table 3-3).  Within alkaloids, the “pyrrole” accumulation rate 
tends to increase with dose such that with the exception of echimidine and lycopsamine, 
the highest dose of each alkaloid is significantly different than the lowest dose of that 
same alkaloid.  There are no significant differences between any alkaloids in either of the 
lowest two doses. “Pyrrole” concentrations and accumulation rates for riddelliine were 
much higher than any other alkaloid.  These high rates were consistent and repeatable as 
riddelliine was used as a positive control for the various experimental phases.  Riddelliine 
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accumulation rate was included in Table 3.3, and was statistically different than all the 
other DHPAs, but removed from the statistical model comparison to facilitate identifying 
differences between other compounds.  Heliotrine, lasiocarpine, and seneciphylline had a 
higher “pyrrole” accumulation rate at 0.13 mmol kg-1 than at the two lower doses, and at 
the highest dose all alkaloids with the exception of echimidine and lycopsamine had a 
significantly higher “pyrrole” accumulation rate when compared with all lower doses of 
the same compound. 
With the exception of riddelliine, the highest “pyrrole” accumulation rates for the 
two high doses were found in the heliotridine base group (heliotrine and lasiocarpine).  
At the 0.13 mmol kg
-1
 dose they were grouped with the remaining two macrocyclic 
diesters (senecionine and seneciphylline).  At the highest dose the “pyrrole” accumulation 
rate for heliotrine and lasiocarpine was significantly higher than all other groups (except 
riddelliine).  The N-oxides tend to form a group that overlaps with both the higher group 
just discussed and the lower group, which is composed of echimidine and lycopsamine.  
Both echimidine and lycopsamine do not show a significant dose dependent increase in 
“pyrrole” accumulation rate.  Based on “pyrrole” accumulation rate, the order of toxicity 
is as follows:  Riddelliine, heliotrine and lasiocarpine, senecionine and seneciphylline, the 
three N-oxides (riddelliine N-oxide, senecionine N-oxide, and lasiocarpine N-oxide), and 
echimidine and lycopsamine. 
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Serum Biochemistry 
Serum biochemistries were analyzed using a principle component analysis after 
standardizing the variables.  Two of the variables, creatine phosphokinase (CPK) and 
sorbitol dehydrogenase (SDH), did not contribute significantly to the variation in the 
model, and were therefore dropped from the analysis.  CPK is a muscle specific enzyme 
which was originally included in the analysis to provide ability to determine if elevations 
in AST were of hepatic or muscle origin.  In no case was there a rise in AST that 
corresponded with a rise in CPK.  Consequently, it was assumed that elevations in AST 
were not of muscle origin.  Three components were included in the principle component 
analysis, and they explained 77% of the variation in the model.   
As explained previously, the three components corresponded to biologically 
relevant aspects of hepatic function or damage.  Major contributors to component one 
were total protein, glucose, cholesterol, and triglycerides, all of which correspond to 
hepatic metabolic functions.  In every case the values for component one are lower for 
the higher two doses than for the lower two doses (Table 3-4A).  Echimidine did differ 
between the 0.01 mmol kg
-1
 and 0.26 mmol kg
-1
.  Unfortunately, due to animal deaths, 
blood was not taken from more than one animal in the following groups:  heliotrine 0.13 
mmol kg
-1
, and lasiocarpine, senecionine, and senecionine N-oxide all at 0.26 mmol kg
-1
.  
Because it was anticipated that lycopsamine would be less toxic than other compounds 
the lowest dose tested was 0.04mmol kg
-1
.   
Principle component two (Table 3-4B) corresponds to hepatocellular damage with 
major contributors of AST, LDH, and to a lesser extent bile acid.  Only heliotrine and 
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echimidine show a dose dependent increase in the value for principle component two.  At 
0.26 mmol kg
-1
, the principle component two value for heliotrine is significantly higher 
than all other compounds.  This corresponds with the histologic characterization of 
heliotrine.  An interesting pattern is present in seneciphylline, riddelliine, riddelliine N-
oxide, lasiocarpine N-oxide, and lycopsamine were there is an increase in the value of 
component two followed by a decrease at the highest dose.  This decrease from the 0.13 
mmol kg
-1
 group to the 0.26 mmol kg
-1
 group was only significant for riddelliine and 
riddelliine N-oxide. 
Principle component three, with major contributions from the inducible hepatic 
enzyme, GGT and bile acid, often demonstrated a trend within a compound where there 
was an initial increase followed by a decrease (Table 3-4C).  This pattern was 
demonstrated particularly well with heliotrine, seneciphylline, riddelliine, and riddelliine 
N-oxide.  Because the rise and fall in value happened at different doses for different 
compounds, it can be difficult to interpret differences between values at any given dose.  
Heliotrine peaks at the 0.04 mmol kg
-1
 dose, seneciphylline, riddelliine, and riddelliine N-
oxide peak at 0.13 mmol kg
-1
, echimidine appeared to increase at least at the 0.26 mmol 
kg
-1
 dose, and lasiocarpine N-oxide and lycopsamine stayed constant throughout.  
Lasiocarpine, senecionine, and senecionine N-oxide had increased values at the 0.13 
mmol kg
-1
 dose, but because only one sample for each of these groups was obtained, 
estimates were not calculated for the 0.26 mmol dose.  Using the dose at which 
component three peaked, crude toxicity rankings can be made.  The most toxic in this 
case is heliotrine, followed by seneciphylline, riddelliine, senecionine, riddelliine N-
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oxide, senecionine N-oxide, and lasiocarpine.  The next most toxic compound is 
echimidine.  Lasiocarpine N-oxide and lycopsamine are the least toxic compounds using 
this criterion. 
Toxicity, from a gross pathology perspective, can be ranked based on the lowest 
dose resulting in ascites.  Heliotrine and senecionine are therefore most toxic at 0.04 
mmol kg
-1
, followed by seneciphylline, riddelliine, senecionine N-oxide, riddelliine N-
oxide, lasiocarpine, and lasiocarpine N-oxide at 0.13 mmol kg
-1
.  Echimidine is next with 
chicks developing ascites at 0.26 mmol kg
-1
, and lycopsamine is least toxic with no 
animals developing ascites.  
 
Histopathology 
 
The majority of DHPA associated lesions were centered in the liver.  There was a 
range of lesions from massive acute hepatic necrosis, which tended to be more common 
in high dose animals, to hepatocellular loss with evidence of regeneration.  The most 
severe lesion and the most common cause of mortality prior to the end of the study was 
centrilobular to massive, diffuse hepatic necrosis.  This was characterized by loss of 
hepatic cords, individualized hepatocytes that often had pyknotic nuclei, collapse of 
lobular structure with vascular sinusoid expansion and massive vascular congestion and 
hemorrhage (Fig. 3-3E).  Lesions tended to have a patchy distribution, and within the 
same animal it was common to see large areas of necrosis separated by areas that 
appeared relatively normal.  Although the necrotic areas appeared to be primarily 
centrilobular, the lesions were not diffuse in most cases, such that centrilobular areas   
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were not all equally affected.  In severely affected animals the necrosis within lobules 
was more likely to be massive and there were fewer unaffected/less affected areas.  In 
less severely affected individuals, hepatocytes were often swollen with microvesiculated 
cytoplasm, and necrotic foci occupied a much smaller proportion of the liver.  There were 
microscopic foci of angiectasis characterized by a focal loss of hepatic cords with the 
potential space taken up by peripheral blood and typically surrounded by a single layer of 
endothelium. 
More chronic lesions consisted of an overall loss of hepatocytes visualized by a 
closer proximity between portal areas.  These portal areas were often characterized by 
biliary hyperplasia and bile duct reduplication (Fig. 3-4).  The capsule was occasionally  
 
 
Figure 3-4. Liver from a chick exposed to riddelliine N-oxide (0.26 mmol kg
-1
) showing 
regeneration.  Regenerative cells often form small ducts (arrow).  There is a hepatocyte 
with a mitotic figure (open arrow). 
Figure 3-5. Liver from a chick exposed to senecionine (0.13 mmol kg
-1
) that has capsular 
serositis.  Not the markedly thickened capsule (line).  In some cases capsular serositis 
was accompanied by foci of mononuclear inflammatory cells in the subcapsular 
hepatocellular parenchyma (arrow). 
4 5 
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thickened and composed of a variably dense mixture of inflammatory cells, fibroblasts, 
an eosinophilic acellular matrix (interpreted as collagen), and fibrin (Fig. 3-5). 
Figure 3.6 demonstrates the probability of the hepatocellular necrosis score falling 
into each category, and is organized by alkaloid and dose. For all alkaloids excepting 
lycopsamine, the proportion of higher histologic hepatocellular necrosis scores increased 
as dose increased.  Similar to weight and survival data, the heliotrine dosed animals 
tended to have the highest hepatocellular necrosis scores.  At the lowest dose, all groups 
fall into the normal (0) score except for heliotrine and senecionine.  These two alkaloids 
had a relatively small proportion that fell into a hepatocellular necrosis score of one or 
much less likely a score of two.  At the 0.04 mmol kg
-1
 dose all but four alkaloids 
(lasiocarpine, lasiocarpine N-oxide, echimidine, and lycopsamine) had a greater than 
50% proportion that fell into a hepatocellular necrosis score of at least one.  At this dose 
both heliotrine and senecionine had greater than 50% of their scores falling into a score 
category of 2.   
At 0.13 mmol kg 
-1
 the greatest proportion of lycopsamine and lasiocarpine N-oxide 
were still normal (score of 0), whereas all other alkaloids fell primarily into a 
hepatocellular necrosis score of one or higher.  At this dose the majority of echimidine 
scores were in category one.  Lasiocarpine, riddelliine, seneciphylline, senecionine N-
oxide, and riddelliine N-oxide all had a majority of their scores that fall into the two 
category.  Heliotrine and senecionine both had a majority of hepatocellular necrosis 
scores that fell into category three, however a substantial proportion (around 40%) of 
scores from the heliotrine group fell into a category of four.   
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Hepatocellular Necrosis  
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Figure 3-6.  Probability of necrosis score for each alkaloid falling into each of the different 
categories  Hepatocellular necrosis was scored on a scale of 0 to 4.  Necrosis score was compared as a 
multinomial outcome with alkaloid and dose as fixed factors in the model.  The bar graphs demonstrate 
the probability of the hepatocellular necrosis score for each alkaloid falling into each category.  Graphs 
are arranged by dose. 
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At the 0,26 mmol kg dose the majority of lycopsamine scores remained in category 
0, but other compounds caused more severe effects.  The majority of lasiocarpine N-
oxide scores moved up to category one for the high dose.  The majority of echimidine 
scores moved up to score category two joining lasiocarpine, seneciphylline, senecionine 
N-oxide, and riddelliine N-oxide.  The major proportion of riddelliine scores moved up to 
three with senecionine, and the majority of heliotrine scores moved up to category four.  
For a comparison of patterns for different alkaloid necrosis scores see Table 3-5.   
In the highest two dose groups of lasiocarpine, chicks developed a moderate to 
severe necrotizing colitis (Fig. 3-7), and all five animals in the highest dose group also 
developed necrotizing enteritis.  In the 0.26 mmol kg
-1 
group, intestinal lesions were more 
severe (all were scored as 4 out of 5 where 0 is normal and 5 is severe) than the 0.13 
mmol kg
-1
 group (all received a score of 2 on the same scale).  Lesions were 
characterized by segmental, mucosal, necrosis with blunting and loss of villi in the small 
Table 3-5. Comparison of the distribution of hepatocellular necrosis scores from male, 
California White chicks exposed to dehyropyrrolizidine alkaloids.  Comparisons are between 
all alkaloids at all doses.  Superscript letters denote a statistical difference at p < 0.05. 
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abcd 
Seneciphylline
bcd 
Riddelliine N-oxide
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intestine, and significant loss of mucosal epithelium in the large intestine accompanied by 
marked attenuation of remaining epithelium.  This extrahepatic involvement was 
sufficient to be the cause of morbidity and mortality in these animals.  Similar large 
intestinal lesions were present in two 0.26 mmol kg
-1
 group of riddelliine dosed animals 
(scored as 3 out of 5), one 0.13 mmol kg
-1
 group of riddelliine dosed animals (scored 4 
out of 5), and one 0.13 mmol kg
-1
 group of lasiocarpine N-oxide animal (scored 2 out of 
5).  In addition to the large intestinal lesions necrotizing enteritis was observed in five 
animals in addition to the lasiocarpine highest dose group; one each in the 0.04 and 0.26 
mmol kg
-1
 lasiocarpine N-oxide groups, the 0.13 and 0.26 mmol kg
-1
 heliotrine groups 
and the 0.13 mmol kg
-1
 riddelliine group.   
 
 
Figure 3-7. Large intestine from a chick exposed to lasiocarpine (0.26 mmol kg
-1
).  The 
epithelium is markedly attenuated (closed arrow).  Crypt epithelium is also markedly 
attenuated and the crypts are filled with necrotic debris and occasional inflammatory cells 
(open arrows). 
 
Histologic ranking based solely on the hepatic necrosis toxicity rankings from most 
to least toxic are as follows:  Heliotrine, senecionine, riddelliine, senecionine N-oxide, 
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seneciphylline, riddelliine N-oxide, lasiocarpine, echimidine, lasiocarpine N-oxide, and 
lycopsamine.   
Toxicity of the different compounds were ranked based on weight gain, survival 
time, “pyrrole” accumulation rate, presence of ascites at necropsy, and the histologic 
hepatocellular necrosis score (Table 3-6).  Combining the results from those five factors 
the DHPAs used in this study can be grouped into four somewhat overlapping groups.  
The most toxic group is composed of heliotrine, lasiocarpine, riddelliine, senecionine, 
and seneciphylline.  The next most toxic group contains the three N-oxides tested  
(riddelliine N-oxide, senecionine N-oxide, and lasiocarpine N-oxide).  These N-oxides 
tended to be slightly less toxic than their respective free base form in every category.  
Table 3-6. Summary of Toxicity Rankings  Male California White chicks were 
orally exposed to one of 10 different dehydropyrrolizidine alkaloids and toxicity was 
ranked with output variables of weight gain, survival, pyrrole accumulation rate, 
presence of ascites at necropsy, and histologic scoring of hepatocellular necrosis.  
ECH = echimidine, HEL = heliotrine, LAS = lasiocarpine, LNO = Lasiocarpine N-
oxide, LYC = lycopsamine, RID = Riddelliine, RNO = Riddelliine N-oxide, SEN = 
senecionine, SNO = senecionine N-oxide, SPH = seneciphylline 
 
 
Weight gain Survival “Pyrrole” 
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Rate 
Ascites Histopathology 
(Hepatocellular 
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SNO SNO RNO RNO 
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The two remaining DHPAs (echimidine and lycopsamine) were consistently less toxic 
than all others tested.  Of these two, echimidine was more toxic in this model. 
 
Discussion 
 
 
The intent of this study was to compare multiple DHPAs with key structural 
differences in a single more biologically relevant model, and if possible rank them 
according to toxicity.  Comparisons were made with weight gain, survival time, “pyrrole” 
adduct accumulation rate, gross pathology, histopathology, and serum biochemistries.  
Serum biochemistry was informative, but did not lend itself to ranking toxicity in this 
study.  The toxicity rankings using the remaining five factors are very similar, although 
not exactly the same.   
Comparing the results of the present study with the previously published results in 
Table 3-7 it is evident that overall the conclusions are similar.  Based on these previous 
studies it was expected that lasiocarpine and the three macrocyclic diesters would 
compose the most toxic group.  These four compounds were in fact, among the most 
toxic compounds tested.  Heliotrine was far more toxic in this present study than 
expected, and was in the majority of comparisons the single most toxic DHPA.  This 
suggests that although much of what was found in the present study is similar to previous 
research, for some compounds (such as heliotrine) the differences could be very 
substantial.  It is important not to underestimate the toxicity of a given DHPA because of 
assumptions solely based on structure. 
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Table 3-7. Compilation of DHPA relative toxicity data (LD50) from published 
literature.  LD50  data are in mg kg
-1
 and all data was obtained using a male rat 
model and intraperitoneal injection unless otherwise indicated. 
 
 Retronecine 
 
Heliotridine 
 
Macrocylic 
Diesters
 
 
Riddelliine  
105 IV mouse
1
, 80 PO male 
rat
2 
Senecionine 
 50
3
, 77
4
, 85
5
,57.3 PO mice
6 
Seneciphylline  
77
7
  
 
1 (IARC 1976, Cheeke 1998); 2 (Dalefield, 
Gosse et al. 2012); 3  (Bull, Culvenor et al. 
1968, Mattocks 1972); 4 (WHO 1988); 5 
(Cheeke 1998) ; 6 (Wang et al. 2011); 
7(Bull, Culvenor et al. 1968, Mattocks 1972) 
 
 
 
 
 
 
 
 
 
 
Open Chain 
Diesters
 
 
Echimidine 
200 (Bull, Culvenor et al. 
1968) 
 
 
 
 
Lasiocarpine 
77 (Bull, Culvenor et al. 
1968, Mattocks 1972) 
72 (WHO 1988, Cheeke 
1998)  
88 IV Rat (Rose, Harris et 
al. 1959) 
Monoesters
 
 
Lycopsamine 
1500 (Cheeke 1998) 
Intermedine 
1500 (Cheeke 1998) 
 
Heliotrine  
296 (Bull, Culvenor et al. 
1968, Mattocks 1972) 
300 (Downing and 
Peterson 1968, Mattocks 
and White 1968) 
N-Oxides 
 
Riddelliine N- Oxide 
~250 PO male rat estimated 
from adduct production 
(Chou, Wang et al. 2003) 
Senecionine N-Oxide 
~2000 (Culvenor, Edgar et al. 
1976) 
 
Lasiocarpine N-Oxide 
547 (Bull, Dick et al. 
1958) 
~1100 (Culvenor, Edgar et 
al. 1976) 
 
OtonecineRetronecine Heliotridine
Figure 1 Structure of three necine bases
OtonecineRetron cine Heliotridine
Figure 1 Structure of three necine bases
Riddelliine 
Lasiocarpine 
Lycopsamine 
Riddelliine N-Oxide 
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Results from in vitro assays using an immortalized chicken hepatocyte cell line 
were similar to those found in the present study (Field, et al. 2015).  In both cases 
heliotrine was found to be similar in toxicity to the heliotridine based open chain diester, 
lasiocarpine, as well as the retronecine based macrocyclic diesters senecionine and 
seneciphylline.  There is one rather notable difference in which the present study excels.  
The same three N-oxides were studied in the in vitro work, and they were found to be 
similar in toxicity to lycopsamine.  They were consistently more toxic than lycopsamine 
in this live chick model.  The difference is most likely due to microbial reduction of the 
N-oxides in the gastrointestinal tract, reducing the N-oxide to the free base form. 
Ranking the toxicity of N-oxides based on previously published literature would be 
difficult.  Using data obtained from intraperitoneal exposure studies would be expected to 
markedly underestimate their toxicity.  More work is needed to determine the mechanism 
of N-oxide DHPA toxicity.  Current hypothesis are they reduced to the free base in the 
gastrointestinal tract via intestinal microbes, or alternatively it has also been shown they 
can be reduced by the liver xenobiotic enzymes.  Based on intraperitoneal studies the 
three N-oxides would be expected to be similar, although perhaps slightly more toxic 
than lycopsamine.  In the present study, the three N-oxides were consistently more toxic 
than both lycopsamine and echimidine.  They behaved more closely to their associated 
free base, although somewhat less toxic. 
Echimidine and lycopsamine were more similar to each other than might have been 
expected based on previous research.  Echimidine was consistently more toxic than 
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lycopsamine, but higher doses (particularly of lycopsamine) would need to be used to 
more accurately determine their relative toxicity.   
Another unanticipated result was the very high “pyrrole” accumulation rate of 
riddelliine.  When comparing DNA adduct production between different DHPAs Xia et 
al. (2013) found lasiocarpine exposure resulted in a higher proportion of DNA adducts 
than riddelliine.  It is worth noting however, that riddelliine is the only DHPA classified 
by the National Toxicology Program as a possible human carcinogen.  DHPAs are 
thought to cause cancer because of their ability to form DNA adducts.  If riddelliine has 
an increased propensity to produce adducts, measured in the present study as “pyrrole” 
accumulation rate, this markedly higher “pyrrole” accumulation rate may contribute to 
the carcinogenicity of this compound.  On the other hand it may be specific to this model. 
Lasiocarpine exposure resulted in profound intestinal lesions.  A similar set of 
lesions was reported by Hooper (1975) in sheep, rats and mice when exposed IP to high 
doses of lasiocarpine.  In that study lesions were most severe in the proximal intestine.  In 
the present study no such pattern was present, but the lesions were very similar.  Hooper 
suggested a possible etiology to be cleavage of glutathione from the pyrrole after biliary 
excretion into the duodenum.  Xia et al. (2015) recently reported that glutathione bound 
pyrrole is unstable and in the presence of DNA bases formed DNA pyrrole adducts in 
vitro.  Alternatively, it is possible that lasiocarpine was bioactivated in enterocytes, and 
the intestinal lesions developed as a result.  However, taking the previous two studies into 
account in combination with the results of the present study, it appears likely that the 
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glutathione bound pyrrole is unstable in the intestinal environment, and that lasiocarpine 
has a particular propensity for creating such intestinal lesions. 
In this study weight, survival analysis, and presence of ascites at necropsy, although 
nonspecific for pathogenesis, appeared to be a good indicators ranking of relative DHPA 
toxicity.  These indicators allowed for ranking of different compounds based on toxicity, 
and the order of toxicity was very similar to the histologic analysis.   
The hepatocellular necrosis score was a very good indicator of toxicity for those 
compounds which appear to be at least primarily hepatotoxic at the doses used, and in 
this model.  If only hepatocellular necrosis was used to rank the toxicity of DHPAs 
compounds that produce more extrahepatic lesions, such as lasiocarpine, would be ranked 
as less toxic than they truly are.  Consequently, it is important to examine a wide variety 
of tissues.  It is also beneficial to use multiple indicators of toxicity.  Histology is 
probably the best indicator of toxicity for this model. 
When performing principle component analysis of the serum biochemistries, the 
principle components conveniently separated into biologically relevant divisions.  
Principle component one was composed of total protein, glucose, triglycerides, and 
cholesterol, all of which are metabolic products produced in the liver.  Consequently, a 
decrease in the value of principle component one corresponds with toxicity.  Because a 
decrease in this component corresponds to decreased hepatic function, it would require a 
period of time for this value to drop.  This time would correspond to a combination of the 
serum half-lives of the four biochemistries under consideration as well as the amount of 
time it took for the functional hepatic mass to decrease.  In some of the highest dose 
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groups such as heliotrine, and seneciphylline, the animals did not survive long enough for 
this change to be manifest and as a result a comparison between the highest doses may 
not be completely relevant.  This also explains why the component one value for the 0.13 
mmol kg
-1
 group is lower than the value for the 0.26 mmol kg
-1
 group for seneciphylline.   
For principle component two, because its major contributors are hepatocellular 
leakage enzymes, a higher value corresponds with increased toxicity.  In this case those 
animals that died or were euthanized prior to the end of the study would be expected to 
have higher values due both to an expected increase in the number of damaged 
hepatocytes as well as a shorter time between damage and blood being taken.  This is 
evident in the 0.26 mmol kg
-1
 heliotrine group.  Because all of the animals in this group 
died within one day of initiating treatment, it is logical that they would have very high 
values for component two.  Unfortunately, this may make comparisons between other 
compounds impossible. 
Principle component three is slightly more difficult to interpret than the other two.  
Heliotrine, seneciphylline, riddelliine, riddelliine N-oxide, and lasiocarpine N-oxide all 
have a distinct pattern to their component three values.  There is an initial rise followed 
by a decrease that is typically below the lowest dose value.  Presumably lasiocarpine, 
senecionine, and senecionine N-oxide would follow this same pattern if the highest doses 
could be analyzed.  The value for echimidine continues to rise at the highest dose tested.  
It is also interesting that the highest point for seneciphylline, riddelliine, riddelliine N-
oxide, and lasiocarpine N-oxide is at the 0.13 mmol kg
-1
 dose, whereas for heliotrine the 
highest value is at the 0.04 mmol kg
-1
 dose. 
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This study was designed to maximize lesions observed histologically.  As a result 
histology, particularly if all lesions are considered, is the most comprehensive indicator 
of toxicity for this model.  Weight was also a sensitive indicator, but tells little about 
pathogenesis.  The reason for decreases in weight gain could be due to decreased food 
intake, or metabolic deficiency due to liver damage.  Survival is of course a valuable 
indicator, but when used for toxicity modeling, it not as sensitive as would be desired.  
“Pyrrole” accumulation rate is a valuable indicator, and may help determine the relative 
carcinogenicity of different DHPAs.  Serum biochemistries were the least helpful in 
determining the relative toxicity of different compounds in this model.  There were 
clearly adverse effects detectable via serum biochemistry, but there is perhaps too much 
variation in serum biochemistry values in this model to effectively rank toxicity of 
different compounds. 
 
Conclusion 
 
The results of this research are vitally important because multiple structurally 
different DHPAs were compared at biologically relevant doses and routes in the same 
model.  In this model, heliotrine appears to be at least as toxic as retronecine based 
macrocyclic diesters and heliotridine based diesters, and much more toxic than expected 
based on previously published IP exposure studies.  The N-oxides used in this study were 
also more toxic than would be expected based on either IP exposure studies or cell based 
assays.  The retronecine based diester, echimidine, was unexpectedly less toxic than 
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heliotrine, the heliotridine based monoester.  Lycopsamine was the least toxic of the 
compounds assessed in this study. 
Tissue “pyrrole” adducts were present in the livers from chicks exposed to all of the 
compounds, and the accumulation rate can be used as a toxicity indicator. The “pyrrole” 
accumulation rate was much higher in riddelliine exposed chicks than in any other group, 
which may be biologically relevant with respect to carcinogenicity.  Future research on 
the relative carcinogenicity of structurally diverse DHPAs would be valuable. 
Extrahepatic lesions present in the highest dose of lasiocarpine exposed animals, in 
combination with results from other studies suggest that excreted conjugated pyrroles 
may be unstable in the intestine and may cause damage post excretion for some DHPAs.  
This adds credence to the concern with consumption of tissues such as liver from animals 
that have been exposed to DHPAs, and this potential instability should be evaluated in 
future studies.   
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CHAPTER IV 
THE COMPARATIVE TOXICITY OF A REDUCED, CRUDE COMFREY 
(SYMPHYTUM OFFICINALE) ALKALOID EXTRACT AND THE PURE, 
COMPHREY-DERIVED PYRROLIZIDINE ALKALOIDS, LYCOPSAMINE AND 
INTERMEDINE IN CHICKS (GALLUS GALLUS DOMESTICUS) 
 
Short Abstract
1
 
 
Comfrey (Symphytum officinale), a commonly used herb, contains pro-toxic 
dehydropyrrolizidine alkaloids, including lycopsamine and intermedine, and has 
consequently been internationally regulated with respect to its use.  To help further define 
the toxicity of S. officinale, male, California White chicks were used to compare the 
toxicity of a crude, reduced comfrey alkaloid extract to purified lycopsamine and 
intermedine.  Based on clinical, serum biochemical, tissue adduct concentrations, and 
histopathological analysis the reduced comfrey extract was more toxic than either pure 
lycopsamine or intermedine.  This suggests a cautionary note when estimates of herbal 
toxicity are based upon the observed toxicity of isolated toxins. 
 
  
                                                          
Ammon W. Brown, Bryan L. Stegelmeier, Steven M. Colegate, Dale R. Gardner, Kip E. 
Panter, Edward L. Knoppel, and Jeffery O. Hall
 
(in review). The Comparative Toxicity of 
a Reduced, Crude Comfrey (Symphytum officinale) alkaloid extract and the Pure, 
Comfrey-Derived Pyrrolizidine Alkaloids, Lycopsamine and Intermedine in Chicks 
(Gallus gallus domesticus). Journal of Applied Toxicology. 
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Abstract 
 
 
Comfrey (Symphytum officinale), a commonly used herb, contains 
dehydropyrrolizidine alkaloids that, as a group of bioactive metabolites, are potentially 
hepatotoxic, pneumotoxic, genotoxic and carcinogenic.  Consequently, regulatory 
agencies and international health organizations have recommended comfrey be used for 
external use only.  However, in many locations comfrey continues to be ingested as a 
tisane or as a leafy vegetable.  The objective of this work was to compare the toxicity of a 
crude, reduced comfrey alkaloid extract to purified lycopsamine and intermedine that are 
major constituents of S. officinale.  Male, California White chicks were orally exposed to 
daily doses of 0.04, 0.13, 0.26, 0.52, and 1.04 mmol lycopsamine, intermedine or reduced 
comfrey extract kg
-1
 bodyweight for 10 days.  After another seven days, chicks were 
euthanized.  Based on clinical signs of poisoning, serum biochemistry, and 
histopathological analysis, the reduced comfrey extract was more toxic than lycopsamine 
and intermedine.  This work suggests a greater than additive effect of the individual 
alkaloids and/or a more potent toxicity of the acetylated derivatives in the reduced 
comfrey extract.  It also suggests that safety recommendations based on purified 
compounds may underestimate the potential toxicity of comfrey. 
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Introduction  
 
Comfrey has been used for a wide variety of medicinal purposes for over 2,000 
years (Rode 2002), and it continues to be consumed as an herbal tea or a vegetable in 
many countries (Mei, et al. 2010).  More recently, controlled studies have found multiple 
comfrey-based topical treatments to be beneficial for treatment of a variety of muscle and 
joint pains (Koll, et al. 2004; Staiger 2012).  The anti-inflammatory and analgesic effects 
of comfrey are thought to be due to the imidazolidinylurea allantoin and the 
phenylpropanoid rosmarinic acid (Staiger 2012).  Comfrey also contains 
dehydropyrrolizidine alkaloids (DHPAs) which are pro-toxins that are hepatotoxic, and 
potentially pneumotoxic, genotoxic, and carcinogenic (Mei, et al. 2010).  As a result of 
the health hazards posed by DHPAs, health organizations and food and drug safety 
agencies in several countries have developed regulations and recommendations regarding 
the sale and use of comfrey.  In 2001 the US Food and Drug Administration sent an 
advisory letter to manufacturers of dietary supplements requesting that they remove all 
comfrey products intended for consumption from the market (FDA 2001).  In Germany, 
the Federal Institute for Risk Assessment (BfR) conducted a risk assessment for DHPAs 
and concluded that exposure should be kept as low as possible limiting tolerable daily 
intake to 0.007 μg of unsaturated pyrrolizidine alkaloids kg-1 bodyweight (BW) (BfR 
2011).  In 2008, the UK Committee on Toxicity of Chemicals in Food, Consumer 
Products and the Environment released a statement on DHPAs in food, which supported 
that of the BfR, limiting daily oral exposures to less than 0.007 μg DHPAs kg-1 BW oral 
(Committee on Toxicity of Chemicals in Food 2008).  The World Health Organization, 
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Dutch National Institute for Public Health and the Environment, and European Food 
Safety Authority have all conducted similar reviews with similar concerns and 
recommendations (EFSA 2011; RIVM 2005; WHO 2011).  The Food Standards Australia 
New Zealand authority recommends a somewhat higher tolerable exposure of 1 μg 
DHPAs kg
-1
 BW per day based exclusively on hepatotoxicity as opposed to potential 
carcinogenicity (FSANZ 2001). 
DHPA-related toxicity has been associated with its in vivo oxidation to a 
didehydropyrrolizidine alkaloid metabolite, referred to as the “pyrrolic” or 
dihydropyrrolizine (DHP) metabolite, that is a bifunctional alkylating agent of 
macrobiomolecules forming adducts with proteins and DNA (Edgar, et al. 2014).  The 
indirect detection of these “pyrrolic” adducts by their oxidative cleavage from the tissue 
adducts has been used as an indicator of exposure to the DHPAs (Lin, et al. 2011; 
Mattocks and Jukes 1990; 1992a; 1992b; Stegelmeier, et al. 1996; Winter, et al. 1990).  
Therefore, the observation of adverse clinical signs or pathological changes in this study 
will be correlated with the indirect detection of “pyrrolic” adducts in an attempt to 
quantify exposure.  
A California White male chick model has recently been investigated to assess the 
comparative toxicity of pure DHPAs in a biologically-relevant manner and using less 
alkaloid than some other models (Stegelmeier et al., unpublished).  Therefore, the 
objective of this study was to use this model to compare the toxicity of a reduced, crude 
comfrey alkaloid extract with that of pure lycopsamine and intermedine, the two major 
alkaloids isolated from the reduced comfrey extract.   
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Materials and Methods 
 
 
Animals 
Three-day-old male, California White chicks (GALLUS GALLUS DOMESTICUS) 
were purchased from Privett Hatchery (Portales, New Mexico) through Intermountain 
Farmers Association (Hyde Park, Utah).  California White chickens are a commercial 
hybrid resulting from the cross of a White Leghorn hen and a California Grey rooster 
touted as a hardy breed that is somewhat easier to handle than the White Leghorn.  
During a 3-day acclimation period before initiation of treatment, the chicks were weighed 
and outliers culled such that test birds were of a uniform size and body condition.  Chicks 
were housed in heated brooder cages that provided a thermal gradient within their 
microenvironment ranging from roughly 16 to 25°C.  All animals had free access to fresh 
water and a commercial 20% protein poultry starter purchased from Intermountain 
Farmers Association (Salt Lake City, Utah).  The brooder cages were housed in a 
windowed room and thus exposed to ambient sunlight.  Room lights were used such that 
there was a minimum of twelve hours of light each day.  Humidity in the brooder cages 
was essentially room-ambient humidity which ranged from approximately 30% to 60% 
during the course of this study.  This research was conducted with the approval of the 
Utah State University Animal Care and Use Committee (IACUC Protocol #2055). 
 
Preparation of Dehydropyrrolizidine Alkaloid Test Samples 
Dry, powdered root of common comfrey (Symphytum officinale) was purchased 
from Starwest Botanicals (Cordova, CA, USA) or from Take Herb (Alhambra, CA, 
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USA).  After mixing the powdered comfrey root from both sources a crude extract of the 
comfrey root alkaloids (including reduction of N-oxides to their free base forms) and the 
monoester DHPAs lycopsamine and intermedine (Fig. 4-1) were isolated from a reduced, 
crude alkaloidal extract of the powdered comfrey as previously described (Colegate, et al. 
2014). The extract and purified samples were analyzed using high pressure liquid   
 
 
Figure 4-1. The structures of lycopsamine, intermedine and their 7-acetyl derivatives. The 
HPLC-esi(+)MS ion chromatograms show a high purity for the isolated lycopsamine (B) and 
intermedine (A) and a mixture of lycopsamine, intermedine and their 7-acetyl derivatives (D) in 
the comfrey reduced alkaloid sample. Also present in the latter are minor, residual concentrations 
of intermedine and lycopsamine N-oxides (C). The MS/MS profiles confirm the identity of 
lycopsamine and intermedine, and C7 as the site of acetylation rather than C13. 
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chromatography coupled to an electrospray ionization mass spectrometer operated in the 
positive ion full scan and tandem mass spectrometry mode (HPLC-esi(+)MS and 
MS/MS). 
 
Experimental Design 
 
Eighty chicks were randomly divided into 16 groups of five and assigned to a dose 
group for comfrey extract, lycopsamine or intermedine.  Each test compound(s) was 
administered at five doses i.e., 0.04, 0.13, 0.26, 0.52, and 1.04 mmols DHPA free base 
kg
-1
 BW per day.  Five animals were assigned to the control group that received a volume 
of absolute ethanol equal to the largest volume received by any of the other groups.  
Dosing was based on purified alkaloid toxicity studies using the same model 
(Stegelmeier, et al., unpublished).  In the purified alkaloid studies doses were 0.01, 0.04, 
0.13, and 0.26 mmols DHPA free base kg
-1
 BW per day.  Because lycopsamine was 
found to be less toxic than the other purified alkaloids tested, the two higher doses were 
added. Daily doses were divided into two equal portions half of which was given in the 
morning and the other half was given in the afternoon via gavage.  Water was added to all 
doses such that the final volume was 0.5 mL.  All animals were weighed three times per 
week, and doses were recalculated prior to the next treatment. The chicks were dosed for 
10 days and maintained for another seven days before they were euthanized with carbon 
dioxide for necropsy examination.  Chicks were monitored at least twice daily for the 
duration of the study.  Any animals that became moribund were euthanized with carbon 
dioxide and necropsied. 
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Tissue Preparation 
At post-mortem examination, gross abnormalities were recorded and the entire 
brain, heart, spleen, and right liver lobe, and representative samples of lung, kidney, 
testicle, crop, proventriculus, ventriculus, small intestine, colon, cecum and bursa of 
Fabricius were collected, preserved in neutral buffered formalin, embedded in paraffin 
and subsequent sections were stained with hematoxylin and eosin via standard procedures 
for histopathologic analysis.  A random number chart was used to determine the start 
location for sectioning the right liver lobe.  The entire right liver lobe was sectioned every 
3 mm transversely along the long axis prior to embedding and staining.  Blood samples 
were taken immediately after euthanasia via cardiac puncture, divided into serum and 
packed cells, and frozen.  The left liver lobe was collected and stored at -80°C for 
“pyrrole” adduct analysis. 
 
Histologic Grading 
Liver size was quite variable between animals and consequently all sections of the 
right liver lobe could occupy from one to four slides.  Each slide was graded by 
examining all sections on that slide and scored for necrosis as follows:  0 - no observed 
hepatocellular necrosis; 1 - scattered individual cell death; 2 - multifocal areas of necrosis 
which encompassed up to 25% of the sections on that slide; 3 - larger areas of necrosis 
were present accounting for between 25 and 50% of the sections; and 4 - greater than 
50% of the observed sections were necrotic (Fig. 4-2).  The hepatic necrosis score for 
each animal was computed by taking the average of the necrosis scores for each slide of 
liver tissue from that animal. 
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“Pyrrole” Adduct Detection 
The indirect detection of hepatic “pyrrolic” adducts was an adaptation of methods 
originally reported by Mattocks and Jukes (Mattocks and Jukes 1992a; 1992b) and more 
recently described by Lin et al.(Lin, et al. 2011) (Fig. 4-3).  
Monocrotaline (crotaline), tetrachloro-o-benzoquinone (ο-chloranil, 97%), boron 
trifluoride diethyletherate (BF3•O(C2H5)2) and silver nitrate were purchased from 
Sigma-Aldrich (St. Louis, Missouri).  ρ-Dimethylaminobenzaldehyde (DMABA) was 
from ICN Biochemical (Cleveland, Ohio).  Acetonitrile was HPLC grade (Sigma-
Aldrich), and absolute ethanol was (reagent grade).  Formic acid (98%, Sigma Aldrich) 
used for HPLC was diluted with purified water (18.2 M cm-1) (WaterPro PS Station, 
Labconco, Kansas City, MO, USA) to a concentration of 0.1% (V/V).  Ehrlich’s solution 
was prepared by dissolving DMABA (0.2 g) in ethanol (10 mL) with purified, redistilled 
BF3•O(C2H5)2 (2 mL).   
Dehydromonocrotaline (DHMC), used for the positive control standard, was 
prepared by oxidizing monocrotaline using a modification of procedures previously 
reported (Culvenor, et al. 1970).  ο-Chloranil (30 mg) was added to a solution of 
monocrotaline (30 mg) in chloroform (4 mL) and shaken for 30 to 60 sec.  A saturated 
solution of potassium hydroxide (KOH) containing 2% (w/v) sodium borohydride 
(NaBH4) (4 mL), purchased from Mallinckrodt (Paris, Kentucky) was added to the 
oxidation solution and shaken until the color faded.  The solvent layers were separated by 
centrifugation; the organic layer was filtered through anhydrous sodium sulfate; and the 
solvent was removed by roto-evaporation at 40˚C and reduced pressure to afford 
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Figure 4-2. H&E Examples of hepatocellular necrosis scores  A. 200X. Necrosis score 0.  
Normal liver from a control chick.  B. 400X.  Necrosis score 1. Liver from a chick exposed to 
0.52 mmol kg
-1
 body weight (BW) day
-1
 comfrey extract with a necrosis score of one.  Note the 
individual cell death (arrow).  C. 200X. Necrosis score 2.  Liver from a chick exposed to 1.04 
mmol kg
-1
 BW day
-1
 comfrey extract with a necrosis score of two.  Note the individualized 
hepatocytes that are surrounded by hemorrhage (arrows) and the lake of hemorrhage (*) where 
hepatic cords should be.  D. 100X.  Necrosis score 3.  Liver from a chick exposed to 1.04 mmol 
kg
-1
 BW day
-1
 comfrey extract with a necrosis score of three.  Note the large lakes of hemorrhage 
(*), with occasional rafts of hepatocytes. 
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C 
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Figure 4-3. Schematic outline of the indirect detection of pyrrole liver adducts starting with the 
metabolic oxidation of comfrey alkaloids, hydrolysis of pyrrolic adducts and formation of 
pyrrole-DMABA complex (A).  The HPLC-esi(+)MS/MS total ion chromatograms (TIC) and 
reconstructed ion chromatograms (RIC) from pyrrole-DMABA standard (top) and then that 
obtained from chick liver (B: middle and bottom).  MS/MS spectrum of the pyrrole-DMABA 
standard (C).  
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the oxidation product (30 mg).  Integration and comparison of the H2, H3, H7 and H9 
resonance signals for DHMC and monocrotaline in the 1H-NMR spectrum (Culvenor et 
al., 1970) (Fig. 4-4) of the oxidation product indicated an 87:13 mixture of DHMC to 
residual monocrotaline.  A measured quantity of oxidation product was dissolved in 
absolute ethanol to give a 2.69 µmol mL
-1
 pyrrole equivalent standard stock solution. 
Ethanolic silver nitrate was prepared by dissolving silver nitrate (625 mg) in 
deionized water (0.5 mL) with sonication for 1-2 minutes.  Absolute ethanol (25 mL) was 
added, and the mixture was sonicated until all of the silver nitrate had redissolved 
(approximately 5 min). 
“Pyrrole” calibration standards were prepared by diluting an aliquot (50 µL) of the 
pyrrole standard stock solution with ethanol (900 µL) and Erlich’s solution (50 µL) to 
afford a “pyrrole” concentration of 135 nmol mL-1. An aliquot (50 µL) was further 
diluted with ethanol (950 µL) i.e., 6.8 nmol “pyrrole” mL-1 which was further serially 
diluted (1/5) to give standards at 1.35, 0.27, 0.054, 0.11 and 0.002 nmol “pyrrole” mL-1.   
Entire left liver lobes frozen from individual chicks were freeze-dried using a 
Labconco® freeze dryer.  Portions of the lyophilized liver lobes were placed in conical 
tubes with small copper coated steel spheres.  The conical tubes were then placed in a 
Retech® MM301 shaker at 20 revolutions s
-1
 for 10 min.  An accurately weighed portion 
(ca. 25 mg) of the crushed, lyophilized chicken liver was then placed into a plastic snap-
cap conical tube.  Ethanolic silver nitrate (1.0 mL) was added to the sample and the 
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Figure 4-4.  1H-NMR Spectrum of dehydromonocrotaline.  The ratio of dehydromonocrotaline to 
that of the residual monocrotaline was measured from integration of the H2 and H3 protons from 
dehydromonocrotaline versus the H7 and H9 protons from the residual monocrotaline. 
 
sample mixed for 30 min on an auto rotator.  Trifluoroacetic acid (10 µL) was added to 
the mixture after 30 min and samples further mixed on the auto rotator overnight (~16 
hrs).  The samples were then centrifuged at 13000 rpm (16000 G) for 10 min.  An aliquot 
(20 µL) of the supernatant was added to absolute ethanol (170 µL) containing of Erlich’s 
reagent (10 µL) in an HPLC autosampler vial.   
The HPLC-esi(+) MS/MS system consisted of a Agilent 1260 Infinity HPLC 
System (Agilent Technologies, Santa Clara, CA, USA).  Samples (5 µL) were injected 
onto a Synergi Hydro RP column (75 x 2 mm, 4) fitted with a guard column of similar 
monocrotaline 
dehydromonocrotaline 
H3 
H9 H7 
H2 
H7 
H9 
H2 
H3 
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adsorbent.  A gradient flow (300 L min-1) of 0.1% formic acid in water (A) and 
acetonitrile (B) was used to elute the sample components from the column using the 
following linear gradient: 20% B (0-1 min); 20% - 45% B (1-2 min); 45% - 75% B (2-11 
min); 75% B (11-15 min); 75% - 20% B (15-16 min); and 20% B (16-21 min) for re-
equilibration of the column.   
Flow from the HPLC column was connected to a Velos Pro LTQ mass spectrometer 
(Thermo Scientific, Waltham, MA, USA) equipped with a heated electrospray ionization 
(HESI) source.  The capillary temperature was set at 275°C, the ionization spray voltage 
at 3.45 kV, the HESI source heater temperature at 305°C and the sheath gas flow was 40 
units with an auxiliary flow of 5 units.  The mass spectrometer was monitored in a 
positive ion MS/MS mode, scanning product ions from a mass range of m/z 90-350 after 
fragmentation of the parent ion (MH+ = 341) using a relative collision energy setting of 
45% with high-energy collision induced dissociation (HCD). Under these conditions the 
“pyrrole”-DMABA compound eluted with a retention time of 4.4 min and the resulting 
MS/MS spectrum contained major fragment ions at m/z 252 and 296.  The detected 
“pyrrole” peak area was measured from the reconstructed ion chromatogram displaying 
m/z 296 (Fig. 4-3) and quantitated based on an external calibration curve established 
from the standards. The resulting “pyrrole” concentration (nmol mL-1) of the injected 
sample was converted to nmol g
-1
 of liver.   
 
Serum Biochemistry Analysis 
Frozen serum samples were outsourced (Antech Laboratories, Indianapolis, 
Indiana) for analysis of total protein, glucose, triglycerides, cholesterol, gamma glutamyl 
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transferase (GGT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), 
sorbitol dehydrogenase (SDH), bile acid, and creatine phosphokinase (CPK). 
Statistical Analysis 
Statistical analyses were performed using Proc GLM and Proc Freq in SAS 9.3 
(SAS Institute, Cary, NC).  A two way ANOVA with Tukey-Kramer adjustment for 
multiple comparisons was used to compare average daily gain, liver weight / body 
weight, necrosis scores, “pyrrole” concentration, and serum biochemistries.  A Pearson 
correlation was used to determine the relationship between pyrrole and dose for each 
alkaloid.  Proc Freq was used to compare the frequency of ascites present at necropsy 
between different groups.  A p-value of <0.05 was considered significant. 
 
Results 
 
 
Test Samples 
HPLC-esi(+)MS and MS/MS analysis showed that the reduced crude extract was 
comprised mainly of the monoester DHPA lycopsamine, its C13 epimer intermedine, and 
their C7-acetylated derivatives (Fig. 1).  Minor concentrations of intermedine and 
lycopsamine N-oxides observed were residual due to an incomplete reduction step.  
Traces  (< 1% based on integrated areas of HPLC ion chromatogram peaks) of the open 
chain diester DHPAs symlandine and symphytine, were also observed. No other DHPAs 
reported to be found in comfrey (e.g., echimidine or its N-oxide) were observed in the 
reduced comfrey extract.  Based on the relative integrated areas of the HPLC-MS base 
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ion chromatogram the ratio of lycopsamine, intermedine and the combined acetylated 
derivatives was 1.3 : 1.5 : 1.  
The test sample solutions were prepared by accurately weighing sub-samples of the 
crude alkaloidal extract or of the purified lycopsamine and intermedine and dissolving 
them in ethanol to concentrations of 54.5 mg total alkaloid mL
-1
; 59.8 mg lycopsamine 
mL
-1
; and 60.4 mg intermedine mL
-1
.  The calculated concentrations were confirmed by 
quantitative HPLC-esi(+)MS analysis against a lycopsamine standard calibration curve. 
Furthermore, pre- and post-dosing HPLC-esi(+)MS analysis of the samples did not reveal 
any degradation in ethanol solution over the 10 day dosing period. 
 
Clinical 
 
At the doses used in this study, the chicks in the lycopsamine or intermedine-dosed 
groups did not show any difference in weight gain over the course of the study compared 
to controls.  The reduced comfrey extract-dosed animals showed a dose-dependent 
decrease in average daily gain (Table 1).  The chicks in the 1.04 and 0.52 mmol kg
-1
 
groups gained an average of only 1.6 and 4.2 g day
-1
 respectively, whereas the controls 
gained an average of 7.4 g day
-1
.  All five of the chicks in the 1.04 and one of the chicks 
in the 0.52 mmol kg
-1
 reduced comfrey extract groups developed ascites over the course 
of the study (Table 1).  Two high dose (1.04 mmol kg
-1
) reduced comfrey extract-exposed 
chicks had to be euthanized at 7 and 10 days into the study. 
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Table 4-1.  Group averages and (SD) of chicks dosed with comfrey, lycopsamine, intermedine 
and control at 0.4, 0.13, 0.26, 0.52, and 1.04 mmol/kg BW per day.  Comparisons were made 
with average daily gain (ADG), percent of liver weight to total body weight, number of animals 
with ascites at necropsy, the average necrosis score for the group, the average “pyrrole” 
concentration in the liver, and serum sorbitol dehydrogenase (SDH), bile acid, and glucose at 
death.  Different superscript letters denote differences at P<0.05.  All comparisons were made 
using a two way ANOVA with the exception of number of animals with ascites where a Fisher’s 
exact test was used.  Numbers in parenthesis are one standard deviation.   
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Serum Biochemistry 
 
Serum activity of the cytosolic hepatocellular enzyme SDH was increased in the 
two highest doses of comfrey (Table 4-1) when compared to controls.  Bile acid was also 
increased in the chicks from the highest dose reduced comfrey extract group when 
compared to all other groups.  Serum glucose concentrations were lower in chicks from 
all of the 1.04 mmol kg
-1
 groups compared to controls but, only the chicks from the 1.04 
mmol kg
-1
 reduced comfrey extract group were significantly different compared to the 
lower dose cohorts.  No differences were detected between any groups at any 
concentration for total protein, triglycerides, cholesterol, GGT, AST, LDH, and CPK. 
 
Gross Observations and Histopathology 
 
At necropsy, all livers were weighed after excising and emptying the gall bladders.  
The percent of liver weight to body weight was low in the chicks from the 1.04 mmol kg
-
1
 reduced comfrey extract group, which was the only group that differed significantly 
from controls; however, they were not significantly different from the chicks in other 
reduced comfrey extract groups or to the chicks in the 1.04 mmol kg
-1
 intermedine group. 
The most serious histologic change was centrilobular, or zone three, hepatic 
necrosis that extended through the entire lobule in the most severe cases.  In less severely 
affected individuals there were occasional small foci or individual hepatocytes that were 
surrounded by hemorrhage and had pyknotic nuclei.  Histologic hepatic necrosis scores 
tended to be higher in the three highest doses of the reduced comfrey extract-treated 
animals.  The average hepatic necrosis scores were significantly higher than controls in 
both the 1.04 and 0.52 mmol kg
-1
 reduced comfrey extract groups, but only the 1.04 
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mmol kg
-1
 group was significantly higher than the corresponding lycopsamine and 
intermedine groups.   
Angiectasis (Fig. 4-5) was present in three, four and three of the 0.26, 0.52, and 
1.04 mmol kg
-1
 lycopsamine-treated animals respectively.  One chick each of the 0.13 
and 0.26 mmol kg
-1
, and two and three of the 0.52 and 1.04 mmol kg
-1
 reduced comfrey 
extract groups respectively also had angiectasis.  Angiectasis was not observed in any of 
the animals in the intermedine-dosed groups.   
In this study, regeneration was an uncommon finding, only observed in two reduced 
comfrey extract-treated animals (one each in 0.26 and 1.04 mmol kg
-1
 dose groups). It 
presented primarily in portal areas and was composed of increased numbers of bile ducts 
with fewer, more basophilic-staining hepatocytes, indicative of immature hepatocytes, 
and occasional mitotic figures.   
Capsular serositis (Fig. 4-6) was only present in chicks from the two higher dose 
reduced comfrey extract groups, and ranged from mild to severe.  The capsules were 
diffusely and variably thickened and composed of spindle cells (likely fibroblasts), a 
variably dense eosinophilic matrix, and mononuclear inflammatory cells.  Occasionally 
vascularization of the capsule was present.  In the 1.04 mmol kg
-1
 dose group four of five 
animals had a capsular serositis.  The one animal that did not was euthanized on day 7 of 
the study.  One of the five animals in the 0.52 mmol kg
-1
 group also had capsular 
serositis.   
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Figure 4-5. H&E 200X.  Angiectasis (peliosis hepatis) in a chick liver from a California 
White chick exposed to 1.04 mMol kg
-1
 comfrey. 
 
 
 
Figure 4-6. H&E.  Capsular serositis  A. 100X Liver from a comfrey treated chick (1.04 
mMol kg
-1
 group) with a proliferative capsule (double headed arrow).  B. 200X is an 
enlargement of the box in A.  The capsule is composed of spindle cells and a variably 
dense fibrillar matrix and occasional small caliber vessels.  C. 200X is a normal liver 
from a control chick.  Note the very thin capsule (arrow).  
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Virtually every section of liver from all animals in all groups, including controls, 
showed mild to moderate periportal inflammation.  There appeared to be no difference in 
frequency, intensity, type or distribution of inflammation between groups. 
 
Tissue “Pyrrole” Adduct Detection 
 
“Pyrrole” was detected (Fig. 3) in chicks from the 0.13, 0.26, 0.52, and 1.04 mmol 
kg
-1
 BW reduced comfrey extract and lycopsamine-dosed groups. Similarly, “pyrrole” 
was detected, albeit at lower concentrations than for the chicks in the reduced comfrey 
extract and lycopsamine groups, in chicks from the 0.04, 0.52, and 1.04 mmol kg
-1
 BW 
intermedine-dosed groups.  “Pyrrole” concentration tended to increase with dose for all 
alkaloids.  Correlation coefficients for dose and reduced comfrey extract, lycopsamine 
and intermedine are 0.93, 0.58, and 0.58 respectively.  “Pyrrole” concentration tended to 
be higher in comfrey extract and lycopsamine exposed chicks however, the variation 
between animals was too great, with the number of animals used, to determine 
significance (Table 1). Indeed, among the equivalent-dose groups, the only statistically 
significant difference that was observed was between the 1.04 mmol kg
-1
 groups dosed 
with the reduced comfrey extract or intermedine.  
 
Discussion 
 
California White chicks are highly sensitive to DHPA toxicity and this model 
allowed direct comparison of various clinical (general health and weight gains) and 
pathologic (gross pathology, serum biochemistry, histopathology and tissue adducts) 
indicators of toxicity.  The pure lycopsamine and intermedine, and the reduced, crude 
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comfrey root alkaloid extract all resulted in some evidence of toxicity.  However, the 
total alkaloid extract of comfrey root was more toxic than an approximately molar 
equivalent dose of either pure lycopsamine or pure intermedine with respect to clinical, 
serum biochemical, tissue “pyrrole” accumulation and histopathological comparisons.  
This is unexpected as lycopsamine and intermedine are the major DHPAs in this comfrey 
sample and they are enantiomers as they differ only in rotation of the chiral carbon on the 
ester side chain.   
Previously reported toxicities of lycopsamine and intermedine are both 1500 mg kg
-
1
 (LD50 for single IP injection in rats) (Cheeke and Shull 1985).  No data are available 
for intraperitoneal exposure of comfrey in rats, but a diet containing 30% comfrey or 
about 1000 mg kg
-1
 day
-1
 for 21 days resulted in a significantly reduced weight gain 
(Garrett, et al. 1982).  It is difficult to compare these estimates because both DHPA 
content and quantity are highly variable in comfrey (Tice 1997). 
It is uncertain why the comfrey extract was more toxic than lycopsamine and 
intermedine in this study.  However, the significant presence of the acetylated derivatives 
in the comfrey extract may be the key factor.  This is especially so since equimolar 
exposure of the chicks to either lycopsamine or intermedine in the comfrey extract was 
far less than when these DHPAs were dosed in pure form. The decreased polarity of the 
acetylated derivatives may affect initial absorption of the pro-toxins resulting in an 
overall increase in the DHPA load that reaches the liver.  However, if absorption rates are 
approximately the same, then the potential for the acetylated derivatives to be more toxic 
per se is a consideration.  In this regard it has been shown that the acetylated derivatives 
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were more genotoxic in a wing spot test of Drosophila melanogaster following oral 
administration of the alkaloids (Frei, et al. 1992).   
Other possible factors that may have affected toxicity are: a greater than additive 
combined effect of lycopsamine and intermedine, the toxicity of the trace amounts of 
other minor alkaloids such as symphytine or symlandine, or competition for hepatic 
metabolizing enzymes from some other compound in the comfrey extract.  Data 
comparing pure intermedine, pure lycopsamine and a combination of the two are not 
available, thus determining the combined effect is not possible without further research.  
Symphytine and symlandine are potentially about 10 times more toxic than either 
lycopsamine or intermedine (LD50 for symphytine is 130 mg
-1
 kg
-1
 IP, male rat) (Hirono, 
et al. 1979).  It would be unlikely for the proportion of symphytine/symlandine present in 
the comfrey extract to be overtly toxic alone, but it is conceivable that in conjunction 
with the other DHPAs it may have increased the toxicity.   
The last consideration is competition for hepatic metabolizing enzymes from other 
compounds in the crude comfrey extract.  If these other compounds, undetected using the 
HPLC-esi(+)MS analytical method, have a greater affinity for DHPA-detoxifying 
enzymes, then conceivably, if upregulation of these enzymes is slow, there will be more 
DHPA to be activated and lead to “pyrrole”-tissue adducts and consequent damage.   
Histologically the lesions tended to be most severe in the comfrey extract groups, 
followed by the lycopsamine groups, and least severe in the intermedine exposed 
animals.  In the comfrey extract exposed animals the highest dose group had significantly 
more widespread hepatocellular necrosis.  Additionally, only animals exposed to the two 
161 
 
highest doses of comfrey extract developed capsular serositis.  Regeneration 
characterized by oval cell hyperplasia and bile duct reduplication, which is thought to be 
an attempt to regenerate hepatic parenchyma when parenchymal cells have lost this 
capacity (Stalker and Hayes 2007), was only observed in two comfrey-treated animals.  
Angiectasis, which is thought to be a result of loss or weakening of sinusoidal walls 
and/or supporting tissue (Thoolen, et al. 2010) may be an earlier and perhaps more 
sensitive indicator of hepatic insult in this study.  Only animals exposed to pure 
lycopsamine or the comfrey extract developed angiectasis.  Angiectasis is a feature that 
has been reported in mice exposed to DHPAs (Brown, et al. 2015; Ruebner, et al. 1970) 
and may be important because it has been suggested that angiectasis may be a 
preneoplastic lesion in some DHPA-induced neoplasms.  The concentration of “pyrrole” 
adducts tended to be higher in comfrey extract and lycopsamine exposed chicks 
compared to those exposed to intermedine which also suggests that lycopsamine may be 
slightly more toxic than intermedine.  If this is the case it suggests that the 
stereochemistry around the thirteenth carbon is important to toxicity. 
The toxicity of the DHPAs is entirely related to metabolic oxidation to form the 
electrophilic “pyrrolic” mono-and di-alkylating agents that react with nucleophiles on 
biomacromolecules such as proteins and DNA (Edgar, et al. 2014). Therefore, it was 
recognized that extraction and chemical release of these tissue conjugates could be used 
diagnostically to confirm a pyrrolizidine alkaloidosis (Mattocks and Jukes 1990; 1992a; 
1992b; Winter, et al. 1990). Thus, “pyrrole” tissue adducts were originally indirectly 
detected as the diethylethers of 1-hydroxymethyl-7-hydroxy-6,7-dihydropyrrolizine (the 
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“pyrrole”) following oxidative cleavage from tissue adducts with silver using GC-MS.  
The procedure was adapted more recently to use HPLC-MS in which the oxidatively-
cleaved “pyrrole”-diethylether was reacted with Ehrlich’s reagent to indirectly detect 
tissue “pyrrole” adducts in a human patient suffering from DHPA-induced hepatic 
sinusoidal obstruction syndrome (Lin, et al. 2011).  In this present study, the generation 
of a “pyrrole” calibration curve from dehydromonocrotaline enabled a semi-quantitative 
comparison of in vivo “pyrrole” formation for each of the treatments groups.  
The HPLC-MS method has advantages over the previous GC-MS method, 
specifically it is simpler to perform (it has fewer steps) and it is more reliable and more 
quantitative.  Ideally detection of pyrrole tissue adducts in tissue can be more widely and 
effectively used in the diagnostic arena.  This method needs to be validated in multiple 
species, and a greater understanding of the kinetics of tissue pyrrole adducts is necessary 
prior to full implementation as a diagnostic test.  
In the present study there appears to be a dose dependent increase in “pyrrole” 
concentration particularly in the comfrey extract and lycopsamine exposed animals.  
Similar to the histologic analysis, the comfrey extract exposed animals tend to be most 
severely affected followed by the lycopsamine, and the intermedine exposed animals 
appear least affected although there is no statistical difference.  Additional research may 
be helpful to determine the relevance of this trend. 
The comfrey extract used in this study is somewhat different than what would be 
expected from natural exposure.  Comfrey (Symphytum officinale, S. uplandicum) has 
been reported to produce several monoester and open chain diester DHPAs and their N-
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oxides. In this present study, the crude alkaloid extract of the S. officinale powdered root 
was treated in the usual way with zinc and sulphuric acid to reduce most of the N-oxides 
to the free base DHPA forms. The resultant crude, reduced comfrey extract contained 
lycopsamine, intermedine and their acetylated derivatives as the predominant alkaloids 
(Fig. 1).  When ingested DHPA-N-oxides are reduced in the gastro-intestinal tract to their 
parent free base, and although it has been estimated that N-oxides are similar in toxicity 
to their free base form (Frei, et al. 1992), in the present study the toxicity of N-oxides 
was not tested. 
Different comfrey-derived (e.g. leaf, roots, flowers) products, comfrey-based 
products or products that contain comfrey as a minor additive will contain different 
concentrations of the alkaloids and their N-oxides. Therefore, any products that include 
comfrey could be analyzed and the concentrations of the alkaloids determined and 
assessed against the chick toxicity data presented herein to determine the level of risk. In 
this study, comfrey root was used as the source of relatively high concentrations of the 
alkaloids to facilitate the dosing. 
In the assessment of risks presented to human health by dietary supplements, 
medicinal herbs, nutraceuticals or new functional foods, the application of data acquired 
using various in vitro or in vivo models is a major challenge with respect to extrapolation 
to the human situation. Therefore, models are continually changed or modified in an 
attempt to establish meaningful indications of toxicity. In vivo toxicity assessments of the 
pro-toxic DHPAs are complicated by considerable variations in species-, gender- and 
age-related susceptibilities. Additionally, assessment of entire products, crude extracts or 
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purified components presents potential complications associated with any intrinsic 
additive or protective effects of the whole plant or crude extract relative to the purified 
components. In this present study, male California White chicks, that have been shown to 
be sensitive to the DHPAs in terms of dose, duration of exposure and time for clinical 
and pathological signs to develop, were used to compare the hepatotoxicity of an orally-
administered, reduced comfrey extract to that of the purified monoester DHPAs 
lycopsamine and intermedine (Fig. 4-1).   
 
Conclusions 
 
The pure lycopsamine and intermedine, and the reduced, crude comfrey root 
alkaloid extract all resulted in some evidence of toxicity.  In this California White male 
chick model, the total alkaloid extract of comfrey root was more toxic than an 
approximately equivalent (to the total alkaloid content of the reduced comfrey extract) 
dose of either pure lycopsamine or pure intermedine with respect to clinical, serum 
biochemical, tissue “pyrrole” accumulation and histopathological comparisons.  This 
work suggests a greater than additive effect of the individual major components of the 
reduced comfrey extract and/or a more potent toxicity of the acetylated derivatives in the 
reduced comfrey extract. This may result in safety recommendations, based on selected 
purified compounds, underestimating the potential toxicity of comfrey-derived products. 
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CHAPTER V 
HETEROZYGOUS P53 KNOCKOUT MOUSE MODEL FOR 
DEHYDROPYRROLIZIDINE ALKALOID INDUCED CARCINOGENESIS
1
 
 
Abstract 
 
Dehydropyrrolizidine alkaloids (DHPA) are a large, structurally diverse group of 
plant-derived protoxins that are potentially carcinogenic. With worldwide significance, 
these alkaloids can contaminate or be naturally present in the human food supply. To 
develop a small animal model that may be used to compare the carcinogenic potential of 
the various DHPAs, male heterozygous p53 knockout mice were administered a short-
term treatment of riddelliine 5, 15 or 45 mg kg
–1
 bodyweight day
–1
 by oral gavage for 14 
days, or dosed a long-term treatment of riddelliine 1 mg kg
–1
 bodyweight day
–1
 in 
pelleted feed for 12 months. Exposure to riddelliine increased the odds of tumor 
development in a dose-responsive manner (odds ratio 2.05 and Wald 95% confidence 
limits between 1.2 and 3.4). The most common neoplastic process was hepatic 
hemangiosarcoma, which is consistent with published lifetime rodent riddelliine 
carcinogenesis studies. Angiectasis (peliosis hepatis) and other previously unreported 
lesions were also identified. The results of this research demonstrate the utility of the 
                                                          
1
Brown, A. W., Stegelmeier, B. L., Colegate, S. M., Panter, K. E., Knoppel, E. L., & 
Hall, J. O. (2015). Heterozygous p53 knockout mouse model for dehydropyrrolizidine 
alkaloid‐induced carcinogenesis. Journal of Applied Toxicology. 
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heterozygous p53 knockout mouse model for further investigation of comparative 
carcinogenesis of structurally and toxicologically different DHPAs and their N-oxides.  
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Introduction 
 
 
The toxic pyrrolizidine alkaloids are a group of approximately 500 structural 
variants (Wiedenfeld et al., 2008) of monoesters, open chain diesters or macrocyclic 
diesters of the dehydropyrrolizidine alkaloid (DHPA) necine bases retronecine, 
heliotridine, and otonecine (Fig. 5-1A). The DHPAs and their co-occurring (usually the 
major components) N-oxides (Fig. 5-1A) are protoxins requiring activation in vivo by 
cytochrome P450 monooxygenases that result in hepatotoxicity (Campbell, 1956; 
Gilruth, 1904; Johnson et al., 1985; Vardiman, 1952), pneumotoxicity (Stalker & Hayes, 
2007), genotoxicity (Mei et al., 2004, 2005; Mei & Chen, 2007) and carcinogenicity 
(Allen et al., 1975; Schoental, 1975; Schoental & Cavanagh, 1972; Schoental et al., 
1970; Shumaker et al., 1976; Yuzo et al., 1977). In spite of the similarities in 
metabolism, and toxic responses, the National Toxicology Program (a branch of the US 
National Institutes of Health) has labeled only one DHPA, riddelliine, as reasonably 
anticipated to be a human carcinogen (NTP, 2003). This is due, at least in part, to the 
high cost and long duration of conventional carcinogenicity studies and the availability of 
sufficient amounts of pure DHPA for such studies. In this latter regard, riddelliine is one 
of the few DHPAs that can be purified relatively easily in large amounts (Adams et al., 
1942). To obtain sufficient evidence to list riddelliine as a potential human carcinogen, 
the National Toxicology Program assessed years of previous work and then conducted 
comprehensive animal studies using mice and rats.  In these studies, animals were dosed 
orally 5 days per week with riddelliine for 2 years (Chan et al. 2003; NTP, 2003). They 
determined that male and female F344 rats, and male B6C3F1 mice exposed orally to 
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riddelliine were at a significantly increased risk of developing hepatic hemangiosarcoma, 
and that female B6C3F1 mice similarly exposed were at an increased risk of developing 
hepatocellular adenoma/carcinoma (Chan et al., 2003; NTP, 2003).   
For a complete assessment of carcinogenic potential, approximately 950 DHPAs 
(including their N-oxides) would need to be evaluated. Because of the requirement for 
large quantities of purified DHPA, and the time and funding impositions, it is not feasible 
to test all of these compounds using the same animal model as in the National Toxicology 
Program study. Consequently, the objective of this project was to develop a small animal 
model that would require less of the pure alkaloid, less time and, hence, less funding to 
test the carcinogenic potential of DHPAs in a manner relevant to natural exposure in both 
humans and animals. 
The cellular tumor suppressor protein p53 critically regulates the cell cycle to 
reduce the potential for abnormal proliferation and consequent tumor development. 
Donehower (1996) showed that p53-deficient mice were more sensitive to carcinogens 
than normal mice, and that p53-deficient rodent bioassays might require fewer animals 
and less time to perform.  Subsequent studies have shown that heterozygous p53 
knockout mice have an advantage over p53 null mice in that they have a longer tumor-
free period, allowing sufficient time for carcinogen testing without excessive background 
spontaneous cancers (Venkatachalam et al., 2001). Therefore, it is hypothesized that p53 
knockout mice may provide the basis for a small animal carcinogenesis model that could 
be completed in less time. In some species, including mice, males tend to be more 
susceptible than females (Chan et al., 2003; Mattocks, 1986).  On this basis, a study was 
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initiated that represented two potential human exposure scenarios, i.e. a single short 
duration or intermittent exposure, and a long-term, low-dose continuous exposure to the 
suspected carcinogenic DHPA, riddelliine. 
 
Materials and Methods 
 
 
Animals 
Forty-nine, 3 week old, male heterozygous B6, 129-Trp53 mice were purchased 
from Taconic Farms Inc. (Germantown, NY, USA). Mice were raised to maturity (9 
weeks old) and randomly divided into treatment groups. Each group was housed in a 
group cage and had access to feed (Harlan – Rodent diet 8604) and water ad libitum. 
Rodent rooms were maintained at between 20 and 22 °C, with a range of 30–60% 
humidity and a light dark cycle of 12 h. This research was conducted with the approval of 
the Utah State University animal care and use committee (IACUC Protocol no. 1364). 
 
Chemicals 
Riddelliine was sourced from the Poisonous Plant Research Laboratory collection 
and originally extracted and purified from Senecio riddellii using the method described 
by Molyneux et al. (1991). Cognizant of the potential for riddelliine to form ring opening 
addition products with hydroxylic solvents (Colegate et al., 2015), the identity and purity 
(≈95%) were confirmed using high-pressure liquid chromatography-positive ion 
electrospray ionization (+esi) mass spectrometry (Fig. 5-1B), tandem mass spectrometry 
to reveal structural elements (Fig. 5-1C) and proton (1H) nuclear magnetic resonance 
spectroscopy to reveal the characteristic 1H spectrum (Fig. 5-1D). The total riddelliine 
173 
 
required for the study was approximately 400 mg, 270 mg of which was dissolved in 
100% ethanol at a concentration of 15 mg ml
–1
. The remaining 130 mg was used to make 
pellets for the 1 mg kg
–1
 pellet group. 
 
 
Figure 5-1. Some general structures of dehydropyrrolizidine alkaloids (A) a: retronecine 
base; b: heliotridine base; c: otonecine base; d: general N-oxide; e: monoester; f: open 
chain diester; g: macrocyclic diester; and the high-pressure liquid chromatography 
electrospray ionization mass spectrometry base ion chromatogram (B) and the tandem 
mass spectrometry of peak 1 (C) and the nuclear magnetic resonance spectrum (D) both 
consistent with riddelliine. 
 
Experimental Design 
After reaching maturity, mice were randomly divided into four groups of 10 and 
one group of nine, using a random number chart. Mice in three of the groups of 10 
received riddelliine 5, 15 or 45 mg kg
–1
 body weight (BW) day
–1
 (based upon the group 
A 
a b c 
d 
e 
f 
g 
B C 
D 
riddelliine 
Time (mins) m/z 
Chemical Shift 
350 
322 
320 
292 
274 
138 
120 
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mean weight at the commencement of dosing and after 1 week of dosing) for 14 days. 
Thus, a calculated daily dose was administered by oral gavage in two equal portions, each 
further diluted with water (0.5 ml), one in the morning and one in the afternoon. The 
other group of 10 mice served as a negative control receiving an equal volume of 100% 
ethanol in water. After the dosing period, the mice were maintained for another 52 weeks. 
The remaining group of nine mice was fed a weekly ration of riddelliine-spiked pellets to 
the equivalent of riddelliine 1 mg kg
–1
 BW day
–1
 for 12 months.   
Mice were monitored daily for deterioration in health and weighed weekly. Animals 
with grossly visible tumors or significant decline in health were killed with carbon 
dioxide and necropsied. All remaining animals were killed for post-mortem examination 
at 1 year after gavage treatment ended. Tissues (including brain, heart, lung, trachea, 
thyroid gland, esophagus, stomach, small intestine, cecum, colon, pancreas, liver, kidney, 
urinary bladder, spleen, testicles, epididymides, seminal vesicles, skeletal muscle, bone, 
bone marrow and any grossly observed masses) were collected from all animals in 10% 
neutral buffered formalin for histopathology. All tumors were diagnosed based on 
histomorphology of hematoxylin and eosin-stained sections. 
 
Pellet Preparation 
Pellets were made in batches lasting approximately 1 month each, adding riddelliine 
based on the average monthly weight of the mice in the group and the average daily feed 
consumption. Harlan – Rodent diet 8604 was ground using a Thomas-Willey Mill 
“Model #4” with a 1 mm screen. Riddelliine was mixed with the rodent diet using a 
Waring Laboratory variable speed blender. A small amount of water was sprayed on the 
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mixture, and pellets were made using a hammer type pellet machine (c. 1950) with an 
inside diameter of 3.5 cm.  The pellets were air dried at ambient temperature (≈22 °C), 
placed into a plastic bag, labeled and stored at –20 °C until used. 
 
Statistical Analysis 
 
Statistical analysis of average daily weight gain was completed using SAS 9.3 using 
a repeated measures general linear model.  Odds ratios for neoplasia were also calculated 
using SAS 9.3 with a linear regression model with logit transformation. 
 
Results 
 
During the period from commencement of dosing until 4 days after daily gavage 
ceased, i.e., study days 0–18, the groups receiving riddelliine 5, 15 and 45 mg kg–1 BW 
day
–1
 by gavage tended to lose weight in a dose-related manner. However, only the 45 
mg kg
–1
 group was significantly different (P < 0.001) compared to the control group, 
which, along with the spiked pellet, 1 mg kg
–1
 group, gained weight over this period. 
During the following 10 months, all groups gained weight at approximately the same 
rate. However, at about 10 months after the gavage period all groups receiving riddelliine 
began to lose weight (Table 5-1) although only the 45 mg kg
–1
 group was significantly 
different compared to the control (P < 0.001). 
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Table 5-1. Average Daily Weight Gain (g/day) in male heterozygous p53 knockout mice 
exposed to Riddelliine. 
a
 Mice in these four groups were treated by gavage for 14 days. 
b
 Mice in this group were fed riddelliine spiked pellets calculated to provide 1 mg/kg 
riddelliine per day, for the duration of the experiment. 
1,2,3 
Superscript numbers denote statistical significance at p = 0.05. 
 
 
Treatment (Day 0 to 18) 
Pre-clinical (Day 18 – 
320) Clinical (Day 320 – 382) 
Control
a
 0.033
1,2
 0.043
 1
 0.028
 1
 
5 mg/kg
a
 -0.009
2
 0.049
 1
 -0.063
 1
 
15 mg/kg
a
 -0.036
2,3
 0.044
 1
 -0.005
 1
 
45 mg/kg
a
 -0.131
3
 0.042
 1
 -0.238
 2
 
1 mg/kg
b
 0.121
1
 0.048
1
 -0.014
1
 
 
The odds of having a tumor increase with dose in all individually gavaged animals 
(riddelliine 5, 15 and 45 mg kg
–1
 BW groups) compared to the vehicle-gavaged controls, 
with an odds ratio of 2.05 and Wald 95% confidence limits between 1.2 and 3.4 (Table 5-
2). For the 1 mg kg
–1
 group, treatment was associated with a significantly higher 
prevalence of neoplasia with a P = 0.0006 using the chi-squared test. The likelihood of a 
neoplasm being large enough to be grossly recognized also appears to increase at the 
higher doses (Table 5-2).  Similarly, it appears that the likelihood of observing an 
indicative lesion in the location where a neoplasm was detected histologically also 
increased at higher doses. However, the small group size precluded a statistical 
confirmation of these observations. 
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Table 5-2. Neoplasms present in male heterozygous p53 knockout mice exposed to 
riddelliine, arranged by treatment group. 
a
 Mice in these four groups were treated by gavage for 14 days. 
b
 Mice in this group were fed riddelliine spiked pellets calculated to provide 1 mg/kg 
riddelliine per day, for the duration of the experiment. 
n/d
 None detected 
 
 Control 5 mg/kg
a
 15 mg/kg
a
 45 mg/kg
a
 1 mg/kg
b
 
Hemangiosarcoma n/d 1 1 2 5 
Carcinoma, Mammary n/d n/d 1 2 1 
Lymphoma n/d 1 1 n/d 2 
Myeloproliferative Disease n/d 1 1 n/d 2 
Ependymoma, Malignant n/d n/d n/d 3 n/d 
Bronchiolo-alveolar Adenoma 
/ Carcinoma 
n/d 2 n/d n/d n/d 
Osteosarcoma n/d 1 1 n/d n/d 
Adrenocortical Carcinoma n/d n/d 1 n/d n/d 
Epithelial Stromal Tumor n/d n/d n/d 1 n/d 
Histiocytic Sarcoma n/d n/d n/d 1 n/d 
Lacrimal Gland Adenoma n/d n/d n/d 1 n/d 
Leydig Cell Tumor n/d 1 n/d n/d n/d 
Round Cell Tumor  1 n/d n/d n/d n/d 
Total Neoplasms 1 7 6 10 10 
Grossly observed lesions in 
locations with neoplasms 
1 3 3 8 8 
Grossly observed neoplasms 1 1 3 4 6 
Total Animals with Neoplasms 1 5 5 8 8 
 
The number and type of neoplasms observed in each group were organized by 
prevalence (Table 5-2). Because of the indefinable potential for metastasis, when 
multiple foci of the same neoplasm were present within one animal, only one neoplasm 
was counted. In the control group, only one animal had a neoplasm, which was a round 
cell tumor of either lymphocytic or histiocytic origin.  
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 Summed across all the groups, the most common lesions were hepatic vascular 
lesions, and the most common neoplasm was hemangiosarcoma (Fig. 5-2). The latter was 
present in all groups except for the control. Seven of the nine hemangiosarcomas  
observed throughout all the groups were intrahepatic, one was splenic and one was in 
subcutaneous tissue of the right rear leg. Two hepatic hemangiosarcomas were present in 
the 5 mg kg
–1
 group, one was present in the 45 mg kg
–1
 group and four were present in 
the 1 mg kg
–1
 pellet group.  The three hepatic hemangiosarcomas in the short exposure 
groups had one focus observed in each animal. In the 1 mg kg
–1
 pellet group, there were 
21 foci of hepatic hemangiosarcoma observed in eight different liver lobes (separate 
lobes within the same animal or different animals). There was no case where an animal 
had both intrahepatic and extrahepatic hemangiosarcoma. 
 
 
Figure 5-2. Hemangiosarcoma, liver, heterozygous p53 knockout mouse exposed to 1 mg/kg 
riddelliine for 1 year.  Neoplastic endothelial cells form variably sized vascular channels and 
wrap collagen.  Hematoxylin and eosin (HE). 
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Non-neoplastic, hepatic vascular lesions were present and particularly common in 
the 1 mg kg
–1
 continual exposure group.  Variably sized foci of endothelial-lined, blood-
filled spaces (peliosis hepatis) were present (one animal with one focus each in the 5 and 
15 mg kg
–1
 limited exposure groups and eight of nine animals with a total 46 foci in the 
continual 1 mg kg
–1
 exposure group). Endothelial cells lining these lesions were often 
hyperplastic or dysplastic, and with occasional mitotic figures present (Fig. 5-3). In few 
instances, endothelial cells tended to pile up on each other (Fig. 5-4). 
   There were four cases each of mammary carcinoma, lymphoma, and 
myeloproliferative disease. The mammary carcinomas were observed in one animal in the 
15 mg kg
–1
 group, two animals in the 45 mg kg
–1
 group and one animal in the 1mg kg
–1
 
continuous exposure group. The incidences of lymphoma and myeloproliferative disease 
were the same with one case each in both the 5 and 15 mg kg
–1
 limited exposure groups 
and two cases in the 1 mg kg
–1
 continual exposure group.  
 
Figure 5-3. Angiectasis (peliosis hepatis), liver,  heterozygous p53 knockout mouse exposed to 
1 mg kg–1 riddelliine for 1 year. Hematoxylin and eosin, 100x magnification. There are 
multifocal dilated, blood-filled, spaces lined with hypertrophic endothelial cells. 
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Three malignant ependymomas (Fig. 5-5) were present, all in the 45 mg kg
–1
 limited 
exposure group. All were located near a ventricle in the cerebrum and were composed of 
proliferative polygonal cells forming abundant rosettes and pseudorosettes.  These 
ependymomas invaded surrounding neuropil, had a high mitotic rate and included 
multifocal areas of necrosis. In one case, there was invasion through the cribriform plate 
and into the nasal turbinates. 
Multiple neoplasms of lower incidence were also present. Two bronchioloalveolar 
tumors were present, both within the 5 mg kg
–1
 group. One was an adenoma and the other 
was a carcinoma (Fig. 5-6). Two osteosarcomas were also present, one in the 5 mg kg
–1
 
group and the other in the 15 mg kg
–1
 group.  The remaining neoplasms observed, i.e., 
adrenocortical carcinoma, epithelial stromal tumor (in the seminal vesicle), histiocytic  
 
Figure 5-4. Angiectasis (peliosis hepatis), liver, heterozygous p53 knockout mouse exposed to 
1 mg kg–1 riddelliine for 1 year. Hematoxylin and eosin, 400x magnification. Multifocally 
endothelial cells are piled up (*). There are occasional karyomegalic cells (arrowhead). 
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sarcoma (in the urethra, urinary bladder, and seminal vesicle), lacrimal gland adenoma, 
Leydig cell tumor and a round cell tumor that was most likely of histiocytic origin (in 
fibrovascular tissue likely lymph node), all occurred only once. 
 
Figure 5-6. Bronchiolo-alveolar carcinoma, lung, heterozygous p53 knockout mouse exposed to 
5 mg kg–1 riddelliine for 14 days. A single bronchiole remains (*), while the remaining 
pulmonary parenchyma is replaced by neoplastic polygonal epithelial cells. Hematoxylin and 
eosin, 100x magnification. 
 
Figure 5-5. Malignant ependymoma, cerebrum, heterozygous p53 knockout mouse exposed to 
45 mg kg–1 riddelliine for 14 days. Note rosette (*) and pseudorosette (arrowhead) formation 
along with high mitotic rate.  Hematoxylin and eosin, 100x magnification. 
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Figure 5-7.  Osseous metaplasia, liver, heterozygous p53 knockout mouse exposed to 45 mg kg–
1 riddelliine for 14 days. A focus of mature bone, including marrow, replaces pre-existing 
hepatocytes and mildly compresses adjacent hepatocytes. Hematoxylin and eosin, 200x 
magnification. 
A number of other intrahepatic changes were also present. Osseous metaplasia 
within the liver (Fig. 5-7) was limited to the 45mg kg
–1
 group with 18 foci throughout all 
animals in this group. Lesions unrelated to treatment were also present, including 
inflammatory foci and hepatocellular vesicular changes, generally of minimal to mild 
severity. They were present throughout all groups, including controls, with no significant 
differences between any groups. 
 
 
Discussion 
 
It is well known that at least some DHPAs are carcinogenic in various species of 
animals (Allen et al., 1975; Hirono et al., 1978; Johnson et al., 1978; Kuhara et al., 1980; 
Li et al., 2011; Mattocks & Cabral, 1982; NTP, 2003; Shumaker et al., 1976). 
Determining the relative carcinogenicity of the several hundred DHPAs is difficult due 
primarily to the availability of sufficient quantities of DHPAs to conduct such 
experiments and the cost in time and money to conduct the experiments. This present 
study, preliminary portions of which were presented at the 9th International Symposium 
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on Poisonous Plants, was focused on observing any clinical reactions and describing 
gross and histologic lesions in a small rodent model of DHPA-induced carcinogenesis 
that requires less time and less DHPA. The combination of lower overall DHPA 
requirements and a lesser duration of animal exposure and/or post-treatment maintenance 
time may enable more such studies within time and funding constraints. 
Two different dosing strategies, based upon potential human exposures to the 
DHPAs in the diet, as dietary supplements or as medicinal herbs, were examined. The 
short duration (2 week) exposure to riddelliine (5, 15 and 45 mg kg
–1
 BW day
–1
) was 
intended to represent “one-of” or intermittent exposure episodes such as very occasional 
use of a DHPA containing dietary supplement or occasional ingestion of a food, such as 
contaminated flour. The longer, 12-month duration exposure to riddelliine at 1 mg kg
–1
 
BW day
–1
 was targeted at continual users of DHPA containing products, including herbal 
products or specialty honeys produced exclusively from DHPA producing plants. In both 
cases animals received substantially less DHPA than in other models (Table 5-3) (Chan, 
Table 5-3. Comparison of dose and DHPA requirements using traditional long term 
models with mice or rats and using male heterozygous p53 knockout mice in the study 
design used in this study. 
 
Dose 
(mg/kg) Ave. body wt. (kg) 
No. doses / 
animal 
Alkaloid needed / 
animal (mg) 
B6C3F1 Mice 3 0.045 525 70.9 
Fischer Rats 1 0.450 525 236.3 
Male Heterozygous 
P53 Knockout Mice 45 0.045 14 28.4 
 
1 0.045 365 16.4 
 
184 
 
2001; NTP, 2003). 
Between study days 0 and 18, which included the 14 days of gavage treatment, 
there was a trend of weight loss for all animals gavaged with riddelliine, which was only 
significant at the highest dose (Table 5-1). For approximately 10 months following the 
completion of the daily exposure to riddelliine, all animals appeared clinically healthy 
although the animals that received 15 and 45 mg kg
–1
 BW day
–1
 always had a lower 
average BW having failed to regain the weight lost relative to the controls during the 
gavaging period. Around 10 months all of the groups that received riddelliine began to 
lose weight (Table 5-1). Over the following 2 months, it was evident that the overall 
health (specifically, individual animals with rough, unkempt hair coat and losing weight, 
as well as the presence of grossly visible neoplasms) of all treatment groups was 
declining resulting in a decision to kill them.   
At post-mortem examination, grossly visible tumors included four of the nine 
hemangiosarcomas (one in the 45 mg kg
–1
 group and three in the 1 mg kg
–1
 group), all 
four of the mammary tumors, two of the four lymphomas (both in the 1 mg kg
–1
 group), 
both osteosarcomas, and the adrenocortical carcinoma, histiocytic sarcoma and round cell 
tumor likely of histiocytic origin.   
Compared to the controls, and in the absence of major clinical signs of toxicity until 
10 months into the study, the incidence of neoplastic disease increased on exposure to 
riddelliine regardless of whether that exposure was of higher dose (5, 15 or 45 mg kg
–1
 
day
–1
) and relatively short duration or low-dose (1 mg kg
–1
 day
–1
) with a prolonged 
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duration. Furthermore, even at the lowest total dose of riddelliine used in this study (5 mg 
kg
–1
 BW day
–1
 for 14 days), the risk of tumor development significantly increased.   
Low-dose chronic exposure (1 mg kg
–1
 group) resulted in a high incidence of 
hepatic hemangiosarcomas similar to previous studies in which animals were also 
exposed to low-doses over a long period of time (Chan et al., 2003; NTP, 2003). 
Furthermore, in light of the fact that there were 21 foci of hepatic hemangiosarcomas in 
the 1 mg kg
–1
 group compared to three foci in all of the short duration groups combined, 
either the hepatic hemangiosarcomas developed in this group were more prone to 
metastasis, or there were substantially more de novo hepatic hemangiosarcomas in this 
group. Given that there were eight separate lobes of liver (separate lobes within the same 
animal or different animals) involved, it appears that at least a portion of these 
hemangiosarcomas were derived de novo. Further studies using a similar low-dose and 
chronic exposure, and including other DHPAs, would be valuable in determining the 
relevance of this finding to DHPA carcinogenesis. 
The short duration exposures (5, 15 and 45 mg riddelliine kg
–1
 BW day
–1
) appeared 
to result in a wider range of neoplasms in extrahepatic tissues compared to the long-term, 
low-dose (1mg riddelliine kg
–1
 BW day
–1
) exposure regimen. While it is evident that, for 
whatever reason, specific DHPAs can cause either hepatic or pneumotoxic effects 
(Pessoa et al., 2013; Stalker & Hayes, 2007), it is also reasonable to expect that an 
increased concentration of systemic DHPA, unchanged by hepatic metabolism, may 
result if the exposure dose is increased. Metabolized by P450 enzymes found in 
extrahepatic tissues, these systemic DHPAs can lead to in situ extrahepatic damage. This 
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may account for a wider variety of tissues developing neoplasia in animals in the limited 
exposure groups in this study. Studies using different routes of DHPA exposure often 
resulted in tumors in extrahepatic locations, such as subcutaneous injection resulting in 
rhabdomyosarcomas (Allen et al., 1975). Alternatively, it is also possible that any one of 
the reactive compounds from the DHPA metabolic cascade (Edgar et al., 2011), 
including perhaps a release of adducted metabolites, could escape the liver and 
subsequently cause damage in distant tissues. 
Angiectasis (peliosis hepatis) is thought to be the result of loss or weakening of 
sinusoidal walls and/or supporting tissue (Thoolen et al., 2010). The presence of peliosis 
hepatis has been mentioned in one other report in relation to DHPA exposure in mice 
(Ruebner et al., 1970). In that case, the lesions were not endothelial-lined and were 
presumed to be due to hepatocellular necrosis. In this study, all the lesions are lined with 
endothelial cells that commonly round up, and protrude into the vascular lumen and 
occasionally exhibit dysplastic changes. They are not associated with fibrotic central 
veins or other discernible vascular lesions that would result in increased pressure within 
the sinusoids.  Foci of angiectasis are more common in the low-dose chronic exposure (1 
mg kg
–1
 pellet) group. DHPA-DNA adducts have been shown to have a predilection to 
hepatic endothelial cells (Chou et al., 2004). It is therefore plausible that DHPA-induced 
endothelial injury can result in angiectasis, and that further exposure to DHPAs could 
increase the chance of a neoplastic change in that endothelium resulting in 
hemangiosarcoma. 
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Osseous metaplasia of the liver also indicates previous damage to hepatic tissue. In 
this study, foci of osseous metaplasia were found exclusively in the highest short duration 
dose (45 mg kg
–1
) group, with six of ten animals having at least one focus.  It has not 
been a feature described in other studies. 
The purpose of this study was to determine the effectiveness of this p53 knockout 
mouse model using both long- and short-term exposures to study the carcinogenic 
potential of DHPAs. The results of the chronic exposure group are very similar to 
previous reports of low-dose chronic exposure to DHPAs (Chan et al., 2003; NTP, 2003). 
Hemangiosarcoma as well as leukemia have been reported in association with chronic 
riddelliine exposure. Although there are many studies relating to the carcinogenicity of 
DHPAs, due to the wide variation of methodologies, none is truly comparable to the 
short-term exposure model used in this study. Therefore, it is difficult to determine if 
previously unreported lesions, such as malignant ependymoma or osseous metaplasia, are 
relevant to human exposure or if they are exclusive to this more sensitive model. 
 
Conclusion 
 
This preliminary study clearly demonstrated the positive potential of the male 
heterozygous p53 knockout mouse model for making comparative assessments of the 
carcinogenicity of DHPAs. When treated with the macrocyclic DHPA riddelliine, either 
by daily gavage for 14 days or by continuous, lower concentration dietary exposure, all 
the treatment groups showed an increased incidence of neoplasia within 12 months. The 
shorter time required for tumor development, by virtue of the reduced expression by the 
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p53 gene, leads directly to lower resource requirements to conduct comparative 
assessments of the carcinogenic potential of the many different DHPAs. 
The dosage regimens tested were designed to approximate the pattern, if not the 
actual exposure types, of two human exposure scenarios, i.e., a low-dose, long-term 
continuous exposure and a short duration exposure, as might be expected from regular or 
intermittent use, respectively, of a DHPA containing food, dietary supplement or 
medicinal herb. Interestingly, though the type and distribution of the neoplasms differed 
between dose groups, it was found that all riddelliine exposure rates in this study 
increased the incidence of neoplasia. This suggests DHPA exposure, regardless of the 
dose, may be a greater carcinogenic risk than previously assessed. This observation 
supports the very low limits of exposure to DHPAs in general that have been set by 
European and UK authorities based upon the “single molecular event” potential for 
genotoxic carcinogenicity. 
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CHAPTER VI 
CONCLUSIONS 
 
 
DHPAs pose a risk to both humans and animals, and the extent of this risk is 
currently not completely understood.  Grazing animals consume DHPA containing plants, 
particularly when other forage is not available.  Penned animals, most prominently swine, 
and chickens can be exposed from contaminated feeds when plants or seeds are co-
harvested with forage crops or grains.  
Human exposure is often difficult to quantify.  Major outbreaks have occurred as a 
result of grain contamination, typically in underdeveloped countries (Bras, et al. 1954; 
Mayer and Lüthy 1993; Mohabbat, et al. 1976).  Such outbreaks result in overt symptoms 
of acute toxicity, and consequently the cause and results are therefore relatively 
straightforward.  Other human exposure results from secondary exposure to DHPAs 
found as contaminants in foods such as honey, pollen, or milk.  This is compounded by 
intentional intake of certain DHPA containing medicinal herbs.   
The consequences of low/intermittent dose, chronic exposure to humans are 
unknown.  It has been suggested they increased risk of chronic illnesses such as 
pulmonary hypertension (Gyorik and Stricker 2009), hepatic cirrhosis, or cancer (Edgar, 
et al. 2014).  The risk for DHPA-induced neoplasia in humans is uncertain, although they 
are genotoxic and carcinogenic in other species. 
It is clear that not all DHPAs are of equal potency with respect to acute toxicity.  
Because the mechanism for other chronic diseases such as cancer, is thought to be the 
same as for acute toxicity, it has been purposed that extrapolation of LD50 data might be 
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an appropriate method of risk evaluation.  Because the majority of LD50 data were 
obtained using a single IP injection in a rat model it may not reflect most natural 
exposures.  Oral exposure have been shown to have very different toxicity, especially for 
DHPA n-oxides.  It is imperative that the data are compared to a more biologically 
relevant model (oral exposure model).  
Using a sensitive (male, California White chick) model seven purified DHPAs and 
three DHPA N-oxides comprising different structural classes, were tested.  The results of 
this research are vitally important because multiple structurally different DHPAs were 
compared at biologically relevant doses and routes in the same model at the same molar 
doses.  In this model, heliotrine appears to be at least as toxic as retronecine based 
macrocyclic diesters and heliotridine based diesters, and much more toxic than expected 
based on previously published IP exposure studies.  The N-oxides used in this study were 
also more toxic than would be expected based on either IP exposure studies or cell based 
assays.  The retronecine based diester, echimidine, was unexpectedly less toxic than 
heliotrine, the heliotridine based monoester.  Lycopsamine was the least toxic of the 
compounds assessed in this study. 
We identified tissue DHPA metabolites or “pyrrole” adducts in the livers from 
chicks exposed to all of the compounds.  The adduct accumulation rate can be used as a 
toxicity indicator. The “pyrrole” accumulation rate was much higher in riddelliine 
exposed chicks than in any other group, as riddelliine is one of the few pure DHPAs that 
has been proven to be carcinogenic in several animal models, this may be biologically 
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relevant with respect to carcinogenicity.  Future research on the relative carcinogenicity 
of structurally diverse DHPAs would be valuable. 
Extrahepatic lesions present in the highest dose of lasiocarpine exposed animals, in 
combination with results from other studies suggest that excreted conjugated pyrroles 
may be unstable in the intestine and may cause damage post excretion for some DHPAs.  
This adds credence to the concern with consumption of tissues such as liver from animals 
that have been exposed to DHPAs, and this potential instability should be evaluated in 
future studies.   
Using oral doses in the chick model and based on weight, survival, serum 
biochemistry, and histopathology the most toxic group included the heliotrine, 
senecionine, seneciphylline, and lasiocarpine.  The second group, of moderate toxicity, 
was composed of the three N-oxides (senecionine N-oxide, riddelliine N-oxide, and 
lasiocarpine N-oxide), which were more toxic than echimidine in virtually all parameters 
tested. Consistent with previous research, lycopsamine was the least toxic.  Based on the 
model used it appears that in general, oral toxicity follows fairly close to what would be 
expected from IP LD50 studies; however, based on the marked difference in toxicity of 
heliotrine, it appears that there could be substantial differences in specific alkaloids.  
Consequently, historical IP LD50 data may markedly misrepresent the true risk of some 
compounds. 
Results from in vitro assays using an immortalized chicken hepatocyte cell line 
were similar to those found in these chick toxicity studies (Field R 2013).  In both cases 
heliotrine was found to be similar in toxicity to the retronecine based macrocyclic 
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diesters senecionine and seneciphylline as well as the heliotridine based open chain 
diester, lasiocarpine.  There is one rather notable difference in which the present study 
excels.  In the in vitro work, the same three N-oxides were studied.  In that case they 
were found to be similar in toxicity to lycopsamine.  In this live chick model they were 
consistently more toxic than lycopsamine.  The difference is almost certainly due to 
microbial reduction of the N-oxides in the gastrointestinal tract, reducing the N-oxide to 
the free base form. 
The vast majority of DHPA containing plants contain a mixture of DHPAs in a 
variety of forms (free base, N-oxide, acetylated etc.) as well as other compounds.  If we 
are to use purified alkaloid toxicity studies to evaluate the risk posed by plants, we must 
presuppose that the toxicity of the plant will be equal to the sum of the toxic effects of the 
individual DHPAs found in that plant.   
 
 
Figure 6-1.  Structural diagrams of lycopsamine (A), intermedine (B), and Heliotrine (C) 
 
Comfrey (Symphytum officinale) was used to test this hypothesis.  The comfrey root 
extract used contained almost exclusively two DHPAs (lycopsamine and intermedine) 
and their acetylated derivatives.  Furthermore, these two DHPAs are stereoisomers at 
C13.  Heliotrine has a configuration around C13 similar to intermedine.  Thus an 
evaluation could also be made as to the relative importance of this structural 
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characteristic.  Using the same model as that used to test the purified individual DHPAs a 
three way comparison was made between purified lycopsamine and purified intermedine 
and a reduced crude comfrey root extract (containing lycopsamine, intermedine and trace 
amounts of their acetylated free bases).   
Based on serum biochemistry, tissue pyrrole concentration and histopathological 
analysis, the comfrey extract was more toxic than an approximately molar equivalent 
dose of either pure intermedine or pure lycopsamine.  Furthermore, the only potential 
difference between intermedine and lycopsamine was that lycopsamine tended to have a 
higher tissue pyrrole concentration than intermedine.   
Possible reasons for the increased toxicity of the comfrey extract when compared to 
the two pure DHPAs include:  a synergistic effect of the two alkaloids, a more potent 
toxicity of the acetylated forms, or effects from some other compound present in the 
extract.  If the acetylated forms are more toxic it could be due to increased absorption.  
Presumably the acetylated forms could/would be de-acetylated and then exert their toxic 
effects identically to the free base forms.  In reference to the third possibility, any 
compound present in the crude extract, which was undetected by HPLC, utilizing the 
same enzyme(s) for phase I or phase II metabolism, could alter the rate at which the 
DHPAs were bioactivated and/or conjugated.  Elucidation of the actual mechanism for 
increased toxicity of the crude comfrey extract will require further investigation. 
With respect to the carcinogenic risk of DHPAs, riddelliine has been more 
thoroughly investigated than any other DHPA.  Presumably the mechanism for toxicity is 
the same as the mechanism for carcinogenicity.  Consequently, it has been suggested that 
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LD50 data be used to estimate the risk of carcinogenicity by converting LD50s to 
riddelliine equivalents (Committee on Toxicity of Chemicals in Food 2008).  The risk of 
utilizing IP derived LD50 data has already been discussed.  Assuming the LD50 
information used is accurate, the carcinogenic potential of multiple DHPAs would need 
to be evaluated in order to determine the utility of this method.  Riddelliine is somewhat 
unique in that it is relatively easy to extract and isolate in large quantities, thus it has been 
the most thoroughly investigated.  In order to conduct carcinogenicity studies on other, 
more difficult to obtain DHPAs, a more sensitive model is needed.   
The male heterozygous p53 knockout mouse has been evaluated as a more sensitive 
model.  The study was designed such that it could not only be compared to previously 
conducted chronic dosing studies, but also that it could evaluate the risk of short-term or 
intermittent exposure such as could occur with contaminated food.  Multiple doses (5, 15 
and 45 mg kg
-1
 BW) were used and mice were exposed twice daily for two weeks.  For 
the chronic low-dose exposure mice were exposed to 1 mg kg
-1
 BW riddelliine mixed in 
pellets.  
The significant results of this study were two-fold.  First, the model behaved similar 
to those used in chronic dosing studies funded by the NTP (NTP 2003b), with the 
exception that this model required substantially less pure riddelliine.  Thus the 
heterozygous p53 knockout mouse has potential utility as a more sensitive model for 
investigating other DHPAs that are more difficult to obtain in pure form.  Secondly, there 
was a dose responsive increase in tumor incidence in those animals that were exposed to 
riddelliine for only two weeks.  This supports the very low acceptable intakes 
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recommended by multiple regulatory and food safety agencies (Committee on Toxicity of 
Chemicals in Food 2008; EFSA 2011; RIVM 2005; WHO 2011). 
Through this research, two new models for comparing toxicity and carcinogenicity 
of DHPAs have been introduced.  These two models were controlled for age, gender, and 
strain such that further comparisons can be made with more relevance.  In both the chick 
model for toxicity and the heterozygous p53 knockout mouse model for carcinogenicity, 
some findings were unexpected based on previous research.  In the toxicity model, 
heliotrine was found to be much more compared to other DHPAs than expected.  Using 
the carcinogenicity model the impact of low-dose prolonged exposure was more 
significant than may have been previously anticipated.  In both cases a body of research 
already existed, and conclusions with expectations were made.  Unfortunately, the 
existing research has been done with different routes, species/strains, ages, and genders 
of animals, making it very challenging to directly compare.  This emphasizes the need for 
further research using the same model. 
In an effort to explain differences in toxicity between DHPAs, much effort has been 
given to understanding the chemistry behind bioactivation (Mattocks 1986).  It is 
surprising that through all of the research that has been done, there is a relative paucity of 
understanding with respect to kinetics of the different compounds.  How much of the 
difference in toxicity is actually due to differences in absorption or some other 
biologically relevant, but unexplored factor?  This is particularly important with respect 
to biologically active metabolites.  Little, if any data are available with respect to how 
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long adducts are present in tissues such as liver.  Such information would be invaluable 
with respect to food safety. 
Comparing carcinogenicity studies in an effort to understand the relative 
carcinogenicity of different DHPAs is even more challenging than comparing acute 
toxicity studies.  Studies have been done with a wide variety of species/strains, routes of 
exposure, ages, genders, length of exposure, and time from exposure to euthanization.  In 
order to understand the relative carcinogenic potential of different DHPAs it is critical to 
control for all of these variables.  This p53 knockout mouse model allows for such 
comparisons, and a study using multiple structurally different DHPAs would be very 
beneficial to the current body of literature. 
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